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Chapter 1
General introduction
Edwin Cuppen
Department o f Cell Biology, Institute o f Cellular Signalling, University of Nijmegen, 
Adelbertusplein 1, 6525 EK Nijmegen, The Netherlands.
Processes like cell proliferation, differentiation, and metabolic control in multicellular 
organisms rely on the interpretation of external and internal stimuli in complex signaling 
networks. The response of a specific cell depends on the nature of the wiring and 
intertwining of different signal transduction pathways that transfer information to the 
proper subcellular site(s), and on the type of signals received. Therefore, it may come as no 
surprise that mechanisms that organize this complex network require tight regulation of the 
enzymes involved. Deregulation of these mechanisms may lead to improper cell 
functioning and oncogenesis (Hunter, 1997; Ninfa and Dixon, 1994). In the past few years, 
there has been enormous progress in our understanding of the molecular basis and 
pathobiology of different signaling disorders. A variety of oncoproteins and tumor 
suppressor proteins has been identified and most of these were found to be enzymes, that 
normally regulate mitogenic signaling or that are involved in determining cell morphology 
and motility. Key players like the protein tyrosine kinases (PTKs) were found to be proto­
oncogenes (Porter and Vaillancourt, 1998; Rodrigues and Park, 1994), and consequently, it 
has been assumed that the enzymes that antagonize PTK function, the protein tyrosine 
phosphatases (PTPs) may function as tumor suppressors. Next to signaling enzymes, also 
adapter and scaffold proteins and cytoskeletal components were identified, mainly as tumor 
suppressors or developmentally important proteins (Ben-Ze'ev, 1997; Hulsken et al., 1994; 
Tsukita et al., 1993). Instead of giving a comprehensive overview of all protein 
phosphorylation cascades I will focus here on a specific protein, PTP-BL, that has 
characteristics in common with both signaling enzymes and cell-structural proteins. PTP- 
BL is a member of the large family of protein tyrosine phosphatases (see Schaapveld et al., 
1997 and Zhang, 1998 for an extensive review) and has similarities to several known tumor 
suppressors. Therefore it may play a role in regulating cell growth and differentiation.
1.1 PTP-BL
Gene sequences that are central to the work described in this thesis were initially cloned 
from mouse brain using degenerate primers that were based upon the highly conserved 
catalytic domain of known PTPs (Hendriks et al., 1995). Characterization of the novel 8 kb 
transcript revealed a large open reading frame encoding a protein with a predicted
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molecular weight of 270 kDa. Because of its high overall homology with human PTP-BAS 
(Maekawa et al., 1994), this mouse protein was named PTP-BL, for PTP-BAS-like 
(Hendriks et al., 1995). PTP-BAS was identified as an alternatively spliced transcript from 
differentiated human basophils (Maekawa et al., 1994) and has also been named hPTP1E 
(Banville et al., 1994), PTPL1 (Saras et al., 1994) and FAP-1 (Sato et al., 1995), whereas 
PTP-BL is also known as RIP (Chida et al., 1995). The gene encoding PTP-BL was 
mapped to mouse chromosome 5E/F, and the human orthologue PTP-BAS is located on 
human chromosome region 4 at band q21.3 (Inazawa et al., 1996; van den Maagdenberg et 
al., 1996). This region of the genome is believed to contain putative tumor suppressor genes 
of relevance to several types of human cancers, including liver and ovarian cancers. 
Expression analysis using RNA in situ hybridization experiments shows a predominantly 
epithelial expression pattern for the PTP-BL transcript and characterization of the predicted 
polypeptide reveals that PTP-BL harbors several modular protein domains (Fig. 1; 
Hendriks et al., 1995). At the N-terminus, the protein contains a large domain that entails 
multiple consensus threonine, serine and tyrosine phosphorylation sites and is subject to 
extensive alternative splicing (Chida et al., 1995; E.C. unpublished observations). Since no 
obvious homology to known proteins or protein domains is apparent the function for this 
domain in PTP-BL remains completely elusive. The remaining 200 kDa of PTP-BL 
consists of a FERM domain, five PDZ motifs and finally the catalytic domain which 
distinguishes the molecule as a member of the family of protein tyrosine phosphatases. In 
the human homologue PTP-BAS/PTPL1/hPTP1E/FAP-1 a potential leucine zipper that 
may be involved in homo- or hetero-dimerzation can be discerned just N-terminal of the 
FERM domain (Saras et al., 1994). However, in mouse PTP-BL several critical residues 
within this motif are lacking, making a simple role in protein association unlikely. The 
general characteristics of the FERM, PDZ and tyrosine phosphatase domains in PTP-BL, as 
well as their homology to similar domains in other cytoarchitectural and signaling 
molecules (Fig. 1) will be discussed in the following sections.
1.2 FERM domain
The FERM domain, that is also known as band 4.1-like domain, is a motif of about 300 
amino acid residues originally identified in the protein band 4.1 that was isolated from 
human erythrocyte ghosts (Leto and Marchesi, 1984). The FERM domain of band 4.1 has 
been reported to bind in vitro ATP, phosphatidylinositol 4,5-biphosphate, and 
phosphatidylserine. It also binds to soluble proteins like calmodulin and p55. Furthermore, 
the FERM domain mediates the attachment of protein 4.1 to the plasma membrane by 
binding to the cytoplasmic domains of the transmembrane proteins glycophorin A, 
glycophorin C, band 3 and CD44 (for references see Chishti et al., 1998). Next to the N- 
terminal FERM domain, the band 4.1 protein contains a C-terminal actin-binding domain 
and is therefore thought to function as an important cross-linker between the plasma
11
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>
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merlin/schwannomin 
Expanded
Figure 1: Schematic representation of PTP-BL and its homology to tumor suppressors.
Several modular protein domains with homology to known tumor suppressors can be discerned in 
PTP-BL. The C-terminal catalytic protein tyrosine phosphatase domain, that may counteract 
oncogenic tyrosine kinase activity, shows homology to the tumor suppressor and multi-specificity 
phosphatase PTEN. In the middle part of the protein five PDZ motifs are located, that are also found 
in the Drosophila d iscs-large  tumor suppressor gene product, DlgA. The FERM  domain is also found 
in the product of the neurofibromatosis type II (NF-2 ) gene product merlin/schwannomin and the 
Drosophila tumor suppressor Expanded. The large N-terminal domain displays no overt homologies 
to currently known protein sequences. Stippled box, PTP domain; black oval, PDZ motif; diagonal 
striped box, FERM  domain; white box, putative leucine zipper; black box, SH3  domain; grey box, 
guanylate kinase domain; vertical striped box, tensin homology domain.
membranes and the actin cytoskeleton in red blood cells (Tsukita and Yonemura, 1997). 
Indeed, band 4.1 protein has been shown to be essential for maintaining the stability of the 
erythrocyte membrane and mutations in this protein are associated with human diseases 
causing forms of hereditary elliptocytosis (Conboy, 1993).
The FERM domain has now been identified in a large group of proteins that may function 
in the linkage of the cytoskeleton to the plasma membrane (Chishti et al., 1998). Evidence 
supporting this role comes from occurrence of FERM domains in a subfamily of 
membrane-associated proteins termed ezrin, radixin and moesin (the ERMs; hence the term 
FERM from F for 4.1, E for ezrin, R for radixin and M for moesin). The ERMs function as 
molecular linkers that can bind cell-surface transmembrane proteins such as CD44, CD43, 
ICAM-1 and ICAM-2, and the actin cytoskeleton via their N-terminal FERM and C- 
terminal actin binding domains, respectively. In addition, the N- and C-terminal halves of 
ERMs can bind to each other, resulting in homotypic and heterotypic head-to-tail oligomers 
(for review see Tsukita et al., 1997). Interestingly, FERM domains occur in multiple 
members of the family of protein tyrosine phosphatases, PTP-BAS/PTP1E/PTP- 
BL/RIP/PTPL1 (Banville et al., 1994; Chida et al., 1995; Hendriks et al., 1995; Maekawa et 
al., 1994; Saras et al., 1994), PTP-MEG (Gu et al., 1991), PTPH1 (Yang and Tonks, 1991), 
PTPD1 (Moller et al., 1994) and PTPD2/PEZ/PTP36 (Moller et al., 1994; Sawada et al., 
1994; Smith et al., 1995), but here their function remains largely unknown. A possible
12
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functional involvement o f  the FER M  domain in growth control and differentiation can be 
deduced from  its presence in the brain tumor suppressor neurofibromatosis 2 , N F-2 , 
(Rouleau et al., 1993; Trofatter et al., 1993) and in the D r o so p h ila  tumor suppressor 
expanded (Boedigheimer et al., 1993). Therefore, let us focus on the pathobiological 
significance o f these proteins first.
M erlin /S ch w a n n o m in
Neurofibromatosis type 2 (NF2) is a disorder that occurs w ith a frequency o f  1: 37000  and 
is characterized by the development o f tumors derived from  the central nervous system, like 
vestibular schwannomas, meningiomas, spinal schwannomas, ependymomas, and posterior 
lenticular opacities. The gene responsible for N F2 maps to the long arm o f chromosome 22 
and encodes a protein o f 595 amino acids called merlin (Trofatter et al., 1993) or 
schwannomin (Rouleau et al., 1993) that is about 50%  identical to the ERM s, w ith highest 
hom ology in  the N-terminal FER M  domain. Although merlin does not contain the C- 
terminal actin binding m otif as it is found in the ERM s, the protein localizes to cortical 
actin structures and is particularly enriched in membrane ruffles (G onzalez-Agosti et al.,
1996). Reduction o f merlin expression by antisense oligonucleotides reduces the adhesion 
and increases the proliferation o f Schwann-like cells (Huynh and Pulst, 1996). In contrast 
overexpression o f merlin inhibits growth o f fibroblasts (Lutchman and Rouleau, 1995) and 
rat schwannoma cells (Sherman et al., 1997), clearly demonstrating its tumor suppressive 
capacity. H om ozygous mutations at the mouse N F2 locus leads to embryonic failure 
immediately before gastrulation, indicating that merlin function is critical for normal 
differentiation at a very early stage in development (M cClatchey et al., 1997). M ice 
heterozygous for a mutation in N F2 develop a range o f highly metastatic tumors, this in 
contrast to the limited spectrum o f benign tumors associated with N F2 in humans 
(M cClatchey et al., 1998).
W hat is the molecular basis for merlin’ s tumor suppressive action and what is known about 
the role o f the FER M  domain therein? It has been demonstrated that the N-terminal h a lf o f 
merlin alone can inhibit growth and has an anti-Ras function, indicating that the FER M  
domain is essential for the expression o f tumor-suppressing activity (Tikoo et al., 1994). 
Furthermore, a recent study showed that 7 out o f  11 patients examined had a splicing 
abnormality that lead to absence o f exon sequences that encode the FER M  domain. 
Expression o f these mutant proteins in a fibroblast cell line resulted in decreased adhesion 
and detachment from  the substratum (K oga et al., 1998). Another report showed that the 
tumor suppressive action o f merlin also depends on the presence o f the C-terminal domain 
(encoded by exon 16) and m erlin’ s ability to form  inter- or intra-molecular interactions 
analogous as has been described for the ERM s (Sherman et al., 1997). These findings do 
not contradict, since for an inter- or intra-molecular interaction to occur both an intact 
FER M  domain and the presence o f the C-terminal binding domain are necessary. Finally, it
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has been observed that inactivating mutations do occur in in almost all exons (reviewed in 
Lutchman and Rouleau, 1996), suggesting that multiple determinants in merlin are 
important for its normal cellular function. Taken together, it can now be considered 
established that merlin may regulate membrane-cytoskeletal organization by inter- and 
intra-molecular interactions and thus forms a nodal factor in regulating cell growth and 
differentiation
E x p a n d e d
Genetic methods in D r o so p h ila  make it possible to identify negative regulators o f  cell 
proliferation by the overgrowth phenotype. The expanded gene (ex) was first identified by a 
spontaneous mutation that causes broad wings. Loss o f  function mutations in e x  affect cell 
differentiation and proliferation o f im aginal discs, w hich are composed o f  single epithelial 
layers, causing either hyperplasia or degeneration depending on the nature and 
developmental stage o f the disc (Boedigheim er et al., 1993). Interestingly, overgrowth is 
not caused by prolonging the growth period as for mutations in many other genes, but is 
due to an increased proliferation rate during development (Boedigheimer et al., 1997). 
Furthermore, overexpression o f e x  leads to the opposite phenotype; a decrease in final cell 
number in the w ing (Boedigheimer et al., 1997). The e x  gene product Expanded, that has a 
similar overall organization as merlin/schwannomin, is present in the apical domain o f the 
epithelial disc cells, overlapping precisely w ith the position o f phosphotyrosine-containing 
proteins and presumably adherens junctions. Similar to the situation for merlin, Expanded 
lacks the C-terminal conserved actin-binding site found in other E R M  proteins. This is 
consistent with data that suggest that Expanded does not function as a membrane- 
cytoskeletal linker in the w ay that E R M  proteins generally do, but rather is involved in 
regulating a signaling pathway controlling cell proliferation. First, the presence o f 
consensus SH3 binding sites in Expanded suggest that it functions in the recruitment or 
partitioning o f cytosolic signaling enzymes or adaptor proteins. Secondly, i f  the protein 
would have a role in cross-connecting membrane and cytoskeletal proteins and growth 
regulation one would expect the N - or C-terminal domain to have a dominant negative 
effect by competing with endogenous binding partners. This, in turn, could result in 
overgrowth o f imaginal discs, the similar phenotype as for loss o f function mutants. In 
contrast to this expectation, overexpression o f the N-terminal domain shows no phenotype 
and overexpression o f the isolated C-terminal domain results in reduced cell proliferation, 
similar as for overexpression o f the full-length Expanded protein (Boedigheimer et al.,
1997). Further experiments are thus needed to reveal the mode o f  action o f the FER M  
domain and clarify e x ’ s role in normal and abberant growth behaviour.
1.3 PDZ motifs
P D Z motifs, formerly known as G L G F repeats (Cho et al., 1992) or Discs-large
14
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Homologous Regions (DHRs) (Bryant et al., 1993), are small modular protein domains o f 
about 90 amino acids, that were first identified in the post-synaptic density protein P SD -95 
(Cho et al., 1992), the D r o so p h ila  d is c s-la r g e  tumor suppressor gene product D lg A  (Woods 
and Bryant, 1991), and the tight junction component Z O -1 (Itoh et al., 1993). Nowadays, 
P D Z motifs have been identified in a very heterogeneous group o f proteins in mammals, 
plants, yeast and bacteria (for review see Ponting et al., 1997). It is becom ing clear that 
P D Z motifs mediate protein-protein interactions (Fanning and Anderson, 1996; 
Ranganathan and Ross, 1997; Saras and Heldin, 1996) and can associate with 
transmembrane proteins (Sheng, 1996), cytoskeletal components (Xia et al., 1997) and 
signal transduction enzymes (Ranganathan and Ross, 1997). PDZ-containing proteins have 
been implicated in the clustering o f membrane proteins by binding to their C-terminal 
cytoplasm ic tails (Gomperts, 1996). They also participate in the formation o f 
submembranous protein networks (Fanning and Anderson, 1998) and function as scaffold 
proteins in organizing signal transduction pathways (reviewed in Tsunoda et al., 1998).
The crystal structure o f the third P D Z m otif from  human D lg  reveals a modular structure 
consisting o f a five-stranded antiparallel b-barrel flanked by three a-helices, that resembles 
the overall architecture as for the IR S -1 phosphotyrosine binding domain (PTB) (Morais 
Cabral et al., 1996). Another crystal structure, o f  the third P D Z m otif from  the synaptic 
protein P SD -95 , in com plex with its peptide ligand clearly illustrates the structural basis for 
C-terminal peptide recognition. A  prominent hydrophobic pocket recognizes the terminal 
carboxylate group o f the peptide and the selective recognition o f the consensus peptide 
(T/S-x-V-*) is mediated by specific side chain interactions v ia  an antiparallel b sheet with 
the b strand flanking the peptide-binding groove (Doyle et al., 1996). Although for several 
P D Z motifs a C-terminal consensus binding sequence has been deduced (Schepens et al., 
1997; Songyang et al., 1997; Stricker et al., 1997; W ang et al., 1998), other binding modes 
have also been observed. Firstly, heteromeric P D Z-PD Z interaction have been observed for 
nNOS with P SD -95 and a 1-syntrophin (Brenman et al., 1996) and homomeric PD Z-PD Z 
interactions have been observed for the m ulti-PDZ-containing protein IN A D  (Xu et al.,
1998). Interestingly, the P D Z motifs involved in these interactions are also able to 
recognize C-terminal peptides. For IN A D , the P D Z-PD Z interaction does not prevent C- 
terminal peptide recognition, suggesting the presence o f  different binding interfaces (Xu et 
al., 1998). Contrasting with this, however, a peptide that specifically binds the a 1- 
syntrophin P D Z m otif was found to compete w ith the P D Z-PD Z interaction with the nNOS 
P D Z motif, indicating binding to the same site (Gee et al., 1998). Secondly, P D Z motifs 
have also been found to recognize other internal protein sequences. For example, the third 
P D Z m otif in IN A D  binds an internal S -T -V  sequence in the TRP Ca2+-channel protein 
(Shieh and Zhu, 1996) and the P D Z m otif in A L P  associates w ith the second spectrin-like 
repeat in a-actinin-1 (X ia et al., 1997). Interestingly, the P D Z m otif from  syntrophin can
15
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bind a short C-terminal peptide sequence as w ell as a similar internal peptide that is 
conformationally restricted by an intramolecular disulfide bond (Gee et al., 1998). Clearly, 
P D Z motifs are now w ell recognized as modular protein-protein interaction modules, that 
may display different modes o f  binding, potentially mediated by multiple interfaces on the 
globular P D Z motif. The presence o f these motifs in a very heterogenous group o f proteins 
(Ponting et al., 1997) suggests a general function for P D Z motifs in macromolecular 
organization. Moreover, the ubiquitous nature o f P D Z domains in proteins with a 
(subcortical) membrane location can be o f indirect help to obtain a better understanding o f 
their general biological significance. What follow s is a brief description o f two illustrative 
examples o f P D Z domain-bearing proteins.
D is c s -la r g e
D iscs large (D lgA ) (Woods and Bryant, 1991) was the first member identified o f an 
increasingly important class o f  proteins called membrane-associated guanylate kinase 
homologues (M A G U K s), w hich are often concentrated at cell junctions and contain three 
P D Z domains, an SH3 , a H O O K  and a guanylate kinase (G U K) domain (Woods and 
Bryant, 1993). D lg A  is located at the cytoplasm ic face o f  septate junctions and is necessary 
for the formation o f these junctions and maintenance o f cell apico-basal polarity (W oods et 
al., 1996). D lg A  is also required at neuromusculair junctions and epithelial septate junctions 
for signaling events controlling synaptic vesicle release and cell proliferation, respectively 
(Budnik et al., 1996; W oods and Bryant, 1991). U sing deletion mutants, Hough et al. 
( 1997) convincingly demonstrated which o f the domains in D lg A  are important for these 
functions. They showed that the H O O K  domain is responsible for membrane targeting o f 
the protein, but that the first two P D Z motifs are essential for septate junction localization. 
This is perfectly in  line with the finding that these domains in  mouse D lg  bind to the 
membrane-associated proteins ezrin and protein 4.1 (Lue et al., 1996). P D Z 2 and P D Z 3 
were found to be required for growth regulation but not for epithelial structure, whereas the 
SH3 and H O O K  domain are essential for both functional aspects (Hough et al., 1997). Thus 
far, no obvious function for the G U K  domain, that lacks catalytic activity, has been found, 
although some data suggests that the G U K  domain may act as a negative regulator, 
inhibiting the function o f the rest o f  the protein in controlling cell proliferation (Hough et 
al., 1997).
In a D
Signal transduction in D r o so p h ila  photoreceptors involves several key steps: the absorption 
o f  a photon by the G  protein-coupled receptor rhodopsin; the activation o f rhodopsin o f a 
member o f the Gq class o f  heterotrimeric G  protein; and subsequent activation o f a 
phospholipase C  b (PLCb). Activation o f P L C b  ultimately triggers the opening o f cation 
channels, resulting in the depolarization o f the photoreceptor cell. The predominant divalent
16
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cation-permeability o f  the TRP class o f  light activated channels leads to a rapid influx o f 
C a2+ upon photoexcitation, which is the major signal for feedback regulation o f the 
signaling process. A n  eye-specific isoform  o f protein kinase C  (PK C) acts as the primary 
mediator o f  C a2+-dependent negative feedback regulation (reviewed in Ranganathan and 
Ross, 1997). IN AD , a multivalent adapter protein consisting o f five P D Z domains, is now 
recognized as the central player, that organizes this set o f  excitatory and regulatory visual 
transduction proteins into a single signaling com plex in D r o so p h ila  photoreceptor neurons. 
Evidence for the IN AD-driven formation o f a multiprotein com plex that organizes 
phototransduction signaling, began with the characterization o f a D r o so p h ila  mutatant, 
IN A D  (Inactivation no afterpotential D), that displays abnormal electrical responses in the 
retina (Shieh and Niemeyer, 1995). The mutant phenotype was found to be caused by a 
point mutation in the third P D Z m otif o f  IN AD , resulting in abolishment o f  interaction with 
the TRP Ca2+-channel (Shieh and Zhu, 1996). Subsequent work showed that IN A D  binds 
TRP, P K C  and P L C b  via its third, fourth and fifth P D Z motif, respectively (Tsunoda et al.,
1997), and recently it was demonstrated that also rhodopsin and another channel protein 
TR PL bind directly to IN A D  (Xu et al., 1998). In addition it was shown that P D Z motifs in 
IN A D  mediate homomultimerization o f the com plex (Xu et al., 1998). Taken together, 
IN A D  compartmentalizes all important components for photoreceptor signaling in a 
multiprotein complex, thereby allow ing efficient and specific signal transduction and a 
rapid feedback mechanism. The recent identification o f a putative human hom olog o f 
IN A D  (Philipp and Flockerzi, 1997) and the identification o f other exclusively m ulti-PDZ 
proteins, such as the seven PDZ-dom ain protein GRIP (glutamate-receptor-interacting 
protein; D ong et al., 1997) and the eleven P D Z protein M U P P 1 (multi P D Z containing 
protein-1; Ullm er et al., 1998), suggest a more general role for PDZ-containing proteins in 
organizing highly specialized signaling com plexes or ‘ signalosomes’ .
1.4 PTP domain
Protein tyrosine phosphorylation is a universal mechanism employed for the regulation o f 
diverse cellular processes such as proliferation, differentiation, motility, cell-cell 
interactions, metabolism, gene transcription, and the immune response (Hunter, 1996). The 
propagation and termination o f signaling events controlling these cellular processes are 
determined almost exclusively by the level o f  phosphorylation o f different proteins in a 
cell. Changes in the degree o f protein phosphorylation on a particular protein are regulated 
by tw o opposing enzyme activities: those catalyzed by the protein tyrosine kinases (PTKs), 
w hich covalently attach a phosphate group to a tyrosine residue within a protein, and the 
reverse activity o f  protein tyrosine phosphatases (PTPs). E ver since the discovery o f PTPs 
it has been assumed that they may function as anti-oncogene or tumor suppressor proteins 
(Goldsmith and K oizum i, 1997; Hunter, 1995). Initially, this contention has been 
strenghtened by the observation that treatment o f  cells w ith vanadate, a reasonably specific
17
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PTP-inhibitor, results in an increase o f phosphotyrosine-containing proteins and 
concomittantly in cellular transformation (Klarlund, 1985). Furthermore, overexpression o f 
one o f the earliest discovered PTP fam ily members, the cytoplasmic protein tyrosine 
phosphatase P T P 1B, in fibroblasts transformed by the n e u  oncogene significantly inhibited 
oncogenic transformation (Brown-Shimer et al., 1992). However, we now know that the 
initial conclusions drawn on basis o f  these results give a rather oversim plified picture o f  the 
true (patho)biological significance o f PTPs.
The PTP fam ily o f  proteins consist o f  receptor-like and non-transmembrane enzymes w hich 
share a high degree o f hom ology in their 230-280  amino acids-large catalytic domains. 
B iochem ical studies demonstrate that PTPs utilize a common mechanism for catalysis that 
involves the cysteine within the PTP signature m otif ([I/V]H CX AG X XR [S/T]G ) and a 
highly conserved aspartate. Crystal structure data reveal a very similar three-dimensional 
topology for different PTPs and have shed more light on the molecular basis o f  catalysis 
(for review see Barford et al., 1998). Regulation o f phosphatase activity and specificity o f  
ligand recognition is now believed to be mediated by the bewildering variety o f  protein 
domains that is present in PTPs, in addition to the catalytic domain (Fauman and Saper, 
1996; Mauro and Dixon, 1994; M ourey and Dixon, 1994).
During the past decade we have witnessed a continuous increase in the number o f known 
PTP-gene fam ily members, their gene structure and their chromosomal location. So the 
question is justified whether this has also brought us more insight in the presumed role o f 
this fam ily o f  proteins in control o f  cell growth and behaviour? The general answer is no, 
and we now realize that each PTP may have a fu lly distinct cellular role. Although for 
exam ple some PTPs have been mapped to chromosomal loci that are often deleted in 
specific types o f  tumors, or are able to counteract the transforming potential o f  oncogenic 
kinases in vitro (reviewed in Goldsmith and Koizum i, 1997), no specific PTP has been 
identified yet that behaves as a classical tumor suppressor in vivo. Recently, however, hope 
glimmered because a novel protein was identified, designated PTE N  for Phosphatase and 
Tensin homologue deleted on chromosome Ten. This protein contains the typical 
phosphatase signature and is mutated at a considerable frequency in a wide range o f human 
cancers (Li et al., 1997; Steck et al., 1997). Recombinant PTE N  has been shown to 
dephosphorylate protein and peptide substrates phosphorylated on serine, threonine, and 
tyrosine residues in vitro, suggesting that it is a dual specificity phosphatase (Myers et al.,
1997). Furthermore, PTE N  has been shown to down-regulate integrin-mediated cell 
spreading and the formation o f focal adhesions, and the protein was found to interact with 
the focal adhesion kinase F A K  and to reduce its tyrosine phosphorylation (Tamura et al.,
1998). However, to the surprise o f  many investigators, recent experiments indicated 
unequivocally, that PTE N  also displays phosphoinositide 3-phosphatase activity (Maehama 
and Dixon, 1998) and that the regulation o f PIP3 levels in vivo is critical for its tumor 
suppressive function (Hopkin, 1998; M yers et al., 1998). Moreover, a mutation that was
18
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found in two Cowden disease kindreds specifically ablates the ability of PTEN to recognize 
inositol phospholipids as a substrate, whereas its phosphatase activity was unaffected 
(Myers et al., 1998). From this, we can conclude that the quest for the first genuine PTP 
that acts as a tumor suppressor is still ongoing, and that one should also consider 
unanticipated substrates, like for example phospholipids, as possible targets for PTPs. 
Furthermore, since tyrosine phosphorylation plays an important regulatory role in a wide 
variety of cellular processes, normal PTP function may be involved in divergent processes 
like cell migration, cell morphology and immune response.
1.5 Scope and rationale of the work described in this thesis
The studies described in this thesis were aimed to obtain clues about the biological function 
of a specific protein tyrosine phosphatase, PTP-BL. Initially, most of our working 
hypotheses focussed on growth control regulation and subcellular compartmentalization as 
the protein contains many domains which also occur in tumor suppressor proteins. 
Therefore, important clues may be derived from a better understanding of the intracellular 
partitioning of the protein, and we used a combination of molecular and morphological 
approaches to follow PTP-BL’s dynamic behaviour in cells in vitro. In Chapter 2 the study 
of the subcellular localization of PTP-BL and the protein determinants that govern its 
distribution dynamics are presented. Shortly after starting the thesis research, a potential 
biological function for PTP-BL in Fas-mediated apoptotic signaling was reported (Sato et 
al., 1995). We followed up on this result, and in Chapter 3 we show that there is, however, 
no evidence for such function in the mouse system. Next, to obtain additional cues on PTP- 
BL’s biological function we started the characterization of the molecular environment of 
the molecule. Discovery of the nature and role of associating proteins in proteome networks 
often yields important clues for other protein components that act in the same network. We 
used yeast two-hybrid interaction cloning to identify proteins that can interact with PDZ 
motifs in PTP-BL. The same system was used to type the strength of the interactions and to 
delineate the actual protein domain segments involved. The identification of distinct protein 
partners, characterization of the observed interactions, and expression distribution studies 
of these proteins are presented in Chapters 4, 5, 6 and 7. In Chapter 8, a summary of 
converging results is given and a working model for PTP-BL function is proposed.
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Summary
PTP-BL is a cytosolic multidomain protein tyrosine phosphatase that shares 
homologies with several submembranous and tumor suppressor proteins. Here we 
show, by transient expression of modular protein domains of PTP-BL in epithelial 
MDCK cells, that presence of a FERM domain in the protein is both necessary and 
sufficient for its targeting to the apical side of epithelial cells. Furthermore, immuno- 
electron microscopy on stable expressing MDCK pools, that were obtained using an 
EGFP-based cell sorting protocol, revealed that FERM domain containing fusion 
proteins are enriched in villi and have a typical submembranous location at about 
10-15 nm from the plasma membrane. Immunofluorescence microscopy suggested 
colocalization of the FERM domain moiety with the membrane-cytoskeleton linker 
ezrin. However, at the electron microscopy level this colocalization can not be 
confirmed nor can we detect a direct interaction by immunoprecipitation assays. 
Fluorescence recovery after photobleaching (FRAP) experiments show that PTP-BL 
confinement is based on a dynamic steady state and that complete redistribution of 
the protein may occur within 20 minutes. Our observations suggest that relocation is 
mediated via a cytosolic pool, rather than by lateral movement. Finally, we show 
that PTP-BL phosphatase domains are involved in homotypic interactions, as 
demonstrated by yeast two-hybrid assays. Both the highly restricted subcellular 
compartmentalization and its specific associative properties may provide the 
appropriate conditions for regulating substrate specificity and catalytic activity of 
this member of the PTP family.
Introduction
Reversible phosphorylation of proteins on tyrosine residues is a key event in the regulation 
of various cellular processes, such as proliferation, differentiation, cell motility, cell-cell 
interactions, metabolism, gene transcription, and the immune response (Hunter, 1996). 
Proper initiation, propagation and termination of the signaling cascades involved are thus
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critically dependent on the mode o f action o f individual members o f  the large fam ilies o f 
protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) (Hunter, 1998; 
Ninfa and Dixon, 1994). It is now w ell established that receptor P T K s are activated by an 
intermolecular mechanism upon ligand-induced dimerization (Lemmon and Schlessinger,
1994). Cytoplasm ic PTK s, on the other hand, are activated by both intra- and 
intermolecular mechanisms (Thomas and Brugge, 1997). M uch less is known regarding the 
processes that antagonize the effects o f  P T K s or, for that matter, the functional activation o f 
PTPs. Recent data suggest that for PTPs similar mechanisms as for P T K s do exist 
(reviewed in W eiss and Schlessinger, 1998). For example, ligand-induced dimerization o f 
an epidermal growth factor-receptor-CD45 chimera was found to inhibit PTP activity and 
T C R  signaling (Majeti et al., 1998). The crystal structure o f the first membrane-proximal 
PTP domain o f the receptor-type R P T P a  gives structural support for a model in which 
enzym e inhibition is the consequence o f dimerization, by showing that the active site cleft 
in the subunits is blocked by protruding loops o f  the opposing domain (Bilwes et al., 1996). 
Structural data on the RPTPm membrane proximal PTP domain, however, show that this 
model might not be universally applicable (Hoffmann et al., 1997). A lso, for the cytosolic 
PTP SHP-2 , for example, it was shown that N-terminal SH2 domains are involved in 
blocking its catalytic site in an intramolecular interaction (H of et al., 1998).
Importantly, also targeting o f the enzyme to highly restricted subcellular m icro­
compartments may control PTP activity and substrate specificity. In this light, the existence 
o f  a variety o f  modular protein domains in cytosolic PTPs, that may function as ‘zip codes’ 
by directing the protein to the correct cellular ‘address’ (Mauro and Dixon, 1994), is 
intriguing. Candidate domains that may regulate activity and specificity are particularly 
abundant in the large cytosolic protein tyrosine phosphatase PTP-B L (Hendriks et al., 1995) 
or RIP (Chida et al., 1995), which is the mouse homologue o f human PTP- 
B A S/P T P L 1/PTP1E/FAP-1 (Banville et al., 1994; M aekawa et al., 1994; Saras et al., 1994; 
Sato et al., 1995). The approximately 250  kD a protein, that is expressed mainly in epithelia 
(Hendriks et al., 1995; Cuppen et al., 1998; Thomas et al., 1998), harbors a large N- 
terminal domain with no obvious hom ology to other proteins except for a potential leucine 
zipper (Saras et al., 1994), follow ed by a FE R M  domain, five P D Z motifs and a C-terminal 
PTP domain (see also F ig. 2). Outside its natural context, the P TP-B L phosphatase domain 
has a high rate o f  activity w ith a rather promiscuous substrate specificity (Cuppen et al., 
1998; Hendriks et al., 1995). For example, a P TP-B L phosphatase dom ain-GST fusion 
protein is able to completely eliminate the extensive phosphorylation o f endogenous 
proteins by the activated tyrosine kinase present in E .C o li  T K X -1 cells (E.C., unpublished 
observations). Obviously, a regulatory mechanism must be involved in im posing the proper 
restrictions on P T P -B L ’ s catalytic activity at endogenous sites. The modular domains, like 
the P D Z and FER M  motifs that are present in PTP-B L, may provide this function in vivo. 
P D Z motifs are small protein modules that mediate protein-protein interactions (Fanning
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and Anderson, 1996; Ranganathan and Ross, 1997; Saras and Heldin, 1996) and can 
associate with transmembrane proteins (Sheng, 1996), cytoskeletal components (Xia et al., 
1997) and signal transduction enzymes (Ranganathan and Ross, 1997). Indeed, several 
proteins that interact with PTP-BL PDZ motifs have been identified (Cuppen et al., 1998; 
Saras et al., 1997; E.C. submitted), but thus far no clues as to explain PTP-BL’s subcellular 
localization in vivo have been identified.
The FERM domain in PTP-BL is a segment commonly found in a family of peripheral 
membrane proteins that function as membrane-cytoskeleton linkers (Chishti et al., 1998). 
This family includes erythrocyte protein 4.1, ezrin, radixin and moesin, but also the tumor 
suppressors Expanded and merlin and the protein tyrosine phosphatases PTP-MEG, 
PTPH1, PTPD1 and CDEP. The FERM domain in erythrocyte protein 4.1 binds a wide 
variety of molecules including ATP, PIP2, phosphatidylserine, calmodulin, p55, 
glycophorin A, glycophorin C, Band 3 and CD44 (see Chishti et al., 1998 for references). 
Ezrin, radixin and moesin (ERMs) also function as molecular linkers that connect cell- 
surface transmembrane proteins to the actin cytoskeleton. The ERM subfamily members 
contain a C-terminal actin binding site and their N-terminal FERM domain associates with 
transmembrane molecules like CD44, CD43, ICAM-1 and ICAM-2 (Tsukita et al., 1997). 
Furthermore, the N-terminal FERM domain can associate with the C-terminal domain in an 
intra- or intermolecular manner. Intramolecular association would block the binding sites 
for transmembrane proteins and actin, and may be regulated via phosphorylation on 
tyrosine or threonine residues and by PIP2 levels (Tsukita et al., 1997). The role of FERM 
domains in PTPs remains largely unknown, although, recently the PTPD1 FERM domain 
was found to associate with KIF1C, a new kinesin-like protein on ER-Golgi-like structures. 
However, although KIF1C is phosphorylated on tyrosine residues the physiological 
relevance of this modification is as yet enigmatic (Dorner et al., 1998).
Here we show, using immunofluorescence and immunoelectron microscopy, that the 
FERM domain in PTP-BL is necessary and sufficient for targeting the protein to the apical 
side of the cell, where it localizes at a typical, fixed distance from the cell membrane. 
Furthermore, fluorescence recovery after photobleaching (FRAP) experiments using EGFP- 
tagged proteins in living cells show that PTP-BL localization is dynamic. Also, two-hybrid 
experiments suggest a homotypic interaction of the catalytic PTP-BL phosphatase domain. 
We suggest that subcellular targeting of PTP-BL to a highly restricted microcompartment 
within the cell, together with a dimerization-induced shift in activity, may be an important 
determinant in confining its specificity and activity.
Results
Necessity for cellular confinement of PTP-BL catalytic activity
The importance of regulation of PTP activity becomes evident when the catalytic domain of 
PTP-BL is expressed as an isolated moiety in COS-1 cells, separated from the rest of the
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molecule (as in construct BL-PTP, Fig. 2). Typical cellular protrusions are observed (Fig. 
1A), that are not found in cells expressing the full-length protein. To demonstrate that the 
observed morphological effect is indeed due to PTP-BL’s phosphatase activity only, a 
catalytically impaired mutant was constructed in which the critical aspartate residue is 
changed into an alanine (Flint et al., 1997). Introduction of the BL-PTP-DA mutant into 
COS-1 cells did not result in the typical protrusions as observed for the core PTP domain 
(Fig. 1B). Thus, PTP-BL sequences that precede the catalytic domain harbor regulatory 
potential that shield against dephosphorylating activity at ectopic sites.
The FERM domain in PTP-BL is sufficient for apical localization
The restricted localization of PTP-BL at the apical side of epithelia (Cuppen et al., 1998) 
suggests that subcellular targeting may contribute to the confinement of enzyme activity. 
To study the routing potential of PTP-BL’s modular protein domains, we transiently 
expressed either full-length or truncated PTP-BL proteins (schematically shown in Fig. 2) 
in the epithelial MDCK cell line. Expression of full-length PTP-BL resulted in an apical 
location of the protein (Fig. 3A), nicely in line with the endogenous apical localization in 
epithelia observed in vivo (Cuppen et al., 1998). No canine PTP-BL could be detected in 
the MDCK cells by our antiserum, which was generated against protein of mouse origin. 
Strikingly, PTP-BL is not distributed homogeneously at the apical membrane but is seen in 
a rather typical punctuate pattern, reminiscent of a villi-like localization (Fig. 3A).
Figure 1: Overexpression of PTP domain of PTP-BL induces morphological changes in COS-1 cells. 
COS-1 cells were transiently transfected with an expression construct encoding VSV-tagged wild­
type phosphatase domain of PTP-BL (A) or a catalytic mutant thereof (B). Expression of the tagged 
protein was detected using the monoclonal a-V SV  antibody. Expression of the wild-type PTP 
domain induces typical cellular protrusions that are not seen in transfectants carrying the catalytically 
impaired mutant. Bars, 10 mm.
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Figure 2: Overview of the PTP-BL expression constructs used.
Schematic representation of PTP-BL and the modular protein domains that can be discerned. 
Indicated are the protein segments, as they are produced in transient and stable (below dashed line) 
expression studies. In parentheses, the numbers corresponding to the first and last a.a. positions in the 
PTP-BL (Genbank accession Z32740) segment are shown. The gray and black box indicate the 
presence of an EGFP and VSV-G tag, respectively. Dashed box; FERM domain, black ovals; PDZ 
motifs, open box; PTP domain.
Next, we expressed VSV-G or EGFP epitope-tagged versions of the different modular 
domains of PTP-BL as shown in Fig. 2. When expressed as separate molecular entities, the 
N-terminus (Fig. 3B), the five PDZ motifs (Fig. 3D) and the PTP domain (Fig. 3E) are 
localized throughout the cytosol, whereas the FERM domain (Fig. 3C) shows the same 
apical punctuate localization as observed for full-length PTP-BL. The addition of flanking 
domains, i.e. the N-terminus (Fig. 3F) or the PDZ motifs (Fig. 3G), or the PDZ motifs and 
the catalytic PTP domain (Fig. 3H), does not alter this localization. These results clearly 
show that the FERM domain is both necessary and sufficient for the apical, villi-like 
localization of full-length PTP-BL. Expression of the FERM domain of human PTPD1 (a.a. 
1-339, Genbank accession 2493260), which is 49% homologous to the FERM domain in 
PTP-BL, reveals a completely different, diffuse cytosolic localization pattern (data not 
shown), illustrating target specificity among distinct FERM domains.
250 a.a
Generation of stable expressing MDCKpools
To study the subcellular localization of PTP-BL in more detail, we started immuno-electron 
microscopy studies. Unfortunately, our antibodies against PTP-BL appeared unsuitable for 
this technique, excluding the direct visualization of endogenous PTP-BL in cell lines or 
tissues. Therefore, we decided to make use of epitope-tagged PTP-BL, also because the 
previous experiment had ruled out any effect by the tag on the PTP-BL localization. To
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Figure 3: Apical targeting o f PTP-BL is mediated by the FERM domain.
Full length PTP-BL and truncated epitope-tagged modular protein domains (as shown in Fig. 2) were 
transiently expressed in MDCK cells and the subcellular localization was determined in confluent 
cultures by immunofluorescence assays and detection using confocal microscopy. The upper part of 
each panel represents merges o f 8 to 10 horizontal optical sections and the lower part shows a vertical 
section through the cell. Full length PTP-BL (A) localizes apically showing a typical punctuate 
pattern. The N-terminus (B), the protein segment encompassing the five PDZ motifs (D) and the 
catalytic domain (E) localize throughout the whole cytosol, whereas the FERM domain alone (C) 
shows a similar localization as full length PTP-BL. The presence o f flanking protein segments, like 
the N-terminus (F), the PDZ motifs (G) or PDZ motifs and PTP domain (H), next to the FERM 
domain, has no effect on the subcellular localization. Bar, 10 mm.
overcome both the consistently low transfection efficiencies for full-length PTP-BL and the 
loss of transient expression during the process of polarization, we set out to generate stable 
expressing cell lines. Conventional attempts to accomplish this goal, using different types 
of vectors and epithelial cell lines, failed for unknown reasons (E.C., Derick G. Wansink, 
unpublished observations). We therefore adapted to the use of EGFP-tagged fusion proteins 
and fluorescence activated cell sorting to enrich for expressing cells. Pools of stably 
transfected (G418 resistant) MDCK cells were analyzed using flow cytometry (Fig. 4A) 
and EGFP-fluorescent cells were separated and expanded prior to subjecting them to 
another round of cell sorting. Starting with a pool MDCK cells in which 25% of the cells
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showed detectable levels of wild-type EGFP, we obtained a mixed population consisting for 
99% of high expressors after the two rounds of sorting (Figs 4A and B). The same 
procedure was used to obtain pools of MDCK cells that either express EGFP-tagged 
versions of full-length PTP-BL (BL-FL-EGFP) or of the PTP-BL FERM domain (EGFP- 
BL-FERM) (schematically shown in Fig.2). For EGFP-BL-FERM, we could readily obtain 
a population in which about 80% of cells express the fusion protein after two rounds of 
sorting, starting with a pool consisting for 25% of positive cells (Figs 4A and B). It is of 
note that the average EGFP-mediated fluorescence is much lower for the EGFP-BL-FERM 
expressing cells than for those containing the wild-type EGFP (Fig. 4A). Analysis of total 
cell lysates of both pools on Western blot shows that the proper proteins are made but that 
expression level of EGFP-BL-FERM is significantly lower than that for the unfused EGFP 
(Fig. 4C). In the case of full-length PTP-BL fused to EGFP, the percentage of fluorescent 
positive cells in the unsorted pool is very low (0.4%) when compared to the pools 
expressing EGFP or EGFP-BL-FERM (25%) (Figs 4A and B). Clearly, BL-FL-EGFP 
positive cells can be distinguished using flow cytometry (Fig. 4A), but the very weak 
EGFP-mediated fluorescence in these cells was undetectable using (confocal) fluorescence 
microscopy. Nevertheless, we were able to increase the percentage of positive cells to about 
50% by using two rounds of sorting. The presence of the proper fusion protein was 
demonstrated by an immunofluorescence assay on fixed cells (not shown) and by Western 
blotting (Fig. 4C) using a polyclonal antiserum (a-GFP) recognizing the EGFP moiety in 
the fusion protein. Note that the lane containing BL-FL-EGFP required 10-fold longer 
exposure than the rest of the Western blot, illustrating that the expression of full-length 
PTP-BL is just at the threshold of detection. In retrospect, the very low percentage of 
positive cells in the pool of BL-FL-EGFP before sorting and the gradual loss of expression 
that was observed in the sorted pools (data not shown) provide an explanation for the 
failure to obtain stable cell lines expressing epitope-tagged PTP-BL using the more 
traditional approaches.
Subcellular localization of PTP-BL
Immunofluorescent monitoring of individual cells in the sorted MDCK pools show that the 
EGFP-tagged fusion proteins of BL-FL and the FERM domain have an identical subcellular 
localization, strongly resembling that of the untagged or VSV-tagged proteins (data not 
shown). Based on this observation we decided to use confluent, polarized cultures of the 
sorted MDCK pools for immuno-electron microscopy. The EGFP-tagged proteins were 
visualized in ultrathin cryosections using the rabbit polyclonal antiserum a-GFP and 10 nm 
gold-conjugated protein A. Interestingly, EGFP-BL-FERM specific label is almost uniquely 
found in the apical part of the cell (Fig. 5A), with an enrichment in villi-like protrusions 
(Fig. 5B). Some gold particles are found in the apical cytosolic region, but the majority is 
located regularly spaced at a fixed distance of about 10-15 nm from the apical membrane
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Figure 4: Analysis of MDCK pools stably expressing EGFP fusion proteins.
Flow-cytometric analysis of G418 resistant MDCK cells (A) transfected with expression constructs 
encoding wild type EGFP (second column), EGFP tagged FERM domain (EGFP-BL-FERM, third 
column) and EGFP tagged full-length PTP-BL (BL-FL-EGFP, fourth column), before sorting (first 
row), after one round of sorting and expansion (second row) and after two rounds of sorting and 
expansion (third row). As a control for the determination of endogenous fluorescence levels, 
untransfected M DCK cells were tested before each analysis (first column). The x-axis represents the 
fluorescence at 488 nm on a logarithmic scale in arbitrary units and on the y-axis the number of cells 
are indicated. The dotted lines indicate the fluorescence threshold for positive cells. (B) Numerical 
representation of the data shown in (A). After two rounds of sorting, pools of M DCK cells can be 
obtained, consisting of 99 % expressing cells for wild type EGFP and almost 80 and 50 % for EGFP- 
BL-FERM and BL-FL-EGFP, respectively. (C) Western blot analysis of the M DCK pools after two 
rounds of sorting. Expression of the proper EGFP fusion-protein was detected in total cell lysates 
using an antiserum that recognizes the EGFP moiety (a-GFP). The wild type EGFP protein (1) of 29 
kDa and the EGFP fusion protein of FERM domain (3) of about 80 kDa are readily detectable (left 
panel), whereas detection of the full length PTP-BL fusion protein (4) (about 300 kDa) requires 10 
times longer exposures, indicating a relative low expression level. As a control, a lysate of wild type 
MDCK cells (2) was loaded.
(Fig. 5A). No label was found at sites of cell-cell contact (not shown). For BL-FL-EGFP 
only a low level of labeling was found, again confirming our findings in cell extracts. Like 
for EGFP-BL-FERM, all immuno-gold label is found at a fixed distance from the apical 
membrane, although here no clear enrichment in villi was observed (Fig. 5C). In a 
proportion of the cells within any given preparation we could not detect any immunogold 
labeling, in keeping with the fact that a certain fraction of cells in the sorted pool is indeed 
EGFP-negative as determined by flow cytometry. This result also confirms the high 
specificity of the antiserum used.
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Figure 5: Ultrastructural immuno- 
localization of PTP-BL in transfected 
MDCK cells.
Sorted MDCK pools expressing EGFP 
fUsion proteins of the FERM domain (A 
and B) and BL-FL (C) were used for 
immuno electron microscopy. Ultrathin 
cryosections were incubated with the 
polyclonal antiserum a-GFP and labeling 
was visualized using 10 nm gold particles, 
coupled to protein-A. The FERM domain 
of PTP-BL is localized exclusively in the 
apical compartment, where most label is 
found directly submembraneously at a 
typical fixed distance from the plasma 
membrane (A). Sections through the villi 
show enrichment in these structures (B). 
Although expression of full length PTP- 
BL is much lower, all labeling that is 
detected is located at the apical plasma 
membrane (C). Bars, 0.2 mm.
No direct interaction of the FERM domain of PTP-BL with ezrin
The subcellular localization of PTP-BL shown here is reminiscent of that described for the 
FERM domain containing protein ezrin (Berryman et al., 1993). Because also hetero­
oligomers of ezrin with other members of the FERM protein family have been reported 
(Berryman et al., 1995), we analyzed whether there could be a potential direct interaction 
between PTP-BL and ezrin. Immunofluorescent labeling of endogenous ezrin (Fig. 6B) in 
MDCK cells transiently expressing EGFP tagged BL-FERM (Fig. 6A) shows a typical
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villi-like pattern for both proteins. Overlay of both pictures shows that the PTP-BL FERM 
domain colocalizes with ezrin at identical cellular structures although labeling intensities do 
not completely correlate. Similar data were obtained for full-length PTP-BL (not shown). 
To confirm these observations at the ultrastructural level we next used immuno-gold double 
labeling on ultrathin cyrosections of cells in the sorted MDCK pools. To this end we used 
5-nm gold to visualize ezrin and 10-nm gold for EGFP-BL-FERM (Fig. 6C). Clearly, both 
proteins are present in the same villi, but no extensive colocalization is observed. Since this 
can be due to putative steric hindrance of the immunochemicals, we additionally tested for 
the presence of PTP-BL and ezrin in the same multiprotein complex by co- 
immunoprecipitation of EGFP-BL-FERM or BL-FL-EGFP with ezrin and vice versa. For 
this, we used extracts prepared from the sorted MDCK pools, but there was no coordinate 
pull-down of both proteins under the experimental conditions used, so we must conclude 
that there is no evidence for a direct association between the PTP-BL FERM domain and 
ezrin (data not shown).
Figure 6: PTP-BL colocalizes with ezrin at the light microscopy level but not at the electron 
microscopy level.
Endogenous ezrin was detected in MDCK cells (B), transiently expressing an EGFP fusion protein of 
the FERM domain of PTP-BL. EGFP-mediated fluorescence for the FERM domain (B) overlaps with 
ezrin labeling in a punctuate villi-like pattern. Bar, 10 mm. (C) Immuno-gold double labeling for ezrin 
and EGFP-BL-FERM on ulthrathin cryosections of the sorted MDCK pool. Endogenous ezrin and the 
FERM domain of PTP-BL are visualized with 5 nm and 10 nm gold particles, respectively. 
Coexpression of both proteins in the same villi is evident, but no direct colocalization is detected. Bar, 
0.2 mm.
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PTP-BL dynamics
To find out whether the observed apical localization represents a stable or a dynamic 
distribution fluorescence recovery after photobleaching (FRAP) was used to study PTP-BL 
mobility dynamics in living cells. MDCK cells, transiently transfected with expression 
constructs encoding EGFP-tagged fusion proteins, were examined using a confocal laser 
scanning microscope. An initial image was captured before photobleaching. Next, part of 
the cell was photobleached for 10 seconds by exposure to the 488-nm laser line at full 
power. An averaged image was obtained immediately after photobleaching followed by a 
series of images with intervals of 2 minutes. For EGFP-BL-FERM, the bleaching procedure 
resulted in complete loss of the EGFP signal in the bleached area, whereas the EGFP- 
mediated fluorescence in the rest of the cell was unaffected (Fig. 7A, second frame). Within 
several minutes, EGFP-BL-FERM began to reappear to detectable levels in the bleached 
area, whereas the EGFP signal in the rest of the cell decreases. After 15 to 20 minutes about 
equal EGFP intensities were reached in both areas. Note that EGFP-BL-FERM reoccurs 
homogenous through the bleached area and does not start at the edges of the bleached 
region. To exclude the possibility that the reoccurrence of the EGFP-BL-FERM 
fluorescence was due to spontaneous fluorescence recovery or novel protein synthesis, a 
complete cell was bleached and monitored for EGFP labeling. No photobleaching recovery 
was observed for up to 30 minutes, clearly showing that the effect observed is due to 
exchange of fusion protein while the GFP bleaching itself is irreversible.
Identical experiments were performed with EGFP-tagged fusion proteins containing the N- 
terminus or the five PDZ motifs of PTP-BL, next to the FERM domain. No influence of
Figure 7: Fluorescence recovery after photobleaching (FRAP) reveals a dynamic cytoplasmic PTP- 
BL pool.
MDCK cells transiently expressing EGFP tagged versions of the FERM domain of PTP-BL (A) or 
full-length PTP-BL (B) were used to study the protein dynamics in living cells. Before 
photobleaching an image, consisting of 6 horizontal confocal sections, was acquired (first frame). 
Next, a region of about 1/3 of the cell (indicated by the white square) was photobleached, directly 
followed by the collection of images with intervals of 2 minutes. Already after 2 minutes recovery of 
fluorescence is evident in the bleached area, whereas almost complete redistribution is seen after 15 to 
20 minutes. Bars, 10 mm.
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protein regions flanking the FERM domain in PTP-BL on the kinetics was observed. 
Moreover, EGFP-tagged full-length PTP-BL (EGFP-BL-FL) behaves with similar 
dynamics as EGFP-BL-FERM (Fig. 7B).
Homodimerization as a means to regulate PTP-BL phosphatase activity 
The FRAP results and the immunoelectron microscopy findings points to the existence of a 
dynamic pool of cytosolic PTP-BL molecules in addition to a population of 
submembranous molecules which can be found at a distance of 10-15 nm from the cell 
membrane. Bearing in mind the morphological effects of unrestricted PTP-BL enzyme 
activity (Fig. 1A), the question arises whether the protein is being “captured” in two 
different activity-states in these distinct microenvironments. To answer this question it is 
important to characterize the type of intra- and intermolecular interactions in which PTP- 
BL is involved. For this, we used the different protein domains of PTP-BL (BL-Nter, BL- 
FERM, BL-PDZ-I-V and BL-PTP) as baits in the two-hybrid interaction trap and tested 
whether they could engage in an interaction with the PTP domain of PTP-BL (Table 1). No 
interaction was detectable for BL-Nter, BL-FERM and BL-PDZ-I-V, arguing against a 
direct role for these domains in regulating PTP-BL's catalytic activity. Also, the testing of 
single PDZ motifs did not reveal an interaction. However, we did observe a weak but 
significant homophilic interaction for the PTP-BL PTP domain (Table 1). This interaction 
is not affected by a mutation in the catalytic domain (PTP-DA) and therefore not dependent 
on enzymatic performance. Similar as for CD45 and RPTPa (Bilwes et al., 1996; Majeti et 
al., 1998), dimerization of the catalytic domain may thus result in inactivation of 
phosphatase activity.
Table 1. Two-hybrid interaction trap assays to test for interactions between
the modular domains of PTP-BL with its catalytic domain.
BL-PTP-WT BL-PTP-DA pJG4-5
BL-Nter - - -
BL-FERM - - -
BL-PDZ-I-V - - -
BL-PTP + + -
pEG202 - - -
Baits (left column) and preys (top row) combinations were tested for interaction as 
determined by growth on leucine deficient plates and b-galactosidase activity on X-gal 
plates. Empty bait (pEG202) and prey (pJG4-5) were used as controls. +, interaction (blue 
colonies after 5 days); -, no interaction (no blue colonies after 8 days).______________
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Discussion
Relatively little is known about the biological function and substrate specificity of 
individual members of the family of PTPs. In part this is due to the difficulty in generating 
PTP overexpressing cell lines. Also in the case of PTP-BL only very low levels of 
overexpression could be achieved in transient assays or when generating stable expressing 
pools using EGFP-mediated cell sorting. Intriguingly, we found it impossible to generate 
stable expressing MDCK cells for catalytically impaired mutants of PTP-BL using the same 
strategy (E.C. unpublished observations). This suggests a dominant effect of the mutations, 
probably caused by substrate trapping (Flint et al., 1997), and points to an essential role for 
PTP-BL in cell survival or proliferation. In contrast to these in vitro data, ablation of PTP- 
BL catalytic activity in transgenic mice shows no overt effects (Thomas et al., 1998). 
Although several PTPs have been shown to exhibit extremely stringent substrate specificity 
in vivo, in vitro most PTPs display only modest amino acid sequence specificity using 
phosphopeptides as substrates (reviewed in Zhang, 1998). We found that in COS-1 cells 
overexpression of the catalytic domain of PTP-BL results in dramatic changes in cell 
morphology (Fig. 1). Almost certainly the formation of prominent membrane protrusions is 
not a natural response with relevance for normal cellular behavior, but the observations do 
stress the importance of tight control of enzymatic activity of the phosphatase domain. 
Strikingly, in our experiments we did not see these effects when full-length PTP-BL was 
overexpressed in COS-1 cells, suggesting that elements regulating enzyme activity and/or 
specificity are present in the intact protein. The identification and characterization of these 
elements forms therefore one of the main aims in our study. We here demonstrate that the 
FERM domain is the primarily responsible element for apical targeting of PTP-BL in 
polarized epithelial cells (Fig. 3). FERM domains in band 4.1, ezrin, radixin and moesin 
bind to transmembrane proteins like CD44, CD43, ICAM-1 and 2 (Yonemura et al., 1998). 
If the PTP-BL FERM domain has the same properties and therefore engages in the same 
type of molecular association, it would explain in part the submembranous localization of 
PTP-BL. Unfortunately, direct evidence for this hypothetical model is lacking at present. 
Moreover, another phosphatase, PTPD1, associates with the microtubule motor protein 
KIF1C via its FERM domain and localizes to ER-Golgi like subcellular structures (Dorner 
et al., 1998), preluding on the variability in binding properties that FERM domains may 
display.
Furthermore, it is of note that that the FERM domains in ezrin, radixin, moesin en merlin 
can engage in intra- or intermolecular binding with C-terminal domains in these proteins, 
thereby forming either monomers or concatamers (reviewed in Tsukita et al., 1997). This is 
particularly interesting, as the villi-like appearance of PTP-BL localization is reminiscent of 
that of ezrin. This notion triggered us to study a potential direct interaction between the BL- 
FERM domain and ezrin but we were unable to obtain supportive evidence for this model 
by co-immunoprecipitation from stable expressing MDCK pools. Also, data from
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immunoelectron microscopy suggest that PTP-BL is not incorporated in the structures 
containing head-to-tail ezrin oligomers at the plasma membrane (Tsukita et al., 1997). At 
present we cannot exclude association of PTP-BL with other ERM family members.
So although the precise composition of the structure in which PTP-BL is embedded remains 
enigmatic, the typical subcellular localization pattern, at a constant distance from the cell 
membrane, that is observed for BL-FERM (Fig. 5) does provide strong evidence for it 
being a component of a highly organized, probably membrane- or cyto-skeletal linked, 
structure. FRAP experiments, however, show that PTP-BL is redistributed through the cell 
within 20 minutes (Fig. 7). These observations may either indicate that PTP-BL is highly 
mobile or that the PTP-BL-containing structures are constantly formed and degraded. 
Although the fluorescent signal in the bleached area reoccurs in the same typical punctuate 
pattern as before photobleaching, we cannot conclude from our data whether the individual 
spots represent still the same villi-like structures or are ones that are newly formed. The 
identical kinetics for BL-FERM and BL-FL in the FRAP experiments even leaves open the 
possibility that a large multiprotein complex, including previously described PTP-BL 
associated proteins, relocates in the cell.
Several clues about the mechanism of relocation of PTP-BL are obtained from the FRAP 
experiments. Firstly, we noted that the reoccurrence of fluorescence does not start at the 
borders of the bleached area, but rather results from a gradual increase of signal that is 
equally distributed throughout the entire surface. These observations argue against lateral 
movement as the dominant event. Rather it suggests a mechanism of relocation whereby a 
soluble pool in the cytosol is involved in replenishing the bleached pool of proteins. Indeed, 
in our ultrastructural analyses some immuno-gold labeling is observed in the apical cytosol 
for EGFP-BL-FERM and these signals could potentially represent protein that is in transit 
between the cytosolic and subcortical pools. In addition, preliminary FRAP results indicate 
slower relocation of catalytically impaired mutants, suggesting that reversible tyrosine 
phosphorylation may play a role in the dynamics of the exchange process. This is also 
supported by the observation that the FERM domain of PTP-BL is phosphorylated on 
tyrosine residues in vivo (E.C. unpublished observations).
If PTP-BL relocates dynamically between different sites, it would, at least temporarily, be 
released from its microenvironmental constraints. It seems therefore appropriate to expect 
that alternative regulatory principles are subjected on the enzyme while at different sites. 
One example of a mechanism involved in fine-tuning of enzymatic activity is found in 
SHP-2 where an intramolecular interaction between SH2 and PTP domains regulates the 
catalytic activity (Hof et al., 1998). Using two-hybrid interaction analysis we found no 
evidence in support of intramolecular interactions within the full-length PTP-BL 
polypeptide. Instead, we did observe a weak homotypic interaction for the catalytic PTP 
domain in our two hybrid assays (Table 1). This lends support to a model in which PTP-BL 
is subject to regulation as proposed for RPTPa (Bilwes et al., 1996) and RPTPo (Wallace
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et al., 1998), where homo- or heterotypic interactions between PTP domains may inhibit 
enzymatic activity by blocking the catalytic cleft. Also, there may be similarities to the 
ligand-induced dimerization of an EGFR-CD45 chimeric receptor which inhibited CD45 
PTP function and TCR signal transduction (Majeti et al., 1998). Interestingly, in the human 
homologue of PTP-BL, PTPL1, a potential leucine zipper that could serve as dimerization 
motif can be discerned (Saras et al., 1994) but this motif is not conserved in mouse. Finally, 
intermolecular interactions mediated by proteins that have been found to interact with PDZ 
motifs in PTP-BL, like the small adapter protein RIL (Cuppen et al., 1998), the zyxin- 
related protein ZRP-1 (E.C., unpublished data) and PARG-1 (a protein with a GTPase 
activating domain specific for Rho, Saras et al., 1997), could also play a role in clustering 
and activity-determination of PTP-BL molecules. Especially, RIL is a strong candidate. Its 
C-terminal LIM domain can interact with both the second and the fourth PDZ motif of 
PTP-BL, apparently via different interaction interfaces, enabling di- or even 
multimerization of PTP-BL. Interestingly, the N-terminal PDZ motif of RIL itself is 
competing for the same binding site and, thus, might cause dissociation of such a complex. 
Furthermore, since RIL is phosphorylated on tyrosine in vivo and is a substrate for PTP-BL 
(Cuppen et al., 1998), additional regulation of RIL functioning in PTP-BL aggregation is 
very well possible. The same line of reasoning could be followed for the role of ZRP-1, 
which also colocalizes with F-actin structures (Cuppen et al., unpublished).
In summary, based upon its subcellular localization and the predicted properties of its 
associated proteins, a role for PTP-BL in (re-)organization of the cortical (actin) 
cytoskeleton in or near villi, is suggested. Most likely, its function is dictated by 
compartmentational constraints regulated by its FERM domain. Additionally, PTP activity 
may be (down-) regulated by homotypic association of the catalytic domains, perhaps 
induced by proteins that can interact with the PDZ motifs in PTP-BL. Clearly, future 
experiments will be necessary to validate this model.
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Materials and Methods
E xp ression  p la sm id  con stru ction s - The cDNA restriction fragments encoding segments of PTP-BL 
(Genbank accession number Z 32740) as indicated in Fig. 2 were subcloned in pEGFP vectors 
(Clontech) or in modified versions of the eukaryotic expression vector pSG5 (Green et al., 1988). In 
the pSG5 vector we have introduced an in-frame VSV-G epitope tag sequence to allow the production 
of fusion-proteins that can be detected with the a-V SV  monoclonal antibody P5D4 . Furthermore, we 
introduced either an initiator AUG codon or a stop codon for proper start or termination of translation 
(see also Cuppen et al., 1998). BL-PDZ-I-V and BL-PTP were tagged at their N-terminal end, 
whereas BL-FERM is tagged at its C-terminus. A  single point mutation at amino acid 2344, aspartate 
to alanine, was introduced in BL-PTP by PCR using synthetic oligonucleotides, resulting in the 
catalytic mutant BL-PTP-DA. The BL-Nter and the BL-Nter-FERM constructs were tagged C- 
terminally with EGFP by subcloning into the pEGFP-N3 vector (Clontech), whereas BL- 
FERM+PDZ-I-V and EGfP-BL-FERM were tagged N-terminally by subcloning into the pEGFP-C1 
vector (Clontech). BL-FERM+PDZ-I-V+PTP was expressed as an untagged protein from the pSG5 
vector. Full-length PTP-BL cDNA, including its 3’ -UTR, was inserted into pEGFP-N3, allowing the 
production of untagged PTP-BL (BL-FL). Subsequently, this construct was modified by PCR to 
generate a PTP-BL-EGFP fusion construct (BL-FL-EGFP). To this end, we introduced a XhoI site at 
the position of the stop codon, thereby removing the 3 ’ -UTR including the stop codon, before 
introducing the EGFP moiety. Detailed cloning information can be obtained from the authors upon 
request.
A n tib od ies  - The affinity-purified polyclonal antiserum a-BL-PDZ-I directed against the first PDZ 
motif of PTP-BL and the monoclonal a-V SV  antibody P5D4 have been described elsewhere (Cuppen 
et al., 1998; Kreis, 1986). The polyclonal antiserum directed against ezrin was a kind gift of Dr. Paul 
Mangeat (Montpellier, France). The polyclonal antiserum a-GFP was obtained by immunizing a 
rabbit with a GST-EBFP (Enhanced Blue Fluorescent Protein) fusion protein (Cuppen et al, 
submitted). The resulting antiserum was found to recognize also the widely used EGFP (Enhanced 
Green Fluorescent Protein) in Western blotting, immunofluorescence and immunoprecipitation 
experiments with high specificity.
T issu e cu ltu re a n d  tran sien t c e ll tran sfection  - COS-1 cells were cultured in DMEM/10% fetal calf 
serum (FCS). For each assay, 1.5 x  106 cells were electroporated at 0.3 kV and 125 |mF using the Bio­
Rad GenePulser with a 4-mm electroporation cuvette, in 200 ml of phosphate-buffered saline (PBS) 
containing 10 mg of plasmid DNA. Cells were seeded in 24 wells plates on 14-mm diameter glass 
coverslips coated with poly-L-lysine, cultured for 24 hours in DMEM/10% fetal calf serum and 
subsequently used for immunofluorescence analysis. M DCK cells (type II, a kind gift of K. Ekroos, 
Heidelberg, Germany) were cultured in DMEM/10% FCS. Prior to transfection, cells were seeded 
onto 14-mm diameter glass coverslips (Menzel-Gläser, Germany) in 24 wells cell culture plates. 
Transfection mix was made by adding 0.3 mg plasmid DNA to 2 mg DAC -30 (Eurogentec, Seraing 
Belgium) in 150 ml OptiMEM (Gibco BRL, Gaithersburg, MD) and incubating for 30 minutes at 
room temperature. After replacing the culture medium on the cells (30-70% confluency) with 150 ml 
fresh DMEM/10% FCS, the transfection mix (150 ml) was added to the cells. Following a 5-hour 
incubation at 37°C the medium was replaced with fresh DMEM/10% FCS and incubation was 
prolonged overnight. The cells were subsequently used for immunofluorescence analysis. 
Im m u n o flu orescen ce  - Cells were fixed for 10 minutes in 2% paraformaldehyde in PHEM buffer (60 
mM Pipes, 25 mM Hepes pH 6.9, 10 mM EGTA, 2 mM MgCl2) and permeabilized with 0.5% 
Nonidet P-40 in PBS for 5 minutes. At further steps, solutions are prepared in PBS, cells were 
thoroughly rinsed in PBS between stages, and incubations were performed at room temperature. Free 
aldehyde groups were quenched for 10 minutes in 0.1 M  glycine. 50 ml of affinity-purified rabbit a- 
BL-PDZ-I (1:200 dilution, Cuppen et al., 1998), rabbit polyclonal a-GFP (1:1000 dilution), rabbit 
polyclonal a-ezrin (1:5000 dilution) or mouse monoclonal a-V SV  (P5D4 , ascites fluid; 1:1000 
dilution) was used for a 1 hour incubation with primary antibody. Subsequent incubation was for 1
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hour with 50 ml of FITC- or Texas Red-conjugated AffiniPure Goat anti-rabbit or Goat anti-mouse 
IgG (10 mg/ml; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Finally, coverslips 
were rinsed in PBS and water and mounted on glass slides by inversion over 5 ml Mowiol mountant 
(Sigma Chemical Co.). Cells were examined using an MRC1000 confocal laser-scanning microscope 
(Bio-Rad).
G eneration  o f  sta b le exp ressin g  p o o ls  - MDCK cells were grown in 6-wells plates and transfected at 
50-70% confluency. Transfection mix was made by adding 1.5 mg AflII digested (EGFP-based) 
plasmid DNA to 10 mg DAC-30 (Eurogentec, Seraing Belgium) in 750 ml OptiMEM (Gibco BRL). 
The mixture was incubated for 30 minutes at room temperature and then added to the wells containing 
cells in 750 ml fresh DMEM/10% FCS. Following a 5-hour incubation at 37°C the medium was 
replaced with fresh DMEM/10% FCS and incubation was prolonged overnight. Cells were transferred 
to a T75 culture flask and after 6 hours selection for neomycin-resistant cells was applied (450 mg/ml 
G418). Cells were grown under selection for 10-12 days and replated in T25 or T75 culture flasks 
(depending on the amount of colonies) when colonies became too large. Cells from one T75 culture 
flask (70% confluent) were collected in 1 ml PBS and used for fluorescence activated cell sorting. 
EGFP-mediated fluorescence was detected using the FITC-filter set on the flow cytofluorometer 
(Coulter) and 2000 to 10000 positive cells were sorted, collected in 5 ml DMEM/10%FCS (without 
G418 selection), and reseeded in a T25 culture flask. After expansion to confluency in a T75 culture 
flask, cells were subjected to another round of cell sorting. Expression of the proper EGFP-fusion 
protein was checked by Western blotting. For this, a confluent layer of MDCK cells in a 24-well plate 
was lysed in 100 ml sample buffer (50 mM Tris-HCl, pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% 
bromophenol blue, 10% glycerol) and boiled for 5 minutes. Protein samples (20 ml) were resolved by 
SDS-PAGE on a gradient polyacrylamide gel (4 to 15%), and transferred to nitrocellulose membranes 
(Hybond-C+, Amersham). Blots were blocked using 5% nonfat dry milk in TBST (10 mM Tris-HCl, 
pH 7.5, 150 mM NaCl, 0.05% Tween 20). One hour incubations with primary (5.000 x diluted a- 
GFP) and secondary (10.000 x diluted peroxidase-conjugated goat anti-rabbit IgG (Pierce)) antibody 
and subsequent washes were done in TBST at room temperature. Labeled bands were visualized 
using freshly prepared chemiluminescent substrate (100 mM Tris-HCl, pH 8.5, 1.25 mM p-coumaric 
acid (Sigma), 0.2 mM luminol (Sigma), and 0.009 % H2O2) and exposure to radiography films (X- 
omat, Kodak).
Im m un o-electron  m icroscopy  - Ultrastructural localization studies were performed on sorted pools of 
stable expressing MDCK cells that were grown on polycarbonate filter (Transwell, 0.4 mm, Costar) 
for five days. Cells were fixed with 1% paraformaldehyde (PFA) in PHEM buffer (60 mM Pipes, 25 
mM Hepes pH 6.9, 10 mM EGTA, 2 mM MgCl2) for 1 hour, and stored until use in 1% PFA. Filters 
were stacked in 10% gelatin and fixed in 1% PFA for 24 hours. Ultrathin cryosectioning was 
performed as described before (Fransen et al., 1985). Sections were incubated with the polyclonal 
antiserum a-GFP (1:1000 dilution), followed by a rabbit polyclonal serum against mouse IgG (Dako 
A/S, Glostrup, Denmark) and protein A complexed to 10 nm gold particles (Fransen et al., 1985). For 
simultaneous detection of EGFP-tagged protein and endogenous ezrin, sections were first incubated 
with the polyclonal antiserum against ezrin (1:200) and Protein A complexed to 5 nm gold particles. 
This was followed by a second incubation with biotinylated anti-GFP (1:100), streptavidin and 
biotinylated BSA complexed to 10 nm gold particles (Komuves and Heath, 1992). Electron 
microscopy was performed with a JEOL 1010 electron microscope operating at 80 kV.
F lu o rescen ce  recovery a fter p h o to b lea ch in g  (F R A P ) - FRAP studies were performed using 
transiently transfected MDCK cells (see above) that were grown for 24 hours on 24-mm diameter 
glass coverslips (Menzel Gläser). Cells were cultured and measured in DMEM without phenol red 
(Gibco) in the presence of 10% fetal calf serum, and analyzed in a temperature-controlled chamber 
using a MRC1000 confocal laser scanning microscope (BioRad). An initial image (composed of 6 
optical sections) was acquired, and a selected area was photobleached for 10 seconds using the 488­
nm line of the krypton/argon laser at full power (5 mW). Immediately after the bleaching process, 
images (composed of 6 optical sections) were collected at 2 minutes intervals.
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In tera ction  trap assay  - Plasmid DNAs and the yeast strain used for the interaction trap assay were 
generously provided by Dr. Roger Brent and colleagues (Massachusetts General Hospital, Boston, 
MA) and used as described (Gyuris et al., 1993). Construction of the bait plasmids BL-FERM (also 
named BL-band 4 .1), BL-pDz-I-V and BL-PTP is described elsewhere (Cuppen et al., 1998). The 
bait BL-Nter (a.a. 1 to 509) and the prey BL-PTP (a.a. 2101-2460) constructs were generated by 
introducing appropriate restriction fragments of full-length PTP-BL (Genbank accession number 
Z 32740) in the pEG202 and pJG4-5 plasmid, respectively. For the prey construct BL-PTP-DA the 
insert from the pSG-based expression construct VSV-BL-PTP-DA (see above) was introduced into 
the pJG4-5 vector. For detection of two-hybrid interactions, bait and prey plasmids were transfected 
in yeast strain EGY48 containing the LacZ reporter plasmid pSH18-24. Interactions were validated by 
growth and blue coloring on minimal agar-plates lacking histidine, tryptophan, uracil and leucine, and 
containing 2% galactose, 1% raffinose and 80 mg/ml X-gal, buffered at pH 7 .0 .
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Abstract
Recently, one of the PDZ domains in the cytosolic protein tyrosine phosphatase Fas- 
associated phosphatase-1 (FAP-1)/PTP-BAS was shown to interact with the C- 
terminal tS-L-V peptide of the human Fas receptor (Sato, T., Irie, S., Kitada, S., and 
Reed, J.C. (1995) S c ie n c e  268, 411-415), suggesting a role for protein 
(de)phosphorylation in Fas signaling. To investigate whether this interaction is 
conserved in mouse, we performed yeast two-hybrid interaction experiments and 
transfection studies in mouse T cell lines. For the corresponding PDZ motif in the 
mouse homologue of FAP-1/PTP-BAS, PTP-BL, only an interaction with human but 
not with mouse Fas could be detected. Presence of the tS-L-V motif proper, which is 
unique for human Fas, rather than the structural context of its C-terminus, apparently 
explains the initially observed binding. To test for functional conservation of any 
indirect involvement of PTP-BL in Fas-mediated signaling, we generated T 
lymphoma cell lines stably expressing mouse or human Fas receptor with and 
without PTP-BL. No inhibitory effect of PTP-BL was observed upon triggering 
apoptosis using mouse or human Fas-activating antibodies. Together with the 
markedly different tissue expression patterns for PTP-BL and Fas receptor, our 
findings suggest that protein tyrosine phosphatase PTP-BL does not play a key role 
in the Fas-mediated death pathway.
Introduction
Many signaling pathways depend upon the reversible assembly of protein complexes to 
evoke temporally and spatially distinct effects. Small modular protein domains like Src 
homology 2 (SH2) and SH3 domains and phosphotyrosine-binding (PTB) domains, were 
found to play an important role in signal transduction cascades (Cohen et al., 1995; 
Lemmon et al., 1996; Pawson, 1995). Recently, it has become clear that PDZ motifs have a
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similar role (Fanning and Anderson, 1996). P D Z motifs (acronym for postsynaptic density 
protein P SD -95 , D r o so p h ila  discs-large tumor suppressor D lgA , and the tight junction 
protein Z O -1) are now identified in a wide variety o f  proteins in bacteria (Ponting, 1997) 
and lower and higher eukaryotes (Ponting and Phillips, 1995), many o f w hich are localized 
at specific regions o f cell-cell contact, such as tight, septate and synaptic junctions (Woods 
and Bryant, 1993). For example, P D Z motifs present in membrane-associated guanylate 
kinase (M A G U K ) fam ily members have been found to interact with the C-terminus o f 
diverse transmembrane proteins (Sheng, 1996), thereby inducing clustering o f these 
proteins at specialized cell-cell junctions (Gomperts, 1996). Recent experiments 
demonstrate that P D Z motifs from  different types o f  proteins can recognize unique C- 
terminal peptide motifs (Schepens et al., 1997; Songyang et al., 1997; Yanagisaw a et al., 
1997). A s these interactions have been identified by screenings o f peptide libraries, the in 
vivo  relevance for most o f  them remains to be demonstrated. P T P-B A S (M aekawa et al.,
1994), also known as hP T P 1E  (Banville et al., 1994) and P T P L 1 (Saras et al., 1994) in 
humans, is one o f the few  P D Z containing proteins known so far that contain an active 
catalytic protein domain, i.e. a C-terminal protein tyrosine phosphatase domain. Recently, 
this protein was found to directly associate v ia  one o f its P D Z motifs to the C-terminal 
regulatory domain o f Fas and was termed F A P -1 for Fas-associating phosphatase-1 (Sato et 
al., 1995). This association points to a possible link between reversible tyrosine 
phosphorylation and the apoptotic death cascade mediated by Fas. Activation o f the Fas 
receptor (Itoh et al., 1991), a member o f the tumor necrosis factor receptor superfamily 
(Smith et al., 1994) induces very rapid physiological and m orphological changes in many 
cell types (Nagata and Golstein, 1995). The Fas receptor itself does not contain a catalytic 
protein domain, but in the activated conformation it recruits several proteins to the death- 
inducing signaling com plex (Peter et al., 1996) which can trigger several proteolytic 
cascades and signaling pathways (Nagata, 1997). Direct association o f a protein tyrosine 
phosphatase could have important modulatory effects on Fas signaling, and indeed a 
correlation between F A P -1 expression and (partial) resistance to Fas-mediated apoptosis 
has been noted in the human system (Sato et al., 1995).
The second P D Z m otif o f  the five P D Z motifs as present in F A P -1 (referred to as the third 
out o f  six P D Z motifs in Sato et al., 1995 and Songyang et al., 1997) and the C-terminal 15 
amino acids o f  Fas were found to be necessary and sufficient for the observed direct 
association between F A P -1 and Fas (Sato et al., 1995). Indeed, screenings o f oriented 
peptide libraries em ploying the second P D Z m otif o f  F A P -1 revealed a consensus binding 
sequence o f  t(S/T)-X-(V/I/L) (Songyang et al., 1997; Yanagisaw a et al., 1997) that is 
present in the Fas C-terminus (tS-L-V).
Puzzled by the considerable sequence divergence displayed by the C-terminus o f Fas (Fig.
1), we set out to study whether F A P -1 ’ s presumed role in Fas signaling was evolutionary 
conserved. W e found that mouse Fas does not interact with the mouse homologue o f  PTP-
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BAS/FAP-1, known as PTP-BL (Hendriks et al., 1995) or RIP (Chida et al., 1995). 
Furthermore, studies using transformed mouse cell lines failed to demonstrate any role for 
PTP-BL in the regulation of Fas-mediated signaling. Our results show that the interaction 
between the Fas receptor and PTP-BL is not conserved between mice and men.
Human: F R N E I Q S L V *
Mouse: N E N E G Q C L E *
Rat: N E N E G Q S L E *
Bovine: L Q N E N E N L V *
r / S x V *
Figure 1: Sequence comparison of the Fas receptor 
C-terminus from different species.
The last 9 amino acids of human (GenBank 
accession number M67454), mouse (A46484), rat 
(JC2395) and bovine Fas receptor (U34794) are 
shown and aligned with the proposed PDZ binding 
motif t(T/S)-X-V (asterisks indicate the C- 
terminus).
Results
No interaction between mouse Fas receptor and PTP-BL
The large difference between species that is obvious in the C-terminal Fas receptor 
sequence (Fig. 1) prompted us to test the interaction between Fas receptor and PTP-BL 
using the two-hybrid interaction trap (Gyuris et al., 1993). Baits were generated containing 
either the complete array of PDZ motifs or individual PDZ motifs of PTP-BL and were 
assayed for interaction with both mouse and human Fas C-termini. An interaction of the 
ensemble of five PDZ motifs of PTP-BL (BL-PDZ-I-V) with the human Fas receptor could 
be observed, but no interaction occurred with mouse Fas receptor (Fig. 2). Assays 
employing single PDZ motifs only revealed an interaction for BL-PDZ-II and human Fas 
receptor, but this was rather weak. No interaction of mouse Fas receptor with any of the 
PTP-BL PDZ motifs tested was observed, nor did any of the baits activate transcription of 
the b-galactosidase reporter in the presence of an empty prey vector (Fig. 1).
Finally, two non-related domains, the nNOS PDZ motif, found to recognize the C-terminal 
tG-(D/E)-X-V motif (Schepens et al., 1997; Stricker et al., 1997) and the RIL PDZ motif 
(Cuppen et al., submitted), did not interact with mouse or human Fas receptor. Another 
motif, the second PDZ motif of PSD95/SAP90, known to recognize t(T/S)-X-V (Kornau et 
al., 1995; Niethammer et al., 1996) did interact only with the human Fas receptor (not 
shown; Schepens et al., 1997).
Generation of stable PTP-BL and Fas transformants
To study any functional involvement of PTP-BL in Fas-mediated apoptosis, we generated 
stable transformants of the mouse T cell lymphoma WR19L cell line. This cell line does not 
express PTP-BL (Fig. 3 C) or endogenous Fas receptor as identical flow cytometric staining 
profiles were obtained with (Fig. 3 A) and without the primary anti-Fas antibody (not
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Figure 2: Two-hybrid analysis o f the interaction between PTP-BL PDZ motifs and the C-terminus of 
mouse and human Fas receptor.
A) Schematic overview of the domain structure o f PTP-BL and the protein domains used for the two- 
hybrid interaction analysis. B) X-gal assay plate for a two-hybrid interaction in yeast between PTP- 
BL PDZ motifs as baits and mouse or human Fas receptor C-termini as prey. C) Semi-quantitative 
analysis o f the interaction strength between different PDZ motifs and mouse and human Fas receptor 
C-termini using the two-hybrid interaction trap. The interaction strength for mouse Fas receptor 
(black bar), human Fas receptor (gray bar) and empty prey vector (open bar) as a control, with the 
various PDZ baits, were determined by measuring the b-galactosidase activity in crude yeast lysates. 
Error bars indicate the standard deviation (n=5).
shown). Expression plasmids were introduced by electroporation and protein expression of 
Fas receptor and PTP-BL were analyzed by flow cytofluorometric analysis and Western 
blotting, respectively. No endogenous Fas receptor could be detected in the wild-type 
WR19L cell line. Stable transformants were obtained expressing human Fas receptor in 
combination with (H20 and H25) or without (4B1) PTP-BL (Fig. 3A and C). Similarly 
transformants were generated expressing mouse Fas receptor with (M3 and M5) or without 
(2H2) PTP-BL (Fig. 3B and C). In addition a control line expressing PTP-BL only was 
generated (3C) (Fig. 3B and C). Transformants H20, H25 and M3, M5 express about equal 
amounts of surface-bound Fas receptor, as measured by flow cytofluorometric analysis 
(Fig. 3A and B), but express different amounts of PTP-BL as determined by Western 
blotting (Fig. 3C).
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A
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C
mouse FAS - 
human FAS -
+ +
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Figure 3: Characterization of transformed 
W R19L cells.
Surface expression of human Fas receptor (A) 
and mouse Fas receptor (B) in W R19L 
transformants was detected using specific 
monoclonal antibodies and analyzed by 
flowcytofluorometry. PTP-BL expression in the 
transformants was analyzed by Western blotting 
(C). Equal amounts of protein from total lysates 
were loaded on a 4% polyacrylamide gel, blotted, 
and PTP-BL was detected using an affinity- 
purified polyclonal antiserum (a-BL-PTP). 
Absence (-) or presence (+) of PTP-BL, mouse, 
and human Fas receptor in the different 
transformants is indicated at the bottom.
B
Time response to antibody-induced Fas-mediated apoptosis
Apoptosis was triggered in the human Fas receptor transformants by adding monoclonal 
anti-Fas IgM (CH-11, 250 ng/ml) and apoptosis was measured at fixed time points by 
propidium iodine uptake and flow cytofluorometric analysis. As expected, the wildtype cell 
line WR19L and the transformant that expresses PTP-BL only (3C), which both lack Fas 
receptor expression, do not undergo antibody-induced apoptosis (Fig. 4, A and B). The 
human Fas receptor-expressing transformant (4B1) undergoes rapid apoptosis, and within 8 
hours over 95% of the cells have permeable membranes and take up propidium iodine, 
indicative for the onset of apoptosis. The transformants expressing in addition PTP-BL 
(H20 and H25) undergo rapid apoptosis also, although at a slightly slower pace. However, 
cell lines with and without PTP-BL are indistinguishable when the time points at 20 hours 
incubation are compared. Furthermore, no influence of the amount of PTP-BL protein 
expression is observed (H20 versus H25, Fig. 4A). These results indicate that PTP-BL 
expression has no major influence on human Fas-mediated apoptosis in mouse WR19L 
cells and doesn’t protect against apoptosis.
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Figure 4: Time response curve of W R19L transformants upon antibody-induced Fas-mediated 
apoptosis.
Apoptosis mediated by the human Fas receptor (A) or the mouse Fas receptor (B) was induced by 
adding the monoclonal antibody CH-11 (250 ng/ml) or Jo2 (250 ng/ml) respectively. At fixed time­
points cells were withdrawn and dead cells were stained by propidium iodine uptake and analyzed by 
flow cytofluorometry.
A similar experiment was done with the mouse Fas receptor transformants by triggering 
apoptosis with the monoclonal antibody Jo2 (anti-mouse Fas). Apoptosis in the cell line 
expressing only mouse Fas receptor (2H2) is somewhat slower compared to human Fas 
mediated apoptosis. This difference may be explained by the lower surface expression of 
the mouse Fas receptor on 2H2 (Fig. 3B), or may be due to clonal variations or subtle 
differences in the way these two monoclonal antibodies induce apoptosis.
Compared with the cell line expressing only mouse Fas receptor (2H2), the transformants 
that express PTP-BL as well as mouse Fas receptor (M3 and M5) undergo apoptosis more 
rapidly (Fig. 4B), but at a rate comparable with the human Fas-mediated apoptosis (Fig. 
4A). Again, comparison of the read-out upon overnight incubation of the transformants 
with apoptosis inducing antibody, revealed no effect of PTP-BL at all. Taken together these 
findings indicate that PTP-BL expression is not a significant modulatory factor in mouse or 
human Fas-mediated apoptosis.
Dose response to antibody-induced Fas-mediated apoptosis
Perhaps the impact of PTP-BL on Fas-mediated apoptosis is much more subtle than what 
was proposed for the human counterpart. Therefore, we tested for the influence of PTP-BL 
expression on dose-responsiveness by treating wildtype WR19L cells and its transformants 
overnight with increasing amounts of apoptosis inducing antibody. Even at the highest
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Figure 5: Dose response o f W R19L transformants for antibody-induced Fas-mediated apoptosis. 
Apoptosis was induced in W R19L transformants expressing human Fas receptor (A) and mouse Fas 
receptor (B) by adding increasing amounts o f monoclonal antibody (final concentration ranging from 
10-9 to 10-3 mg/ml). After 20 hours dead cells were stained by propidium iodine uptake and analyzed 
by flow cytofluorometry.
concentration of antibody tested, cells without Fas receptor are refractory to undergo 
apoptosis (Fig. 5A and B). The dose-dependent sensitivity for Fas-mediated apoptosis did 
not significantly differ between Fas receptor transformants with and without PTP-BL. 
Again, this argues against an inhibiting role of PTP-BL in Fas signaling. Moreover, the 
mouse Fas receptor expressing transformant seems to be slightly less sensitive without 
PTP-BL expression, even suggesting a small apoptosis-enhancing effect of PTP-BL.
Tissue expression patterns for PTP-BL and Fas receptor
A Northern blot of total RNA from several mouse tissues was used to determine the tissue 
distribution of both Fas receptor and PTP-BL. The obtained patterns are quite distinct (Fig. 
6). Expression of Fas receptor is very high in lung and thymus and ubiquitously at a low 
level in all tissues examined. PTP-BL, on the contrary, is expressed at a high level in lung, 
kidney, testis, stomach, and skin (Fig. 6).
Discussion
It is now well-established that one of the functions of PDZ motifs is the recruitment of 
proteins via recognition-binding of their C-terminal domain (Gomperts, 1996; Songyang et 
al., 1997). The preferred motif in this domain has an extremely simple consensus structure 
(Saras and Heldin, 1996; Songyang et al., 1997).This raises the question how the cell can 
meet the criteria required for high specificity in binding-interaction, necessary to achieve
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Figure 6: Tissue expression for PTP-BL and Fas receptor.
Northern blot analysis o f PTP-BL (upper panel) and Fas receptor (middle panel) mRNA expression in 
different mouse tissues. The lower panel shows an ethidium bromide staining as a control for RNA 
loading.
correct functioning of the cell signaling network. As a working hypothesis for the studies 
presented here, we assumed that there must be a strong evolutionary preference to conserve 
the optimal interaction-avidity between individual PDZ domains and their preferred 
substrate.
Interestingly, the protein tyrosine phosphatase PTP-BAS/FAP-1, which contains five PDZ 
motifs, was found to directly associate with the Fas receptor via its second PDZ motif. 
However, the C-terminus of the Fas receptor which is involved in this interaction, is not 
strongly conserved between species (Fig. 1). Furthermore, the amino acids demonstrated to 
be important for the interaction with PTP-BAS (Songyang et al., 1997; Yanagisawa et al.,
1997) have been substituted in the mouse Fas receptor. To conserve the interaction, the 
second PDZ motif of the mouse homologue of PTP-BAS/FAP-1, PTP-BL, may have 
adapted to these changes. This is not very likely since this motif is very homologous 
between human (Maekawa et al., 1994) and mouse (Hendriks et al., 1995) (96 % identical) 
and bovine (GenBank accession number 915210) (98 % identical). Alternatively, the PTP- 
BL PDZ-II may be tolerant in peptide recognition, allowing different peptides to bind. This, 
however, would affect high specificity constraints necessary in signaling networks.
Our results show that PTP-BL does interact with the human Fas receptor, but fails to 
interact with the mouse Fas receptor. This indicates that specific peptide recognition is 
conserved between species and that changes, as found in the C-terminus of the Fas receptor 
abolishes the interaction. This last observation is in line with the tightly defined consensus 
motif for binding to the second PDZ domain of PTP-BAS/FAP-1, which was independently 
found to be tS/TxV/I (Songyang et al., 1997) or tS/TxV/L/I (Yanagisawa et al., 1997). 
Furthermore, none of the other PDZ motifs of PTP-BL does interact with the C-terminus of
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the mouse Fas receptor, indicating that PTP-BL does not directly interact with the Fas 
receptor in vivo. This is corroborated by immunoprecipitation experiments, which failed to 
detect PTP-BAS/FAP-1 or an approximately 250 kDa protein in the unstimulated or 
stimulated Fas receptor-complex (Kischkel et al., 1995; Orlinick and Chao, 1996; Peter et 
al., 1996).
However, any indirect involvement of the tyrosine phosphatase PTP-BL in Fas signaling 
cannot be excluded, although even the basal question if tyrosine phosphorylation is 
involved in modulating Fas signaling is not answered yet. For tyrosine kinases as well as 
tyrosine phosphatases, both stimulatory and inhibitory effects on Fas-mediated apoptosis 
have been reported. For example, the protein tyrosine kinase Abl and the tyrosine 
phosphatase PTP-BAS/FAP-1 both were found to inhibit the process (McGahon et al., 
1995; Sato et al., 1995), whereas another cytosolic tyrosine phosphatase, the hematopoietic 
cell phosphatase HCP/SHP-1, and the p59fyn kinase seem to potentiate the apoptotic signal 
induced by Fas (Atkinson et al., 1996; Su et al., 1995). The involvement of HCP/SHP-1 
remains controversial (Takayama et al., 1996). Furthermore, a rapid induction of tyrosine 
phosphorylation of multiple cellular proteins upon stimulation of Fas-mediated apoptosis is 
reported (Eischen et al., 1994). This phosphorylation as well as the apoptotic process could 
be blocked by inhibitors of protein tyrosine kinases in a concentration-dependent manner. 
Findings that a Jurkat cell variant, deficient in this elevation of tyrosine phosphorylation 
upon Fas-ligation, still does undergo apoptosis are contradictory to these findings (Janssen 
et al., 1996). Furthermore, the observed correlation between the levels of endogenous PTP- 
BAS/FAP-1 and resistance to Fas-mediated apoptosis in several cell lines (Sato et al.,
1995), is not confirmed by others (Peter et al., 1996). Taken together, the involvement of 
tyrosine phosphorylation in general and certain protein tyrosine kinases and phosphatases in 
particular in Fas signaling remains controversial. The reported effects may be secondary 
downstream effects and might be cell type-specific.
Functional studies using our model system revealed no obvious role for the protein tyrosine 
phosphatase PTP-BL in the regulation of Fas-mediated apoptosis. A small inhibitory effect 
on Fas-mediated apoptosis was observed in transformants expressing human Fas receptor. 
In contrast, PTP-BL seems to enhance apoptosis in mouse Fas receptor expressing 
transformants. However, both effects are not dependent upon the expression level of PTP- 
BL, since transformants expressing equal amounts of Fas receptor on their surface, but 
expressing different amounts of PTP-BL, behave very similar. Clonal variations and 
differences in the amount of surface expression of Fas receptor for the transformants with 
and without PTP-BL, may partially account for the differences observed. Furthermore, the 
small inhibitory effect of PTP-BL on human Fas-mediated apoptosis may be caused by its 
capability to interact with the C-terminus of the human Fas receptor and thereby inhibiting 
the formation of a functional death-inducing signaling complex rather than its catalytic 
activity. This effect will not occur in the mouse system, because PTP-BL does not interact
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with the mouse Fas receptor. Nevertheless, no influence of PTP-BL expression could be 
observed after overnight incubation with apoptosis-inducing antibodies, clearly 
demonstrating that PTP-BL can not (partially) protect from Fas-mediated apoptosis.
These results, combined with the different RNA expression patterns make an important role 
for PTP-BL in the regulation of Fas-mediated apoptosis in mouse very unlikely. In mouse 
the negatively regulatory C-terminus of the Fas receptor may bind other, so far unknown, 
proteins and perhaps in a PDZ-mediated fashion. Interestingly, we have observed that a 
deletion of the C-terminal region of human Fas potentiates Fas-induced apoptosis in mouse 
L929 cells (Itoh and Nagata, 1993). However, a similar deletion in mouse Fas did not show 
any effect (S.N., unpublished observations). Thus, the role of the Fas C-terminus in 
regulating the apoptotic process remains unclear. Furthermore, the target molecules for the 
PTP-BL PDZ motifs are still to be determined and will aid in elucidating its biological 
function.
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Materials and Methods
Tw o-H ybrid In tera ction  Trap - Plasmid DNAs and the yeast strain used for the interaction trap assay 
were provided by Dr. Roger Brent and colleagues (Massachusetts General Hospital, Boston, MA) and 
used as described (Gyuris et al., 1993). The individual PDZ motifs of PTP-BL were cloned in the 
pEG202 bait vector by amplifying PTP-BL sequences using specific primers containing convenient 
restriction sites for cloning purposes. This results in LexA fusion proteins containing amino acids 
1076-1177 (BL-PDZ-I), 1352-1450 (BL-PDZ-II), 1471-1601 (BL-PDZ-III), 1756-1855 (BL-PDZ-IV) 
and 1853-1946 (BL-PDZ-V) of PTP-BL. The C-terminal 60 residues of mouse Fas were cloned in the 
prey vector pJGBr2 by subcloning a 599 basepares PvuII - D raI restriction fragment from pBOS-EA 
(Watanabe Fukunaga et al., 1992), and for the human Fas C-terminus (40 amino acids) this was done 
by subcloning a 120 basepares BgJII - ApaI restriction fragment from pCMV-hFAS (a kind gift of Dr. 
Anderson, Cambridge MA). Construction of the control baits is described elsewhere (Cuppen et al., 
submitted; Schepens et al., 1997)). Two-hybrid interactions were analyzed by plating yeast containing 
reporter, bait and prey constructs on minimal medium agar plates containing X-gal (5-bromo-4- 
chloro-3-indolyl b-D-galactopyranoside) and lacking tryptophane, histidine, uracil, and leucine and 
subsequent incubation at 30 oC for 4 days. The relative strength of two-hybrid interactions was 
determined by measuring the b-galactosidase activity in crude yeast lysates. For this, a single yeast 
colony was inoculated in 1.5 ml of minimal medium lacking histidine, tryptophan and uracil and 
containing 2% galactose and 1% raffinose. After overnight growth at 30 oC until the culture reached 
OD6oonm»10 , the cells were pelleted and resuspended in 0.2 ml of ice-cold buffer (0.1 M  NaCl, 10 
mM Tris-HCl pH7 .0, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride). About 100 ml acid washed 
glass beads (425-600 mm, Sigma) were added and the suspension was vortexed 6 times for 30 s 
alternated with 30-s incubations on ice. Lysates were centrifuged for 5 min with 14000 rpm at 4oC. 
Supernatants were transferred to fresh tubes and used for protein concentration determination
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(Bradford, 1976). b-Galactosidase activity was measured by adding 10 ml of lysate to 200 ml of 
freshly prepared ONPG buffer (100 mM phosphate buffer pH 7.0, 1 mM MgCl, 10 mM KCl, 50 mM 
b-mercaptoethanol, 0.35 mg/ml o-nitrophenyl-b-D-galactopyranoside (Sigma)) in microtiter plates. 
Reactions were incubated at 30oC and the A 420nm was monitored for 1 h on a CERES U V900C MTP- 
photometer (Bio-Tek). The specific b-galactosidase activity (arbitrary units) was calculated using the 
initial linear part of the A420nm/min curves and normalized for the protein concentration in the sample. 
Every sample was measured in duplicate and for each bait-prey combination, five independent 
colonies were assayed.
C e ll lin e s  an d  c e ll cu ltu re  - Mouse T cell lymphoma W R19L cell line (ATCC TIB52) was grown in 
RPMI 1640 medium containing 10% fetal calf serum. Transformants expressing mouse or human Fas 
and PTP-BL were established by electroporation as described (Itoh et al., 1991). Briefly, 1 x  107 
W R19L cells in 0.5 ml K-PBS (30.8 mM NaCl, 120.7 mM KCl, 8.1 mM Na2PO^ 1.46 mM KH2PO4) 
were cotransfected with 2.5 mg/ml PvuI linearized pcDNA3 (Invitrogen) or pcDNA-BL (full-length 
PTP-BL cDNA (Hendriks et al., 1995) cloned in pcDNA3) and 25 mg/ml VSpI linearized pEF-F58 
(Itoh et al., 1991) or pBOS-EA (Watanabe Fukunaga et al., 1992) by electroporation at 290 V  with a 
capacitance of 960 mF using a Gene Pulser (Bio-Rad). Cells were cultured in 40 ml of RPMI/10 % 
fetal calf serum in 96-well microtiter plates (0.1 ml/well) for 2 days and neomycin-resistant clones 
were then selected in medium containing G418 (900 mg/ml). Cells were analyzed for PTP-BL and Fas 
receptor expression after 14 days of selection.
W estern b lo t d etection  o f  P T P -B L  - W R19L or derived transformed cells were lysed in buffer (10 
mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM EDTA, 0 .5% Nonidet P-40) for 1 h on ice and 
centrifuged for 10 min at 10.000 x  g. Amounts of lysate containing 25 mg of protein were loaded in 
each lane of a 4 % (w/v) polyacrylamide mini-gel (BioRad) and following electrophoresis, proteins 
were blotted onto nitrocellulose (Amersham). The blot was blocked for 30 min in 5 % non-fat dry 
milk in PBST (PBS containing 0.05% Tween-20) and subsequently incubated for 1 h with affinity- 
purified polyclonal antibody directed against the C-terminal catalytic PTP domain of PTP-BL 
(Cuppen et al., submitted) in a one to thousand dilution in PBST containing 1% normal goat serum. 
After subsequent washings, the blot was incubated for 1 h with peroxidase-conjugated goat anti-rabbit 
(20.000 x  diluted, Pierce), washed and labeled bands were visualized using chemiluminescent 
substrate (Pierce) according to the manufacturer’ s instructions.
F lo w  cytofluorom etric an alysis o f  su rfa ce-bo u n d  F a s  recep tor  - Expression of Fas antigen was 
analyzed by incubating 5 x  105 cells in 100 ml of IF buffer (PBS, 1% bovine serum albumine, 0 .1% 
sodium azide) containing 0.5 mg/ml hamster monoclonal antibody Jo2 (Ogasawara et al., 1993) for 
detection of mouse Fas or mouse monoclonal antibody CH-11 (Yonehara et al., 1989) for detection of 
human Fas, for 30 min on ice. The cells were washed twice with IF buffer and incubated with FITC- 
conjugated goat a-hamster-Ig (Jackson Immunoresearch, diluted 1:25 in IF buffer) or FITC- 
conjugated rabbit a-mouse-Ig (Dako, diluted 1:50 in IF buffer). Cells were washed and resuspendend 
in 0.5 ml IF buffer and analyzed on a flow cytofluorometer (Coulter).
A ssa y  fo r  apoptotic resp on se  - Mouse W R19L wild-type or transformed cells were seeded at 1 x  105 
cells/ml in a 24-well tissue culture plate and cultured at 37°C. Cell death was induced by addition of 
anti-Fas monoclonal antibody (Jo2 for mouse Fas or CH-11 for human Fas expressing cells) to a final 
concentration ranging from 10"9 to 10"3 mg/ml. After incubation at 37°C for 1 to 20 hours, dead cells 
were stained by adding propidium iodine to a final concentration of 4 mg/ml and incubating at room 
temperature for 10 min. The percentage of dead cells was determined by flow cytofluorometric 
analysis (Coulter).
N orthern  b lo ttin g  - Total RNA from several tissues was prepared using the guanidium isothiocyate- 
phenol-chloroform extraction method (Chomczynski and Sacchi, 1987). Fifteen mg RNA was loaded 
on a 1% formamide agarose gel, and after electrophoresis the RNA was transferred to nylon 
membrane according to standard procedures (Sambrook et al., 1989). Complete PTP-BL (Hendriks et 
al., 1995) and mouse Fas (Watanabe Fukunaga et al., 1992) cDNAs were radioactively labeled by 
random priming and used as probes for hybridization.
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Abstract
The specificity of protein-protein interactions in cellular signaling cascades is 
dependent on the sequence and intramolecular location of distinct amino acid motifs.
We used the two-hybrid interaction trap to identify proteins that can associate with 
the PDZ motif-rich segment in the protein tyrosine phosphatase PTP-BL. A specific 
interaction was found with the LIM domain-containing protein RIL. More detailed 
analysis demonstrated that the binding specificity resides in the second and fourth 
PDZ motif of PTP-BL and the Lin-11, Isl-1, Mec-3 (LIM) domain in RIL. 
Immunohistochemistry on various mouse tissues revealed a submembranous 
colocalization of PTP-BL and RIL in epithelial cells. Remarkebly, there is also an 
N-terminal PDZ motif in RIL itself that can bind to the RIL-LIM domain. We 
demonstrate here that the RIL-LIM domain can be phosphorylated on tyrosine in 
vitro and in vivo and can be dephosphorylated in vitro by the PTP domain of PTP- 
BL. Our data point to the presence of a double PDZ-binding interface on the RIL 
LIM domain and suggest tyrosine phosphorylation as a regulatory mechanism for 
LIM-PDZ associations in the assembly of multiprotein complexes. These findings 
are in line with an important role of PDZ-mediated interactions in the shaping and 
organization of submembranous microenvironments of polarized cells.
Introduction
Extracellular signals initiate signaling cascades within the cell by activating distinct 
receptor molecules on the cell surface. Signals are then propagated and amplified via 
specific cytosolic proteins or second messengers and ultimately are translated in specific 
cellular responses (Songyang and Cantley, 1995). Separate cascades in this complex 
signaling network depend on specific protein-protein interactions, which are mediated by 
different protein motifs like SH2, SH3, PID/PTB and PH domains (Cohen et al., 1995; 
Pawson, 1995; Lemmon et al., 1996). Reversible tyrosine phosphorylation plays an 
important regulatory role in signal transduction events (Hunter, 1995); for example, SH2 
and PID/PTB interactions are critically dependent on this type of modification. The role of
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protein tyrosine kinases in these processes has been studied extensively; target molecules 
have been identified and a broad range of cellular effects have been characterized. In 
contrast, relatively little is known about the role of protein tyrosine phosphatases (PTPs), 
although many different PTP family members have been isolated over the past years. PTPs 
contain one or two catalytic domains and a bewildering variety of protein motifs, which 
may serve to target the enzymes to restricted microcompartments and specific substrates 
within the cell (Mauro and Dixon, 1994). The current challenge is to obtain a better 
understanding of these features and identify subcellular compartments and binding proteins. 
Mouse PTP-BL (Hendriks et al., 1995) or RIP (Chida et al., 1995) is a large cytosolic PTP 
(Fig. 1A) containing a single catalytic tyrosine phosphatase domain and protein motifs 
which show similarities to both submembranous proteins and known tumor suppressor gene 
products. The human homologue of this protein has been termed PTP-BAS (Maekawa et 
al., 1994), hPTP1E (Banville et al., 1994), PTPL1 (Saras et al., 1994) and FAP-1 (Sato et 
al., 1995). Chromosomal localization of PTP-BAS placed the gene on 4q21, a region for 
which various cytogenetic abnormalities in human tumors have been reported (Inazawa et 
al., 1996; van den Maagdenberg et al., 1996). The PTP-BL polypeptide is split up in several 
distinct segments. Its N-terminus is subject to alternative splicing (Chida et al., 1995; our 
unpublished observations) and contains a putative leucine zipper motif (Saras et al., 1994), 
which may be involved in homo- or hetero-dimerization of the protein. This region is 
followed by a band 4.1-like domain, the common domain in the ezrin, radixin moesin 
family members, which is thought of as a linking segment between the actin cytoskeleton 
and the cell membrane (Tsukita et al., 1993). The band 4.1-like domain is also present in 
the product of the neurofibromatosis type 2 tumor suppressor gene, merlin or 
schwannomin, and in the D r o so p h ila  m e la n o g a ste r  tumor suppressor exp a n d ed , a protein 
involved in the control of cell proliferation in imaginal discs (Boedigheimer et al., 1993; 
Tsukita et al., 1993). At its very C-terminal end, PTP-BL harbors the tyrosine phosphatase 
domain that is catalytically active in vitro on artificial substrates (Hendriks et al., 1995), but 
in vivo substrates remain to be identified.
In between the band 4.1-like and the PTP domain PTP-BL contains five PDZ motifs. PDZ 
motifs, formerly referred to as GLGF repeats (Cho et al., 1992) or discs-large homologous 
regions (Woods and Bryant, 1993) were first identified as 90 amino acid (aa) repeats in 
PSD-95, DlgA and ZO-1. The D r o so p h ila  protein DlgA is the prototype of the family of 
membrane associated guanylate kinases. These proteins contain one or three N-terminal 
PDZ motifs, a SH3 motif and a guanylate kinase motif and are localized to specialized 
submembranous structures. DlgA is required for the maintenance of the septate junction 
structure, for the proper organization of the cytoskeleton and for apicobasal polarity of 
epithelial cells (Woods et al., 1996). Other members of this rapidly growing protein family 
were found to interact with the cytoplasmic tail (T/SxV) of Shaker-type K+ channels and of 
modulatory subunits (NR2) of NMDA-type glutamate receptors (Kim et al., 1995; Kornau
67
Chapter 4
et al., 1995; Niethammer et al., 1996) and thus may play an important role in the clustering 
o f  membrane proteins (Garner, 1996; Gomperts, 1996). Recently, the m olecular basis o f  the 
C-terminal peptide recognition by P D Z motifs was revealed by x-ray crystallography 
(Doyle et al., 1996). It appears that specific side chain interactions and a prominent 
hydrophobic pocket at the P D Z m otif surface explain the selective recognition o f the last 
four or five C-terminal residues o f the target protein. The binding to C-terminal peptide 
motifs is mediated by an antiparallel interaction between b-strands and is reminiscent o f  the 
manner in w hich PID/PTB domains associate with phosphotyrosine-containing peptides 
(Doyle et al., 1996). In addition, it appears that P D Z motifs do not recognize exclusively C- 
terminal motifs. For example, the the binding o f the P D Z m otif in IN A D  to the TRP C a2+ 
channel is critically dependent on an interaction with an internal S T V  peptide (Shieh and 
Zhu, 1996). Furthermore, work on neuronal nitric oxide synthase (nNOS) suggests that 
specific P D Z motifs can recognize C-terminal peptide motifs as w ell as form ing apparently 
homophilic associations with other P D Z motifs (Brenman et al., 1996; Stricker e t a l ,  1997; 
Schepens et al., 1997). M ost recently, a P D Z m otif in A L P  (actinin-associated L IM  protein) 
has been described that binds to the spectrin-like motifs o f  a-actinin -2 (Xia et al., 1997).
Our search for proteins that bind to the five P D Z motifs present in PTP-B L now provides 
evidence for yet another type o f  interaction that can be mediated by P D Z  motifs. The 
second P D Z m otif o f  PTP-B L  as w ell as the P D Z m otif o f  RIL (reversion induced LIM  
gene; Kiess et al., 1995) itself were found to bind specifically to the RIL L IM  domain 
structure. The fourth P D Z m otif o f  P T P-B L  can also interact with RIL, but for this 
interaction to occur both the L IM  domain and the proper C-terminus o f RIL are necessary. 
Thus, along with PDZ-C-terminus and PDZ-internal peptides, PD Z -LIM  interactions may 
contribute to the com plex organization and dynamics o f  macromolecular assemblies at the 
cell cortex.
Results
The reversion-induced LIM-containingprotein RIL interacts with PTP-BL PDZ motifs
Candidate proteins interacting w ith the five P D Z motifs o f  P TP-B L were obtained from  a 
human G 0 -fibroblast cD N A  library using B L-PD Z-(I-V ) (Fig. 1A ) as a bait in the yeast 
two-hybrid interaction trap (Gyuris et al., 1993). Sequence analysis showed that two 
independent but overlapping clones o f  0.6  and 0.5 kb pairs encoding the C-terminal part o f 
the human homologue o f  rat RIL were obtained (hRIL(164-330) and hR IL(188-330), 
respectively, F ig. 1B ). RIL was originally identified as a gene which is down-regulated in 
H-Ras-transformed rat fibroblasts (Kiess et al., 1995). The RIL protein contains a single 
L IM  domain at its C-terminus, which is a special double zinc finger m otif implicated in 
protein-protein interactions in a broad range o f polypeptides (reviewed by D aw id et al.,
1995). The L IM  domain is entirely present in our partial h-RIL cD N A  clones (Figs. 1B  and
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Figure 1: Schematic representation of the protein segments used in the two-hybrid interaction trap. 
Shown are the regions of PTP-BL (A) used as baits and the RIL segments [hRIL(164-330) and 
hRIL(188-330)] (B) as they were retrieved from the GO-fibroblast cDNA library and the RIL PDZ 
domain used as bait to assay for intramolecular interactions. In parentheses, the numbers 
corresponding to the first and last aa positions in the PTP-BL and RIL segments are shown. Band 4 .1- 
like domain, hatched box; PTP, open box; PDZ motifs, black ovals; LIM domain, stippled box.
250 a.a
50 a.a
2). Comparison of the RNA in situ hybridization patterns of RIL (Kiess et al., 1995) and 
PTP-BL (Hendriks et al., 1995) revealed a conspicuous overlap in expression, implying that 
the interaction observed may indeed be of biological relevance.
To further study this interaction, a mouse fetal brain cDNA library was screened using the 
human 0.6 kb pair RIL cDNA insert as a probe. Two cDNAs of 1.2 and 1.5 kb pairs 
respectively, were obtained and their combined sequence (EMBL Nucleotide Sequence 
Database accession number Y08361) predicts an open reading frame resulting in a 330 aa 
polypeptide with a predicted molecular weight of 36,000 (Fig. 2). Transient expression of 
the cDNAs employing the pSG5 vector (Green, 1988) in COS-1 cells resulted in a protein 
product with an apparent molecular weight of 38,000. This is identical in size to 
endogenous RIL as detected on Western blots of several mouse tissue lysates by an affinity- 
purified polyclonal antiserum raised against the C-terminal half of human RIL (our 
unpublished results).
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10 20 30 40 50
mouse MTHSVTLRGP SPWGFRLVGG RDFSLPLTIS RVHAGSKAAL AALCPGDLIQ
rat -- A------ ---------------A----------------  -------S--
human -P-------- --------- --- A-------------- S- ----------
60 70 80 90 100
mouse AINGESTELM THLEAQNRIK GCHDHLTLSV SRPENKNWPS SPDD KAQAHR
rat ---------- ---------- ---------------------  --N-  
human---------- ---------- ---------------GRS---A----S------
110 120 130 140 150
mouse IHIDPEFQDC SPATSRRSSV SGISLEDNRS GLGSPYGQPP RLPVPHNGSS
rat ----- A - - G --------- 1 ---------- -----------  ----------
human----- I--G -T-----P-G T-TGP--G-R S------K-- CF--------
160 I 170 180 I 200
mouse NEATLPAQMS ALHVSPPTSA DTARVLPRNR DCRVDLGSEV YRMLREPAEP
rat --V-- S----------- P-- --P-I----------------  ----------
human --------- -------P-- -P-EA S-GA GS--------  ----------
210 220 230 240 250
mouse TASEPKQSGS FRYLQGMLEA GEGGDRPGSG GPRNLKPAAS KLGAPLSGLQ
rat A--------- ---------- ------------S--------  ----------
human V-A------  ---------- ---- W-P-- ------- T-- ----------
260 270 280 290 300
mouse GLPECTRCGH GIVGTIVKAR DKLYHPECFM CSDCGLNLKQ RGYFFLDERL
rat -------  -------  ------- --------- -------
human--------C- -------- E- ---------- -----------  ----------
310 320 330
mouse YCENHAKARV KPPEGYDVVA VYPNAKVELV *
rat ---------- ---------- ----------
human --S------  ---------- ----------
Figure 2: Sequence alignment o f RIL protein sequences from mouse, rat, and human.
Protein sequences o f mouse (acc.no. Y 08361), rat (Kiess et a l, 1995, acc. no. X 76454), and hRIL 
(Schaefer, unpublished, acc.no. X 93510) were aligned using MULTALIGN. Aas identical to those of 
the mouse sequence are indicated with a dash. The PDZ motif is double underlined and the LIM 
domain is indicated by a single underline. Vertical arrows indicate the start positions of clones 
hRIL(164-330) and hRIL(188-330), which were originally identified in the two-hybrid interaction 
screening with the BL-PDZ-(I-V) bait. A  potential tyrosine phosphorylation site is shaded.
Comparison of mouse, human and rat RIL sequences revealed a high species conservation 
(Fig. 2). The mouse peptide is 96 % identical to rat and 87 % to hRIL. Highest homologies 
were found at the N- and C-termini, suggesting a biological relevance for these regions. 
The C-terminal end brackets the LIM domain (aas 253-303), but in the N-terminus initially 
no conserved protein motif was discerned. Surprisingly, by performing more detailed 
database searches, we found that the N-terminal segment showed significant similarities to 
proteins known to contain PDZ motifs. This led to the identification of a previously 
undiscovered N-terminal PDZ motif (aas 4-84) in RIL (Fig. 3) that shows 40-45% 
homology to any of the three PDZ motifs of DlgA. It is most homologous to thus far 
unnoticed N-terminal PDZ motifs in CLP-36 (77%; Wang et al., 1995) and enigma (67%; 
Wu and Gill, 1994). In the 150 aa spacer region between the PDZ motif and the LIM
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Figure 3: Multiple alignment of PDZ motifs.
The PDZ motif of mouse RIL is aligned with the PDZ motifs of D rosophila  DlgA (DLG1, DLG2 and 
DLG3; acc.no. M 73529), mouse PTP-BL (BL1 through 5; acc.no. Z 32740), rat CLP36 (acc.no. 
U23769), human enigma (PIR:A55050), mouse nNOS (acc.no. D 14552) and mouse LIM K1 (acc.no. 
X 86569). The position number of the initial and last aa of the protein segments that were used are 
shown on either side of the sequence. Sequences presented below RIL are ordered by descending 
homology. Aas similar (score >0.7 in Dayhoff table (Schwartz and Dayhoff, 1979) in 9 of 13 
sequences are shown on a gray background, and the most frequent aa at these positions is indicated in 
the consensus line. Aas identical in more than half of the sequences are indicated in white on a black 
background. Dashes represent sequence gaps.
domain of RIL, the identity between species is much lower and no protein motifs could be 
identified. Interestingly, a potential tyrosine phosphorylation site ([RK]-x(2,3)-[DE]-x(2,3)- 
Y) was found within the LIM domain (Y-274).
Both the second and fourth PTP-BL PDZ motif can interact with RIL
To narrow down the areas involved in the PTP-BL - RIL interaction, single BL-PDZ motifs 
were fused to the LexA bait (Fig. 1A) and assayed for an interaction with both the partial 
hRIL clone [hRIL(164-330)] and mRIL-FL in the yeast two-hybrid interaction trap (Fig. 4).
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None of the baits used was able to activate transcription without prey (our unpublished 
results) or with an empty prey vector present (Fig. 4). For an interaction with hRIL(164- 
330) and mRIL-FL to occur the presence of the second (aas 1352-1450) or the fourth (aas 
1756-1855) PDZ motif of PTP-BL was both necessary and sufficient. Furthermore, no 
interaction could be observed between RIL and the band 4.1-like domain or the PTP 
domain of PTP-BL (Fig. 4). This does not necessarily imply, however, that RIL is not a 
substrate for PTP-BL. Tyrosine phosphorylation levels are extremely low in yeast and 
proper phosphorylation of RIL may be a necessary prerequisite for such an interaction. 
Interestingly, the interaction appears weaker if a single PDZ motif is used as a bait 
compared with the bait containing the five PDZ motifs [BL-PDZ-(I-V)]. This difference 
may be explained by the ability of BL-PDZ-(I-V) bait to bind more than one prey protein, 
leading to stronger transcription activation of the reporter and thereby to a higher b- 
galactosidase activity in this assay. Another explanation may be that the second and fourth 
PTP-BL PDZ motifs bind in a cooperative way to one RIL molecule, thereby stabilizing the 
interaction. Finally, BL-PDZ-(I-V) may form large aggregates through PDZ-PDZ 
interactions and recruit multiple, synergistically acting prey proteins to the complex. 
Therefore we tested whether the PDZ motifs of PTP-BL and RIL can mediate homotypic 
interactions. Because no evidence was found for this type of interactions (Table I), we may 
exclude the latter model as an explanation for our observations.Furthermore, our results
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Figure 4: Determination of the relative strength of two-hybrid interactions.
b-galactosidase activities (arbitrary units) were measured in total lysates of yeast containing a LacZ- 
reporter plasmid. The yeast cells contained plasmids encoding baits as indicated below the bars, and 
the empty prey vector pJG4-5 (A, gray bars), hRIL(164-330) (B, filled bars), or mRIL-FL (C, open 
bars). Error bars indicate SD (n=5).
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indicate that, in contrast to BL-PDZ-II, the interactions of BL-PDZ-(I-V) and BL-PDZ-IV 
with the mRIL-FL are significantly weaker than with the partial hRIL (Fig. 4). This effect is 
not caused by differences between mouse and human RIL sequences, because similar 
results were obtained with the partial mouse RIL clone [mRIL(209-330)], (Fig. 7). These 
data suggest the presence of a negatively regulating element located in the N-terminal part 
of RIL, which does not affect BL-PDZ-II binding.
Table 1: Two-hybrid interaction trap assays to test for PDZ-PDZ and
LIM- LIM interactions
BL-PDZ-(I-V) RIL-PDZ mRIL(209-330)
BL-PDZ-(I-V) - - +
RIL-PDZ - - +
mRIL(209-330) + + -
Baits (top row) and preys (vertical row) were constructed and used as described in 
materials and methods. +, interaction (blue colonies after 3 d); -, no interaction (no 
blue colonies after 7 d)._______________________________________________
RIL can be coprecipitated with BL-PDZmotifs
Although the two-hybrid interaction trap is a very powerful tool to identify potential partner 
proteins, interactions need to be confirmed in test systems that can provide the normal 
cellular environment of the molecules involved. Therefore, we have transiently coexpressed 
epitope-tagged PDZ motifs and RIL in mammalian epithelial cells (COS-1) as substrates 
for immunoprecipitation. Pull-down of the product of the partial RIL cDNA [hRIL(164- 
330)] was demonstrated for BL-PDZ-(I-V), BL-PDZ-II and BL-PDZ-IV (Fig. 5), 
confirming the results obtained in the yeast two-hybrid interaction trap. Again, no 
interaction between the band 4.1-like and the PTP domain of PTP-BL with RIL was 
observed. Strikingly, coprecipitation with single PDZ motifs (BL-PDZ-II and BL-PDZ-IV) 
is much less efficient than with BL-PDZ-(I-V). This is not a concentration effect because 
the amount of epitope-tagged PDZ motif present in the extracts, as determined by Western 
blotting, was comparable for all constructs used (our unpublished observations). The 
difference in the amount of coprecipitated RIL is significantly more than two-fold, 
excluding binding by BL-PDZ-(I-V) of two RIL molecules (via PDZ-II and PDZ-IV) as the 
only explanation for this phenomenon. Interestingly, we consistently observed very low 
concentration of mRIL-FL in our lysates (Fig. 8). This probably explains why 
coprecipitation of mRIL-FL was barely detectable (our unpublished observations). 
Preliminary observations indicate a rapid degradation of mRIL-FL, which in vivo may be 
an important regulatory element in RIL function.
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Figure 5: Coprecipitation of RIL with PDZ motifs.
VSV epitope-tagged PDZ motifs of PTP-BL and RIL were transiently coexpressed in COS-1 cells 
with the C-terminal part of RIL, hRIL(164-330). a-VSV mAbs were used to immuno-precipitate the 
various PDZ motifs. Coprecipitated RIL was detected by Western blotting using a pAb (a-RIL) 
directed against the C-terminal part of hRIL. The labels on top refer to the protein segments outlined 
in Fig. 1 and the dash indicates mock-transfected cells.
PTP-BL and RIL colocalize in situ
To substantiate the biological relevance of the PTP-BL - RIL interaction we studied the 
tissue distribution and subcellular localization of these proteins by immunohistological 
assays (Fig. 6). Affinity-purified rabbit polyclonal antiserum against PTP-BL (a-BL-PDZ-I 
and a-BL-PTP) and hRIL (a-RIL) were used to detect the endogenous proteins. The results 
are in full agreement with those obtained by previous RNA in situ hybridization studies 
(Hendriks et al., 1995; Kiess et al., 1995). Expression of both proteins could be observed in 
various mouse epithelia. Detailed examination of lung cryosections revealed that the 
epithelium covering the bronchi expresses high amounts of both PTP-BL and RIL, whereas 
other parts of the lung show no detectable expression. PTP-BL and RIL are both expressed 
exclusively at the apical site of these epithelial cells. High expression levels were also 
found in the glandular part of the stomach and again both RIL and PTP-BL are consistently 
detected apically in all epithelial cell types studied. In corneal epithelium of mouse skin and 
in the non-glandular part of the stomach (our unpublished observations), both proteins are 
distributed in dot-like structures close to the cellular membrane, suggestive of a 
desmosome-like pattern. In fact, all near-membrane regions in the epidermis are positive 
for both PTP-BL and RIL except for the basement membrane of the basal cell layer which 
is negative for both proteins. The dermis and stratum corneum were found to be completely 
negative, whereas epithelia covering glands and hair follicles were again positive (our 
unpublished observations). Taken together, we may conclude that PTP-BL and RIL are
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Figure 6: Colocalization of PTP-BL and RIL in mouse tissues.
Visualization of the presence of PTP-BL and RIL proteins mouse lung, stomach, and skin was done 
using immunofluoresence labeling with affinity-purified pAb directed against PTP-BL (a-BL-PDZ-I 
and a-BL-PTP) and RIL (a-RIL). Corresponding hematoxylin/eosin-stained sections (HE) are shown 
for comparison. Bars, 25 mm.
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coexpressed apically in all polarized epithelial cell types studied so far, where they may 
play a role in the establishment or maintenance of the polarized phenotype of these cells.
The RIL LIM domain is necessary for interaction with PTP-BL PDZ motifs
Having shown the possibility for PTP-BL and RIL to interact in vivo, we next studied the 
molecular basis of their association. To determine the minimal region in RIL necessary for 
an interaction with the PTP-BL PDZ motifs, a series of N- and C-terminally truncated RIL 
peptides was used as a prey in the interaction trap along with BL-PDZ-II and BL-PDZ-IV 
as baits (Fig. 7). For BL-PDZ-II the entire RIL LIM-domain, including flanking N-terminal 
and C-terminal sequences, is needed to enable a strong interaction. Further truncation 
towards the LIM domain resulted in a weaker but still significant interaction (as determined 
by b-galactosidase activity measurements of total yeast lysates; our unpublished results). It 
is important to note that deletion of the last four RIL residues [mRIL(209-326)] does not 
affect binding. This defines the minimal region of RIL necessary for interaction with BL- 
PDZ-II to the polypeptide stretch between aa positions 249 and 309, which is essentially the 
complete LIM domain (Fig. 7).
In the same way, the minimal region of RIL for BL-PDZ-IV interaction was determined 
and assigned to the complete segment between aas 249 and 330 (Fig. 7). In contrast to BL- 
PDZ-II, deletion of the C-terminal 21 residues or the last 4 residues of RIL resulted in the 
abolishment of any detectable interaction, indicating that these residues are most relevant 
for interaction with BL-PDZ-IV. However, the C-terminal 15 or 21 residues alone, which 
are 100% conserved between mouse and human, did not show any interaction (Fig. 7). 
These results indicate that both the LIM domain and the proper C-terminus are necessary 
for a strong BL-PDZ-IV interaction with RIL, clearly distinguishing this mode of 
interaction from that described for PDZ motifs with C-terminal peptides (Doyle et al.,
1996) and also from the interaction between BL-PDZ-II with the RIL-LIM domain reported 
here.
Because C-terminal consensus binding sequences have been determined for PDZ-II and IV 
of PTP-BAS by screenings of oriented peptide libraries (Songyang et al., 1997), we looked 
for the presence of these motifs in the entire RIL molecule. The last four residues of RIL 
are -VELV and the consensus for PDZ-II and IV binding are -(E/V)(T/S)X(V/I) and -  
(I/Y/V)YYV, respectively, which should be considered a very weak match. Strikingly, 
there is an internal TIV motif within the first loop of the LIM domain. However, mutation 
of this TIV to GIQ did not affect the BL-PDZ-II or IV interaction with RIL (Fig. 7). This 
contrasts markedly with the INAD PDZ motif-binding characteristics to the 19-aa C- 
terminus of TRP, which contains an essential (S/T)XV motif (Shieh and Zhu, 1996).
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Figure 7: Analysis of PDZ-mediated interactions with truncated RIL peptides.
Schematic representation of the regions of RIL used as prey in the two-hybrid interaction trap are 
shown on the left. Interaction results using these constructs combined with BL-PDZ-II, BL-PDZ-IV 
and mRIL-PDZ as baits are represented by + and - signs. +++, very strong interaction (blue colonies 
within 2 d on X-gal assay plates); ++, interaction (blue colonies after 3 d); +, weak but detectable 
interaction (blue colonies after 4-6 d); -, no interaction detectable (no blue colonies after 7 d).
The RIL LIM domain is phosphorylated on tyrosines in vitro and in vivo and is an in 
vitro substrate for PTP-BL
Our results clearly indicated that the entire RIL LIM domain is necessary for the interaction 
with PTP-BL. This domain harbors a potential tyrosine phosphorylation site at position 
274. To study whether the RIL LIM domain can be phosphorylated on tyrosines in vitro 
and may function as a substrate for PTP-BL, we induced GST-fusion proteins in TKX 
bacterial cells, which contain an inducible tyrosine kinase (Stratagene). No tyrosine 
phosphorylation of GST alone or GST-PDZ could be detected by Western blot analysis, 
whereas GST-RIL-LIM was phosphorylated on tyrosines in this bacterial system (Fig. 8A). 
The bands of lower molecular weight in the GST-RIL-LIM lane are most probably due to 
degradation of the fusion protein. Although there are several tyrosines within the GST-RIL- 
LIM sequence, only tyrosine 274 was predicted to be a substrate for tyrosine kinases by the 
PROSITE database. Therefore, we mutated this tyrosine to a phenylalanine (GST-RIL- 
LIM-Y-F). The tyrosine phosphorylation of the Y274F mutant fusion protein is markedly
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F ig u re  8: RIL is phosphorylated on tyrosines in vitro and in vivo and is an in vitro substrate for PTP- 
BL.
(A) GST-fusion proteins were purified from bacterial TKX cells expressing an inducible tyrosine 
kinase. Purified protein was detected by Western blotting using an anti-GST antibody (top panel) and 
analyzed for tyrosine phosphorylation using the phosphotyrosine specific antibody PY20 (bottom 
panel). Only GST-RIL-LIM (aas 209-330) is phosphorylated on tyrosines and mutation of tyrosine 
294 to phenyalanine (GST-RIL-LIM-Y-F) clearly diminishes the phosphorylation level. (B) Purified 
phosphorylated GST-RIL-LIM was incubatedfor 15 min with purified GST or GST-BL-PTP (aas 
2101-2460) and analyzed for its phosphotyrosine content. GST-BL-PTP can dephosphorylate the 
RIL-LIM domain, whereas GST alone does not affect the tyrosine phosphorylation. Furthermore, the 
specific tyrosine phosphatase inhibitor vanadate can completely inhibit the dephosphorylation by 
GST-BL-PTP. (C) COS-1 cells were transfectedwith an expression construct encoding the C-terminal 
half of RIL [hRIL(164-330)] or mRIL-FL. The presence of transiently expressed RIL in total cell 
lysates and anti-RIL immunoprecipitates was detected by Western blotting using anti-RIL antibody. 
(D) The tyrosine phosphorylation content of the same samples as depicted in C was determined by 
Western blotting using the phosphotyrosine-specific antibody PY20. Both the immunoprecipitated 
hRIL(164-330) and the mRIL-FL are found to be phosphorylated on tyrosine residues.
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reduced (Fig. 8A), but other residues are phosphorylated as well in this bacterial system. 
The fact that tyrosine-phosphorylated GST-RIL-LIM can be dephosphorylated by addition 
of purified GST-BL-PTP, whereas GST alone had no effect (Fig. 8B), clearly demonstrates 
that the phosphorylated RIL-LIM domain is an in vitro substrate for PTP-BL. Moreover, 
the specific tyrosine phosphatase inhibitor vanadate can completely inhibit the tyrosine 
dephosphorylation by GST-BL-PTP (Fig. 8B).
To study this phosphorylation in a more physiological context, we immunoprecipitated the 
RIL LIM domain hRIL(164-330) and mRIL-FL from transiently overexpressing COS-1 
cells that were treated for 15 min with vanadate. The presence of the RIL protein in the 
lysate and the immunoprecipitation was demonstrated by Western blotting and 
immunodetection using a-RIL antibodies (Fig. 8C). Tyrosine phosphorylation of both 
mRIL-FL and the RIL-LIM domain was demonstrated by incubating the Western blot with 
the phosphotyrosine specific antibody PY-20 (Fig. 8D).
An intra molecular RIL PDZ - LIM interaction
Because RIL contains a PDZ motif itself (Figs. 2 and 3) the possibility of an intramolecular 
interaction between this N-terminal PDZ motif (aas 4-84) and the RIL C-terminus was 
studied. We tested aas 1-101 of RIL (mRIL-PDZ, Fig. 1B), containing the entire RIL-PDZ 
motif, for binding to mRIL-FL or the C-terminal part of RIL [hRIL(164-330)] using the 
two-hybrid interaction trap. Indeed, a significant interaction was observed, but in contrast to 
the findings with BL-PDZ-IV, the interaction is much stronger with the mRIL-FL than with 
the truncated protein (Fig. 4). This may be explained by the possibility of mRIL-FL to form 
linear multimers via PDZ-LIM interactions, recruiting multiple prey activation domains to 
one bait. The possibility of sequence differences between human and mouse RIL 
influencing the interaction was excluded using truncated mouse RIL [mRIL(209-330)] 
along with the mouse RIL PDZ motif, which gave the same results (Fig. 7). The testing of 
truncated C-terminal RIL peptides for their ability to interact with the RIL PDZ motif 
demonstrated weak but significant interactions for all constructs containing the LIM 
domain (Fig. 7). Interestingly, the RIL-PDZ motif interacts more strongly with the 
construct lacking the last four residues [mRIL(209-326)] than with mRIL(209-330), 
perhaps reflecting an inhibitory effect of these residues on RIL-PDZ binding. Again, the 
interaction between the RIL PDZ motif and the LIM domain could be confirmed by 
coprecipitation of the RIL C-terminus with epitope-tagged RIL-PDZ motif from transiently 
coexpressing COS-1 cells (Fig. 5). Because it has been shown that LIM domains can 
engage in homo- and heterodimerization (Feuerstein et al., 1994), we tested the ability of 
the RIL C-terminus (aas 209-330) containing the LIM domain including flanking 
sequences, to homodimerize using the two-hybrid interaction trap. No interaction was 
observed, by the use of experimental conditions in which RIL-PDZ or BL-PDZ-(I-V) 
interactions could be readily detected (Table 1).
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Discussion
The protein tyrosine phosphatase PTP-BL contains in addition to its catalytic segment a 
band 4.1-like domain and five PDZ motifs, features that predict a restricted localization at 
submembranous or cytoskeletal structures within the cell (Ponting and Phillips, 1995; 
Tsukita et al., 1993). To obtain experimental evidence for this prediction and identify the 
individual protein constituents in the subcellular microenvironment, a two-hybrid screen 
was performed using the segment encompassing the five PDZ motifs of PTP-BL as a bait. 
An interacting protein was obtained that previously had been identified in rat as RIL, the 
product of a gene that is down-regulated in H-Ras transformed fibroblasts (Kiess et al.,
1995). The interaction was confirmed by transfection experiments in COS-1 cells. Perhaps 
more importantly, the possible in vivo relevance of this interaction is firmly corroborated 
by the extensive overlap in RNA expression patterns in mouse (Hendriks et al., 1995; Kiess 
et al., 1995). Also the fact that both proteins are consistently localized at the same 
subcellular structures, such as the submembranous apical side of polarized epithelial cells, 
in mouse tissue sections (Fig. 6) supports our view that this interaction must have 
biological significance. Because PTP-BL is up-regulated by differentiation stimuli in mouse 
erythroleukemia and embryonal carcinoma (F9) cells (Chida et al., 1995) and RIL is 
downregulated in transformed cells (Kiess et al., 1995), it is tempting to speculate that the 
formation of PTP-BL-RIL complexes is a crucial aspect in the control of growth and 
differentiation of epithelial cells.
What could be the features that govern binding interaction and determination of PTP-BL- 
RIL location? The RIL protein contains a C-terminal LIM domain and, in addition, we 
identified a N-terminal PDZ motif (Fig. 3). We demonstrate that these motifs can mediate 
intermolecular and perhaps intramolecular associations because, like the second and fourth 
PTP-BL PDZ motif, the RIL PDZ motif can engage in binding to the RIL LIM domain 
(Figs. 4, 5 and 7). In view of results obtained in other studies (Kim et al., 1995; Kornau et 
al., 1995; Niethammer et al., 1996; Songyang et al., 1997) it is striking that ablation of the 
last four residues of RIL did not affect PDZ-II interaction and enhanced RIL-PDZ binding, 
whereas no PDZ-mediated interactions could be observed with the RIL C-terminus alone 
(Fig. 7). In contrast, for the BL-PDZ-IV binding there is dependence on the integrity of the 
C-terminus of RIL, but again not uniquely on the presence of the very last aa residues only. 
Random mutagenesis of the RIL-LIM domain confirms the above observations (our 
unpublished observations).
How can we reconcile these findings to the known properties of PDZ motifs? Thus far, one 
interaction mode for PDZ motifs has dominated the literature: recognition of a very short 
C-terminal sequence motif (Fanning and Anderson, 1996; Gomperts, 1996). The x-ray 
crystallographic structure of the third PDZ motif from the synaptic density protein PSD- 
95/SAP90 in the absence and presence of a binding peptide has recently been determined 
(Doyle et al., 1996) and provides a solid basis for our understanding of the recognition of
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the T/SXV C-terminus as present in multiple channel and receptor subunits. That PDZ 
motifs are also able to bind to internal peptide segments has been inferred from studies on 
the PSD-95/SAP90 interaction with nNOS (Brenman et al., 1996; Schepens et al., 1997). 
An explanation for this was provided by assuming that not only a C-terminal sequence, but 
also an internal B-strand may interact with PDZ motifs in a similar manner (Harrison,
1996). This can indeed be witnessed in the crystal structure of the PDZ-III domain of hdlg, 
which displays a dimer mediated by b-strands in both molecules (Morais Cabral et al.,
1996). Also, the binding of the INAD PDZ motif to the TRP store-operated channel 
deviates from the C-terminus rule. Although the interaction was localized to the 19-aa C- 
terminus of TRP, it appeared critically dependent on the presence of an internal STV motif 
(Shieh and Zhu, 1996). It has been proposed that alterations of residues within the 
carboxylate-binding loop of PDZ motifs could facilitate this binding of a peptide-internal 
segment (Fanning and Anderson, 1996). Strikingly, PDZ II and IV of PTP-BL and also the 
RIL PDZ motif share features with INAD, in that they contain a SLGI/F instead of a GLGF 
motif, and perhaps this represents a signature motif for domains with internal peptide­
segment avidity. Further elaboratingon an analogy to the INAD PDZ-TRP binding (Shieh 
and Zhu, 1996), an internal TIV peptide can be found within the first zinc-finger of the 
RIL-LIM domain. However, mutation of this peptide does not affect the interaction with 
PTP-BL, indicating that sequences outside this tripet are more important.
Taken together, the experimental data presented here provide compelling evidence for a 
novel type of protein-protein interaction mediated by PDZ motifs and LIM domain 
structures, that is structurally different from the C-terminus recognition mode by other PDZ 
motifs. The sequences flanking the LIM domain, including the C-terminus, may be directly 
involved in binding (in the case of PDZ-IV) or they may be important for stabilizing the 
LIM domain structure. Our results of course do not exclude that the PDZ motifs of PTP-BL 
can engage in more classical interactions or interactions with proteins other than RIL. For 
example, screening of an oriented peptide library with PDZ-II of the human homolog of 
PTP-BL, PTP-BAS, revealed the consensus C-terminal target T/SxV/I (Songyang et al.,
1997). This sequence is present in human Fas and indeed it has been shown that PDZ-II of 
PTP-BL can interact with human Fas (Sato et al., 1996, Saras et al., 1997a, Cuppen et al.,
1997) but not with mouse Fas, as this has a different C-terminal end (Cuppen et al., 1997). 
However, the interaction was found to be 30- to 40-fold weaker than the binding to the 
RIL-LIM domain in our assays (Cuppen et al., 1997; Fig. 4). Also for nNOS two different 
binding modes have been described (Schepens et al., 1997) and even the presence of 
separate binding interfaces on the PDZ protein module can not be excluded. In fact, a 
coordinate involvement of different binding interfaces on both the PDZ and the RIL-LIM 
motifs is suggested by our findings. Coprecipitation of truncated forms of RIL from cell 
lysates is much more efficient for constructs containing the PTP-BL PDZ motifs II and IV 
together, than for those harboring a single PDZ motif (Fig. 5). This effect cannot just be
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explained by the binding of two RIL molecules to a single PDZ-(I-V) peptide and one has 
to assume a cooperative or stabilizing effect resulting from the binding of two distinct PDZ 
motifs to one and the same LIM domain. Moreover, the observation that PDZ-II and PDZ- 
IV differ in their minimal requirements for interaction with RIL LIM sequences (Fig. 7) is 
in line with the presence of two binding interfaces in the LIM domain. This would explain 
why the binding of the RIL PDZ motif to the RIL LIM domain does attenuate the binding 
of the fourth but not the second PDZ motif of PTP-BL in the two-hybrid experiments (Fig. 
4). The possibility of two interacting interfaces on a single LIM domain has also been put 
forward by Arber and Caroni (1996) and from structural data it can be deduced that distinct 
binding interfaces may reside in the two independent zinc finger modules, each with 
different aa composition of their loop (Hammarstrom et al., 1996; Perez Alvarado et al.,
1996).
If the RIL-LIM domain can indeed bind two different PTP-BL molecules very large 
clusters could be formed. The unoccupied PDZ motifs of PTP-BL and RIL in this assembly 
may in turn interact with other proteins, thus generating even larger heterogeneous protein 
complexes in which the band 4.1-like domain of PTP-BL may be responsible for a proper 
submembranous localization. The ability of RIL to form an intramolecular PDZ-LIM 
interaction, inducing disassembly or rearrangements of the complex, could then function as 
a regulatory principle. It is also conceivable that the phosphorylation of tyrosine residues 
within the RIL LIM domain, which we have demonstrated to occur in vitro and in vivo 
(Fig. 8), may function as such a regulatory switch for clustering behavior. In addition, the 
tyrosine phosphatase domain of PTP-BL may be a determinant of the phosphorylation 
status of proteins in such a complex. The recent identification of a GTPase-activating 
protein for Rho, PARG, which can interact with the human homolog of PTP-BL (Saras et 
al., 1997b) and the colocalization of RIL with F-actin (our unpublished observations), 
implicate a role for such a multiprotein PTP-BL complex in actin-cytoskeleton dynamics. 
The principle of PDZ-LIM-mediated interactions as demonstrated here could have 
widespread biological significance because, in addition to RIL, several other LIM domain- 
containing proteins, such as CLP-36, ALP, enigma, LIMK1 and LIMK2 also harbor PDZ 
motifs intramolecularly (Okano et al., 1995; Wang et al., 1995; Wu and Gill, 1994; Xia et 
al., 1997). If these proteins function as adapter molecules in bringing together diverse 
molecules in a defined but dynamic microenvironment at specialized submembranous or 
cytoskeletal structures, a disturbance of such structures could lead to pathological 
phenomena like tumorigenesis and developmental abnormalities. Indeed, LIMK1 (or Kiz- 
1), a serine/threonine kinase containing two N-terminal LIM domains followed by a single 
PDZ motif that is strongly expressed in brain, has been recently implicated in impaired 
visuospatial constructive cognition in the developmental disorder Williams syndrome 
(Frangiskakis et al., 1996). Also for PDZ-containing proteins, like DlgA (Bryant et al.,
1993), Canoe (Miyamoto et al., 1995), Dsh (Theisen et al., 1994) and INAD (Shieh and
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Zhu, 1996) in D r o so p h ila  and L IN -2 (Hoskins et al., 1996), L IN -7 (Simske et al., 1996) 
and P A R 3 (Etemad M oghadam  et al., 1995) in C a e n o rh a b d itis  e leg a n s, the severe impact 
o f mutations on growth and differentiation has been documented. Further characterization 
o f the exact topological and dynamic constraints that govern the interactive capacities o f 
L IM  and P D Z domains should therefore help us in understanding the molecular 
mechanisms underlying these defects.
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Materials and methods
Intera ction -trap  assay  - Plasmid DNAs and the yeast strain used for the interaction-trap assay were 
provided by Dr. Roger Brent and colleagues (Massachusetts General Hospital, Boston, MA) and used 
as described (Gyuris et al., 1993). From 106 transformants of a human G0-fibroblast library (a kind 
gift of Dr. C. Sardet, Cambridge, MA) 12 clones were retrieved showing an interaction. Comparison 
of cDNA sequences with database entries were done using the BLAST program (Altschul et al., 
1990). Two of the clones were found to represent overlapping RIL cDNAs. The sequence content and 
schematic representation of the various PTP-BL and RIL peptide regions used in the two-hybrid 
interaction trap are shown in Fig. 1. The single PTP-BL PDZ motifs were obtained by polymerase 
chain reaction (PCR) using specific primers with PTP-BL cDNA (European Molecular Biology 
Laboratory [EMBL] accession number Z 32740, Hendriks et al., 1995) as template, and cloned in­
frame in the pEG202 bait vector (Gyuris et al., 1993) using standard procedures. The band 4 .1-like, 
PDZ-(I-V) and PTP domain of PTP-BL and the PDZ motif of RIL were introduced in the pEG202 
vector by standard subcloning procedures. The deletion constructs of RIL (Fig. 7) were made by 
subcloning the appropriate restriction fragments [full-length mouse RIL (mRIL-FL), mRIL(209-330), 
mRIL(209-309), mRIL(249-309), mRIL(249-330) and mRIL(309-330)] or specific PCR fragments 
[mRIL(315-330), mRIL(209-326) and mRIL(TIV-GIQ)] of mouse RIL in-frame in the pJG4-5 prey 
vector (Gyuris et al., 1993). A ll constructs generated by PCR were checked for mutations by DNA 
sequencing. For two-hybrid interaction assays, plasmids were introduced in yeast strain EGY48 and 
tested for an interaction on minimal agarplates lacking histidine, tryptophan, uracil, and leucine, 
containing 2% galactose, 1% raffinose and 80 mg/ml of 5-bromo-4chloro-3-indolyl-b-D- 
galactopyranoside (X-gal).
b -g a la cto sid a se a ctivity  assay  - Determination of the relative strength of two-hybrid interactions was 
done by measuring the b-galactosidase activity in crude yeast lysates. A  single yeast colony was 
inoculated in 1.5 ml of minimum medium lacking histidine, tryptophan and uracil, containing 2% 
galactose and 1% raffinose and grown overnight until OD6oonm»1 0 . Cells were pelleted and 
resuspended in 0.2 ml ice-cold buffer (0.1 M NaCl, 10 mM Tris-HCl pH7.0, 1 mM EDTA, 1 mM 
phenylmethyl-sulfonyl fluoride). About 100 ml acid washed glass beads (425-600 mm, Sigma
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Chemical, St. Louis, MO) were added and the suspension was vortexed six times for 30 s alternated 
with 30-s incubations on ice. Lysates were centrifuged for 5 min with 14,000 rpm at 4oC. 
Supernatants were transferred to fresh tubes and used for protein concentration determination 
(Bradford, 1976). b-Galactosidase activity was measured by adding 10 ml lysate to 200 ml freshly 
prepared ONPG buffer (100 mM phosphate buffer pH 7 .0, 1 mM MgCl, 10 mM KCl, 50 mM b- 
mercaptoethanol, 0.35 mg/ml O-nitrophenyl-b-D-galactopyranoside, Sigma) in microtiter plates. 
Reactions were incubated at 30oC and the OD420nm was monitored for 1 h on a CERES U V900C 
MTP-photometer (Bio-Tek, Winooski, VT). The specific b-galactosidase activity (arbitrary units) was 
calculated using the initial linear part of the OD420nm/min curves and corrected for the protein 
concentration of the sample.
Iso la tio n  and sequ en cin g  of m ou se R IL  cD N A s - The 0.6 kbp hRIL(164-330) insert, encoding the C- 
terminus of human RIL (hRIL), was isolated, labeled radioactively by random priming and used to 
screen a mouse brain l-ZAPII cDNA phage library (Stratagene, La Jolla, CA) following standard 
procedures. O f 0.65 x  106 plaques, two were found to be positive for the RIL cDNA. These phages 
were plaque-purified and inserts were rescued as pBluescript SK- plasmids according to the 
manufacturer’ s protocols. Nucleotide sequences were determined by double-stranded DNA dideoxy 
sequencing using T3 and T7 sequencing primers on rescued plasmids and derived subclones. The 
mRIL-FL cDNA sequence was compared with database entries using the BLAST program (Altschul 
et al., 1990). Alignments with RIL cDNAs from various species and other PDZ containing proteins 
were made using MULTALIGN, were adapted manually and homologies were calculated using 
DISTANCES (Program manual for Wisconsin Package, Version 8, Genetics Computer Group, 
Madison, WI).
P o ly clon a l an tibodies (pA bs) - Restriction fragments encoding aas (amino acids) 1056-1284 
(including PDZ-I) or aas 2101-2460 (including the PTP domain) of PTP-BL and the insert of 
hRIL(164-330), encoding the C-terminal half of hRIL, were cloned in appropriate pGEX prokaryotic 
expression vectors (Pharmacia, Piscataway, NJ). GST-fusion proteins were isolated (Frangioni and 
Neel, 1993) and used to immunize rabbits. Affinity-purified pAbs (a-BL-PDZ-I, a-BL-PTP and a ­
RIL, respectively) were obtained by applying whole serum to Affigel-15-immobilized (Bio-Rad, 
Richmond, CA) purified GST-fusion protein and eluting bound antibodies.
T ra n sien t exp ression  and im m unoprecipitation  - Mouse PTP-BL and RIL protein parts were 
expressed from the eukaryotic expression vector pSG5 (Green et al., 1988), which was modified to 
generate an in frame V SV  epitope tag for detection or immunoprecipitation of the produced peptide 
using the monoclonal anti-VSV antibody P5D4 and, i f  necessary, an initiator AUG codon or a stop 
codon. hRIL(164-330) was expressed from the eukaryotic expression vector pMT.HAtag, a modified 
pMT2 vector that contains an initiator AUG codon followed by a hemagglutinin (HA) epitope tag 
sequence immediately upstream of the cloning site (Serra Pages et al., 1995), and mRIL-FL was 
expressed from the pSG5 expression vector by cloning the mRIL-FL-3 cDNA, containing its own 
initiator AUG codon, in the multiple cloning site. COS-1 cells were cultured in DMEM/10% fetal calf 
serum. For each assay, 1.5 x  106 cells were electroporated at 0.3 kV and 125 |mF using the BioRad 
GenePulser with a 4 mm electroporation cuvette, in 200 ml phosphate-buffered saline (PBS) 
containing 10 mg of plasmid DNA. Cells were plated on a 10 cm dish and cultured for 48 h in 
DMEM/10% fetal calf serum. Cells were harvested by scraping in ice-cold PBS, pelleted by 
centrifugation (1000 rpm, 5 min) and lysed in 500 ml of lysis buffer (50 mM Tris-HCl pH8.0, 150 
mM NaCl, 5 mM EDTA, 0 .5% Non-idet P-40, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin 
and 10 mg/ml pepstatin A). After a 1-h incubation on ice, the lysate was centrifuged for 10 min at 
10.000xg at 4oC and the supernatant was cleared with 20 ml protein-A Sepharose CL-4B (Pharmacia) 
for 2 h rotating at 4oC. After addition of monoclonal antibody (mAb) P5D4 (2 ml ascites fluid) or pAb 
a-RIL (5 mg affinity purified) and rotation for 2 h at 4oC, 30 ml of Protein A-Sepharose CL-4B were 
added and incubation was prolonged overnight. The immunoprecipitates were washed 4 times with 
0.5 ml lysis buffer and boiled for 5 min in 20 ml 2x sample buffer (100 mM Tris-HCl pH6.8, 200 mM
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dithiothreitol, 4% SDS, 0 .2% bromophenol blue, 20% glycerol), and proteins were resolved on 12% 
polyacrylamide gels and transferred to nitrocellulose membranes by Western blotting. Blots were 
blocked using 5 % nonfat dry milk in 10 mM Tris-HCl (pH8.0), 150 mM NaCl, and 0 .05% Tween-20 
(TBST). Affinity-purified pAb a-RIL (1:1000 dilution) was used to detect coprecipitation of RIL 
protein and mAb P Y -20 (Transduction Laboratories, 1 mg/ml) to detect tyrosine phosphorylated 
proteins. Incubations with primary and secondary antibodies [Alkaline Phosphatase-conjugated 
AffiniPure goat anti-rabbit IgG (0.06 mg/ml), Jackson ImmunoResearch Laboratories, West Grove, 
PA] and subsequent washes were done in TBST. Labeled bands were visualized using CPD Star 
chemiluminescence according to the manufacturer (Tropix, Bedford, MA).
Im m u n oflu orescen ce A ssa y  - Cryo-sections of unfixed tissues (6 mm) were cut and mounted on 
Superfrost/Plus slides (Menzel Gläser, Germany). After thawing, sections were fixed for 5 min in 
cold methanol (-20oC) for a-BL-PDZ-I and a-BL-PTP or in 3% paraformaldehyde in PBS for a-RIL, 
and subsequently washed twice with PBS/0.05% Tween-20 (PBST). Tissue sections were incubated 
in affinity-purified pAb (diluted 1:200 in PBST) for 1 h at room temperature. in the presence of 1% 
normal swine serum, and washed three times for 5 min in PBST. Specific labeling was detected by 
subsequent incubation in fluorescein-conjugated swine anti-rabbit IgG (12 mg/ml, Dako, Carpinteria, 
CA) in PBST for 1 h and washing in PBST. Sections were mounted in Mowiol (Sigma). 
Hematoxylin/eosin-stained sections were prepared according to standard histological procedures.
In  vitro tyrosine phosp horylation  an d  dephosphorylation  assay  - The plasmid encoding GST-BL- 
PTP (aas 2101-2460) was generated as described above. GST-RIL-PDZ (aas 1-101) and GST-RIL- 
LIM (aas 209 to 330) were made by subcloning restriction fragments of mRIL-FL in the appropriate 
pGEX vector. The tyrosine-to-phenylalanine mutant of the RIL-LIM domain, GST-RIL-LIM-Y-F 
(aas 209-330), was made by PCR using oligonucleotides harboring the desired mutation and GST- 
RIL-LIM as a template. The mutated sequence of GST-RIL-LIM-Y-F was confirmed by sequencing. 
GST-fusion proteins were produced in bacterial TKX cells according to the supplier’ s instructions 
(Stratagene). Cells were lysed by sonification in PBS containing protease inhibitors (1 mM PMSF, 10 
mg/ml aprotinin, 10 mg/ml leupeptin and 10 mg/ml pepstatin A) and GST-fusion proteins were purified 
using glutathione-Sepharose CL4B (Pharmacia) and analyzed on 12% polyacrylamide gels. Samples 
representing about 1 mg of fusion protein were loaded on each lane and the presence of GST-fusion 
protein and tyrosine phosphorylation was detected by Western blotting using the mAbs 2F3 (a-GST) 
and P Y -20 (a-P-tyr, Transduction Laboratories, Lexington, KY), respectively. For the 
dephosphorylation assay, 1 mg of purified phosphorylated GST-RIL-LIM was incubated for 15 min at 
37°C in PBS containing protease inhibitors with 0.1 mg of purified GST-BL-PTP or, as a control, with 
0.1 mg of GST. As a specific protein tyrosine phosphatase inhibitor, NaVO3 was used at a final 
concentration of 1 mM.
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Abstract
The small adaptor protein RIL consists of two segments, the C-terminal LIM and the 
N-terminal PDZ domain, which mediate multiple protein-protein interactions. The 
LIM domain binds to PDZ domains in the protein tyrosine phosphatase PTP-BL and 
can also interact with the N-terminal PDZ domain in RIL. Here, we describe and 
characterize the interaction of the PDZ domain with the zyxin-related protein ZRP- 
1, a protein containing three C-terminal LIM domains. The second LIM domain in 
ZRP-1 is sufficient for a strong interaction with RIL although also an interaction 
with the third LIM domain, including the proper C-terminus, is evident. ZRP-1 also 
interacts with the second out of five PDZ motifs in PTP-BL. For this interaction to 
occur both the third LIM domain and the proper C-terminus is necessary. RNA 
expression analysis revealed overlapping patterns of expression for ZRP-1, RIL and 
PTP-BL, most notably in tissues of epithelial origin. Furthermore, ZRP-1 can be co­
precipitated with RIL and PTP-BL PDZ polypeptides and a striking co-localization 
of ZRP-1 and RIL with F-actin structures is evident in transfected epithelial cells. 
Taken together, PTP-BL, RIL and ZRP-1 may function as components of 
multiprotein complexes that are involved in the dynamics of specialized actin-based 
sub-cellular structures.
Introduction
It is becoming increasingly clear that multiprotein complexes, as found at cell-cell and cell- 
substratum contacts, are dynamic structures that function as important cellular signal 
transduction centers for relaying extra-cellular stimuli to cellular responses. Scaffold, 
anchoring and adaptor proteins (Pawson and Scott, 1997) play an important role in 
coordinating the assembly and dynamics of these complex structures, thereby defining the 
architecture of sub-cellular domains and the ‘wiring’ of signaling pathways. Small protein 
domains, like SH2, SH3, PH, LIM, WW, WD, PDZ and PTB domains (Bork et al., 1997),
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are often found as modular building blocks mediating specific and dynamic interactions 
between the different components and cytoarchitectural elements of the cellular context. 
We are studying the protein tyrosine phosphatase PTP-BL (Hendriks et al., 1995) or RIP 
(Chida et al., 1995), which is the mouse homologue of human PTP-BAS (Maekawa et al.,
1994), PTPL1 (Saras et al., 1994), PTP1E (Banville et al., 1994) and FAP-1 (Sato et al.,
1995), as a potential organizer of specialized multiprotein complexes in polarized cells. 
PTP-BL is expressed mainly in epithelia where it localizes apically (Cuppen et al., 1998; 
Hendriks et al., 1995) and it has several characteristics that make it a potential scaffold 
protein (Fig. 1A). The protein harbors a FERM domain (Chishti et al., 1998), that may 
target the protein to its highly restricted sub-cellular site, and five PDZ motifs (Ponting,
1997). PDZ motifs themselves are small protein modules that mediate protein-protein 
interactions (Fanning and Anderson, 1996; Ranganathan and Ross, 1997; Saras and Heldin,
1996) and can associate with transmembrane proteins (Sheng, 1996), cytoskeletal 
components (Xia et al., 1997) and signal transduction enzymes (Ranganathan and Ross,
1997). The five PDZ motifs in PTP-BL may thus function as anchoring or scaffolding sites 
for other proteins, thereby enabling the formation of multiprotein complexes in which the 
phosphotyrosine phosphatase action of PTP-BL itself can be combined with potential 
downstream substrates, competitor signaling proteins and putative upstream regulatory 
molecules. Indeed, proteins that interact with PDZ motifs of PTP-BL have been identified. 
Saras and coworkers (Saras et al., 1997) identified a 160 kDa protein with Rho-GAP 
activity, PARG1, that binds to the fourth PTP-BL PDZ motif. We characterized a novel 
bromodomain-containing protein, BP75, that specifically interacts with the first PDZ motif 
(Cuppen et al., submitted) and found the small adaptor protein RIL (Kiess et al., 1995) to be 
a binding target for both the second and fourth PDZ motif of PTP-BL (Cuppen et al., 1998). 
RIL is down-regulated in H-Ras-transformed fibroblasts (Kiess et al., 1995) and basically 
consists of a C-terminal LIM domain, that is indispensable for interaction with PTP-BL, 
and an N-terminal PDZ motif, that can also interact with the RIL C-terminal LIM domain. 
LIM domain proteins form a widely diverged protein family which can be divided in three 
groups based upon their homologies and function (Dawid et al., 1998). Group 1 consists of 
homeodomain-containing LIM proteins that are primarily nuclear and implicated in 
transcriptional regulation. Group 2 represents the LIM-only proteins that may function in 
regulating group 1 proteins by LIM-LIM interactions. RIL belongs to the group 3 LIM- 
domain proteins, consisting of members that contain one or multiple C-terminal LIM 
domains. The members of this group are located primarily cytoplasmic and some, like 
zyxin, CRP and paxillin, are associated with the actin-based cytoskeleton. RIL is highly 
homologous to the PDZ/LIM proteins CLP-36 (Wang et al., 1995), ALP-1 (Xia et al.,
1997) and enigma (Wu and Gill, 1994). Some binding partners have been identified for 
these proteins. LIM domains in enigma recognize tyrosine-containing motifs in the insulin 
receptor and the receptor tyrosine kinase Ret (Wu et al., 1996), and the PDZ motif in
93
Chapter 5
actinin-associated LIM-protein, ALP-1, is found to interact with a spectrin-repeat in a- 
actinin-2 (Xia et al., 1997).
To identify additional components of the multiprotein complex containing PTP-BL and 
RIL, we searched for proteins that specifically interact with the PDZ motif of RIL. We here 
describe the identification and characterization of the LIM domain-containing protein 
zyxin-related protein 1, ZRP-1, also described as TRIP6 (Lee et al., 1995) and Opa- 
interacting protein, OIP1 (Williams et al., 1998). Interestingly, ZRP-1 was also identified in 
an interaction screening using the second PDZ motif of the human homologue of PTP-BL, 
hPTP1E (Genbank accession AF000974; Murthy, K.K., Shen, S.-H and Banville, D., 
unpublished results). This interaction is confirmed by our data and we here show that the 
LIM domains in ZRP-1 are important for interaction with the RIL and PTP-BL PDZ motifs. 
The potential role of these interactions in the architecture or dynamics of specialized sub­
cellular actin-based structures will be discussed.
Results
ZRP-1 interacts with PDZ motifs in RIL and PTP-BL
Candidate proteins interacting with the PDZ motif of RIL were obtained from a human fetal 
brain cDNA library using RIL-PDZ (Fig. 1A) as a bait in the yeast two-hybrid interaction 
trap (Gyuris et al., 1993). From 0.5 x 106 transformants several interacting clones were 
identified. One of them, AL7 (Fig. 1B), encodes the C-terminal half of the LIM domain- 
containing zyxin-related protein-1 (ZRP-1; Genbank AF000974, Murthy, K.K., Shen, S.-H 
and Banville, D., unpublished results), also described as thyroid receptor interacting 
protein-6, TRIP6 (Lee et al., 1995) and Opa-interacting protein, OIP1 (Williams et al.,
1998). ZRP-1 was submitted to the public database as a protein resulting from a two-hybrid 
screening using the second PDZ domain of the cytosolic protein tyrosine phosphatase 
hPTP1E as bait (Murthy, K.K., Shen, S.-H. and Banville, D., unpublished results). ZRP-1 is 
a 476 amino acid protein that contains three LIM domains in its C-terminal half. 
Interestingly, we recently found that the single C-terminal LIM domain of the protein RIL 
interacts with PDZ motifs in PTP-BL, the mouse homologue of hPTP1E (Cuppen et al.,
1998). Therefore, we also used the five PDZ motifs of PTP-BL as a bait (BL-PDZ-I-V, Fig.
1A) and indeed an interaction with AL7 could be demonstrated (Fig. 1B). Subsequent 
testing of single PDZ motifs of PTP-BL showed that only the second PDZ motif of PTP-BL 
interacts with AL7 (data not shown), in line with the observations made for hPTP1E 
(Murthy, K.K., Shen, S.-H and Banville, D., unpublished results).
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A RIL (1 -330)
RIL-PD Z (1 -1 0 1 ) 0 -  
PT P-B L  (1 -2 4 6 0 )
BL-PDZ-I-V (1 0 0 2 -2 0 1 8 )
250 a.a.
B
interaction with: RIL-PD Z BL-PDZ-I-V
0 RIL-LIM (1 6 4 -3 3 0 ) ++ +++
■o RIL-LIM C-4 (1 6 4 -3 2 6 ) ++ +
-0 j2 3 ■ Z R P (1-480) nd nd
■ C32P1R
h­L
<
0)84-6(2 +++ +++
Z R P 1 2 3 (2 9 6 -4 6 7 ) +++ -
Z R P 2 3 (3 3 7 -4 6 7 ) +++ -
[ Z R P 3 (3 9 7 -4 6 7 ) - -
a Z R P 2 (3 3 7 -4 0 1 ) ++ -
0 ■ Z R P 2 3 C (3 3 7 -4 8 0 ) +++ +++
■ Z R P 3 C (3 9 7 -4 8 0 ) + +
I] Z R P 1 2 (2 9 6 -4 0 1 ) ++ -
- Z R P C (4 6 5 -4 8 0 ) - -
]00■ * Z R P 1 2 3 C -2 (2 9 6 -4 7 8 ) +++ -
Figure 1: Schematic representation of the protein segments used in the two-hybrid interaction trap. 
Depicted are the RIL and PTP-BL proteins and their PDZ segments that were used as bait (A) in the 
two-hybrid interaction trap. Also the ZRP-1 and RIL segments represented in the prey constructs are 
shown (B). Numbers that correspond to the first and last a.a. positions in the PTP-BL (Z32740), RIL 
(Y08361) and mZRP-1 (AF097511) protein segments are shown in parentheses. Two hybrid 
interaction results with either RIL-PDZ or BL-PDZ-I-V are schematically indicated: +++, very strong 
interaction; ++, strong interaction; +, weak, but significant interaction; -, no interaction detectable; nd, 
not determined. FERM domain, hatched box; catalytic PTP domain, open box; PDZ motifs, black 
ovals; LIM domains, gray boxes.
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Presence of LIM domains and the C-terminus of ZRP-1 have differentia! effects on 
binding to RIL and PTP-BL
To determine the requirements for binding to the RIL and PTP-BL PDZ motifs a series of 
deletion mutants of AL7 was constructed and tested using the interaction trap assay (Fig.
1B). None of the constructs used contained a complete first LIM domain, since this domain 
was only partially present in the original clone. For an interaction with the RIL-PDZ motif 
either the second LIM domain (ZRP2) or the third LIM domain together with the proper C- 
terminus (ZRP3C) of ZRP-1 are sufficient. Neither the C-terminus (ZRPC) nor the third 
LIM domain (ZRP3) alone can mediate the interaction with RIL-PDZ. Importantly, a 
conventional C-terminus recognition mode can be excluded because removal of the last two 
amino acids of ZRP-1 (ZRP123C-2) does not affect RIL-PDZ binding (Fig. 1B). Similarly, 
deletion of the last four residues in the RIL C-terminal half (RIL-LIMC-4) also has no 
effect on the interaction of this protein segment with the RIL-PDZ motif (Cuppen et al.,
1998).
For an interaction with BL-PDZ-I-V to occur a C-terminal segment of ZRP-1 that includes 
the third LIM domain and the proper C-terminus (ZRP3C) is essential. Presence of the 
second LIM domain (ZRP23C) does enhance the interaction strength, whereas removal of 
either the LIM domain (ZRPC) or the proper C-terminus (ZRP3) totally abolishes the 
interaction. In contrast to the situation as for RIL-PDZ, deletion of the last two amino acids 
(ZRP123C-2) from the originally identified clone, completely destroys the interaction with 
BL-PDZ-I-V (Fig. 1B). Using only the second PDZ motif of PTP-BL as bait, the same 
results as for BL-PDZ-I-V were obtained (not shown).
Identification and characterization of full-length mouse ZRP
Sequence information on human ZRP-1 was used to screen public EST databases for mouse 
homologues. An EST clone with Genbank database accession number W58878 was found 
to contain the complete open reading frame encoding mouse ZRP-1 (mZRP-1), but part of 
the 5’ untranslated region was lacking. The insert of this EST clone was completely 
sequenced and assigned the database accession number AF097511 by Genbank. 
Comparison of mouse and human ZRP-1 (AF000974) reveals 76% and 86% identity at the 
nucleotide and amino acid level, respectively (Fig. 2A). The C-terminal part of the protein,
Figure 2: (facing page) Comparison of mouse ZRP-1 with related peptide sequences.
The mouse ZRP-1 (M-ZRP-1; AF097511) protein sequence is shown, aligned with its human 
homologue (H-ZRP-1; AF000974) (A) and with the homologous LIM domain-containing proteins 
human LPP (U49957) and mouse zyxin (Q62523) (B). Single horizontal black lines indicate the LIM 
domains and the zinc-coordinating residues are marked by vertical black lines. The protein segment 
corresponding to the functional nuclear export signal in zyxin (Nix and Beckerle, 1997) is double 
underlined. The black arrowhead points to the beginning of the human ZRP-1 segment as present in 
clone AL7. Identical residues in two or three sequences are shown in black on a gray background or 
in white on a black background, respectively. Gaps are indicated by dashes (-).
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encompassing the three LIM domains, is almost completely conserved, whereas the N- 
terminus is less conserved and contains a small four amino acid insertion in mouse. 
Comparison of the predicted 51 kDa mZRP-1 polypeptide with entries in public protein 
databases revealed highest overall homology with the LIM domain-containing proteins 
lymphoma preferred partner (LPP; U49957) and the adhesion plaque protein zyxin 
(Q62523). Alignment of these proteins reveals very high homology in the region 
encompassing the three LIM domains (Fig. 2B). Also, the region N-terminal to the first 
LIM domain that in chicken zyxin corresponds to a nuclear export signal (Nix and 
Beckerle, 1997) is highly conserved. In contrast, the N-terminal half of mZRP-1 shows low 
overall homology with LPP and zyxin but, as in zyxin, this region is very rich in proline 
(19%) and glycine (15%).
mZRP-1 expression pattern
The observed interaction of ZRP-1 with RIL and PTP-BL can only be of biological 
significance when there is overlap in expression patterns. Previous studies have shown an 
epithelial expression pattern for PTP-BL (Cuppen et al., 1998; Hendriks et al., 1995) and
Figure 3: Tissue distribution of mZRP-1 messenger RNA.
Northern blot analysis of the mZRP-1 expression levels in total RNA isolated lrom different adult 
mouse tissues (A). As controls for RNA loading, hybridization results for the housekeeping gene 
GAPDH (B) as well as the ethidium bromide staining pattern of the gel (C) are shown. mZRP-1 is 
highly expressed in lung, heart, kidney, testis, and stomach. No expression is detected in skeletal 
muscle. The 28S and 18S ribosomal bands, corresponding to 4.6 and 1.9 kb transcript lengths, 
respectively, are indicated.
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expression o f RIL in various epithelia and different types o f  muscle (Kiess et al., 1995). 
The m ZRP-1 cD N A  was used to probe a Northern blot o f  total R N A  from  several different 
mouse tissues. A  transcript o f  about 1.8 kb was detected that is highly expressed in kidney, 
stomach, lung, heart and testis, whereas low  expression levels are found in brain, colon, 
thymus, pancreas and skin (Fig. 3). To further delineate the m ZRP-1 expression pattern we 
used an antisense R N A  probe for in  s itu  hybridization on mouse embryo cryosections. 
m ZRP -1 expression is found throughout development in all embryonic stages ( 10.5 dpc to
18.5 dpc) that were analyzed (Fig. 4 and data not shown). In 16.5 dpc embryos m ZRP -1 is 
highly expressed in skin, lung, thymus, duodenum and the ependymal cell layer 
surrounding the ventricles in brain. High expression is also observed in the salivary glands, 
vibrissae, choroid plexus, blood vessel walls, oesophagus and midgut. L ow  levels o f  
m ZRP -1 m R N A  are found in spinal cord, heart and liver (Fig. 4B). No positive signal was 
obtained using a m ZRP-1 sense R N A  probe (Fig. 4 C). In summary, m ZRP -1 is prominently 
expressed in epithelial and endothelial cell types and only low  expression is found in 
neuronal and muscle cells. It is o f  note that high expression o f m ZRP -1 coincides w ith that 
o f  RIL and PTP-B L, most notably in the epithelium o f the lung, the epidermis and the 
ependymal cell layer surrounding the ventricles in brain.
Figure 4: mZRP-1 mRNA in situ hybridization on 16.5 dpc mouse embryo sections.
A bright field (A) and dark field images of parasaggital cryosections of 16.5 dpc mouse embryos 
hybridized with an antisense mZRP-1 RNA probe (B) and a sense mZRP-1 probe (C) are shown. 
High expression is evident in lung, skin, blood vessels, duodenum, salivary glands, vibrissae and the 
ependymal layer surrounding the ventricles in brain. A, abdominal aorta; BV, blood vessels; CP, 
choroid plexus, D, duodenum; H, heart; Li, liver; Lu, lung; O, oesophagus; OE, olfactory epithelium; 
S, skin; SC, spinal cord; T, thymus, Vi, vibrissae. Bars, 1 mm.
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mZRP-1 co-precipitates with the RIL and PTP-BL PDZmotifs
To confirm the observed interaction in a more physiological surrounding, we co-transfected 
mammalian epithelial cells (COS-1) with expression constructs encoding an EGFP-mZRP 
fusion protein and VSV-G epitope-tagged versions of RIL-PDZ, the five PDZ motifs of 
PTP-BL, or the second PDZ motif of PTP-BL alone. All transiently expressed proteins are 
readily detected in the lysates by Western blotting (Figs. 5A and B). Pull-down of EGFP- 
mZRP was demonstrated for all PDZ constructs used, whereas the control (EGFP alone) 
remains negative (Fig. 5C). In the reciprocal experiment, co-precipitation of VSV-G 
epitope-tagged proteins with EGFP-mZRP could clearly be shown for the RIL PDZ motif, 
and to a lesser extend for the five PDZ motifs of PTP-BL (not shown). Unexpectedly in this 
experiment, we could not demonstrate co-precipitation of EGFP-mZRP and the second 
PTP-BL PDZ motif alone. Taken together, these findings confirm independently the results 
obtained in the yeast two-hybrid interaction trap.
Sub-cellular localization of RIL
We used an affinity-purified polyclonal antibody directed against RIL (Cuppen et al., 1998) 
to identify cell lines that express RIL endogenously and found that the human epidermoid
mZRP-1 +
A
C
eGFP-mZRP
BL-PDZ-I-V
BL-PDZ-II
RIL-PDZ
eGFP-mZRP
Figure 5: mZRP-1 co-precipitates with PDZ 
motifs of RIL and PTP-BL.
COS-1 cells are co-transfected with a construct 
encoding EGFP-tagged mZRP-1 and a construct 
encoding either VSV-tagged peptides of the RIL 
PDZ motif, the five PDZ motifs of PTP-BL (BL- 
PDZ-I-V) or the second PDZ motif of PTP-BL 
alone (BL-PDZ-II). As a control, empty vector (-) 
was co-transfected. Western blotting using an a- 
GFP antibody detects a single 80 kDa EGFP- 
mZRP fusion protein in the total cell lysates (A), 
whereas the a-VSV monoclonal antibody 
specifically detects the tagged PDZ motifs (B). 
After immunoprecipitation of the PDZ motifs, 
pull-down of EGFP-tagged mZRP-1 with the 
PDZ motifs is demonstrated (C). No pull-down of 
mZRP-1 is observed in lysates of COS cells co­
transfected with empty vector.
IP: a-VSV, WB: a-G FP
B
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carcinoma cell line A-431 expresses RIL at low but detectable levels. Clear co-localization 
of endogenous RIL with the filamentous actin stress-fibers is evident (Figs. 6A and B). To 
facilitate detection, RIL levels were increased artificially by transfection of full-length RIL 
in A-431 cells. Again, the same sub-cellular location and co-localization with F-actin was 
found (Figs. 6C and D) but now RIL staining was much more intensive, underscoring the 
specificity of the RIL polyclonal antiserum. In addition, weak perinuclear cytosolic staining 
for RIL is evident, which may be due to the high level of overexpression (note that 
endogenous RIL in neighboring untransfected cells is not visible under these sampling 
conditions, Fig. 6C). Likewise, in the human adenocarcinoma cell line Caco-2, endogenous 
RIL was barely detectable (not shown), but also here transfected RIL consistently co­
localized with F-actin structures (Figs. 6E and F). In these cells, however, besides being 
localized at stress fibers, focal and cell-cell contacts, RIL was also present in the nucleus. 
Since RIL itself does not contain obvious motifs for direct F-actin binding, we tested 
whether either its PDZ or LIM domain could be responsible for (indirect) binding to F-actin 
structures. Transient expression of epitope-tagged RIL-PDZ and RIL-LIM protein segments 
showed that both domains were guided to F-actin containing cell-cell contacts. In addition, 
cytosolic staining and a typical nuclear localization with a distinct distribution pattern for 
each of the two segments, was observed (Figs. 6G and H).
Co-localization of mZRP-1 with RIL and F-actin
Next, to study the sub-cellular localization of mZRP-1 we transiently expressed the EGFP- 
mZRP fusion protein in Caco-2 cells. Because autofluorescence of EGFP signal was barely 
detectable, a biotinylated polyclonal antibody that recognizes EGFP in combination with a 
streptavidin-FITC conjugate was used to visualize the fusion protein. As shown in Fig. 7, 
panels A and B, a clear co-localization of mZRP-1 with F-actin at cell-cell contacts is 
evident. Also, mZRP-1 is found throughout the cytosol in a typical punctuate distribution 
pattern. Using antibodies against LAMP-1 and LAMP-2 (Carlsson et al., 1993) we could 
exclude co-localization with lysosomes for these structures (not shown). In the highest 
expressing cells the appearance of the speckles is most intense, suggesting that they result 
from overexpression and most likely represent aggregates of surplus EGFP-mZRP fusion 
protein. It is of note that formation of these aggregates is not caused by the EGFP moiety, 
since identical effects were observed for a cMyc epitope-tagged version of mZRP-1 (not 
shown). Also in transfected A-431 cells such aggregates have been observed next to the 
EGFP-mZRP decorated stress fibers (data not shown). When mZRP-1 and RIL are 
overexpressed simultaneously in Caco-2 cells, their co-localization with F-actin-containing 
structures at sites of cell-cell contacts and in lamellipodia remained evident (Figs. 7 C and 
D).
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Figure 7: mZRP-1 co-localizes with F-actin and RIL
A construct encoding an EGFP-mZRP fusion protein was transfected in Caco-2 cells, alone (A, B) or 
together with a construct encoding full-length mouse RIL (C, D). mZRP-1 detection was enhanced 
using a biotinylated antibody directed against EGFP (A, C) and cells were double labeled with 
phalloidin-Texas Red for visualization of F-actin (B) or with a-RIL antibody for detection of 
overexpressed RIL (D). mZRP-1 localizes to F-actin-rich structures at cell-cell contacts but also 
typical dot-like structures, that may be overexpression artifacts, are observed. Also, weak cytosolic 
and nuclear staining is evident for mZRP-1.
Figure 6: (facing page) Subcellular localization of RIL in A-431 and Caco-2 cells.
Endogenous (A) and overexpressed RIL (C, E) is detected in untransfected A-431 cells (A, B) and A- 
431 (C, D) or Caco-2 (E, F) cells transfected with a construct encoding full-length mouse RIL. Cells 
were double labeled for F-actin using phalloidin-Texas Red (B, D, F). In A-431 cells endogenous RIL 
decorates stress fibers in a typical punctuate manner, as detected by an a-RIL polyclonal antibody. 
Overexpression of RIL in A-431 cells shows a similar co-localization with F-actin, but also weak 
cytosolic and nuclear staining is evident. In Caco-2 cells, that have less stress fibers than A-431 cells 
but do make cell-cell contacts, hardly any endogenous RIL can be detected (not shown). Transiently 
overexpressed RIL (E) co-localizes with the F-actin containing adhesion belt (F). Clearly, nuclear 
localization of the RIL protein can be seen in these cells (E). VSV-epitope-tagged peptides of both the 
RIL-PDZ motif (G) and the RIL-LIM domain (H) localize to stress fibers in A-431 cells (not shown) 
and to the adhesion belt in Caco-2 cells (G, H). Again, cytosolic and typical nuclear staining is evident.
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Discussion
In our search for proteins that interact with the single, N-terminal PDZ motif of the small 
adaptor protein RIL, we identified a multiple LIM domain-containing protein termed zyxin- 
related protein-1 or ZRP-1. As the RIL-PDZ can also engage in binding to the single, C- 
terminal RIL-LIM domain, and, in turn, this latter domain can bind to the second and fourth 
PDZ motif of mouse protein tyrosine phosphatase PTP-BL (Cuppen et al, 1998) we tested 
whether the PDZ domains in RIL and PTP-BL or the LIM domains in ZRP-1 and RIL 
showed functional homology. Indeed, we and others found an association of ZRP-1 with 
the second PDZ motif in PTP-BL (Fig. 1) or its human counterpart hPTP1E (Genbank 
accession AF000974; Murthy, K.K., Shen, S.-H. and Banville, D., unpublished). Further 
support for a biological significance of these interactions comes from the demonstration of 
co-precipitation of mZRP-1 with RIL and PTP-BL PDZ motifs from lysates of transiently 
overexpressing cells (Fig. 5), from the overlap in cell-type specific distribution patterns 
(Figs. 3 and 4), and the sub-cellular localization studies (Fig. 7).
Characterization of the RIL and PTP-BL PDZ-mediated interactions using deletion mutants 
of ZRP-1 showed that these are critically dependent upon the presence and integrity of 
ZRP-1 LIM domains, but differ in the requirement of the proper C-terminus. PDZ motifs 
are best known as interactors which specifically recognize short C-terminal peptides (Saras 
and Heldin, 1996; Songyang et al., 1997). It is conspicuous, however, that both RIL and 
ZRP-1 C-terminal ends (-VELV* and -TTDC*, respectively) do not match the consensus 
C-terminal PDZ recognition site (-T/SxV*) (Songyang et al., 1997). Still, deletion of only 
the last four or two residues, respectively, dramatically affects the interaction with PTP-BL 
PDZ motifs (Fig. 1). The very same mutations, however, do not affect RIL-PDZ binding at 
all. This suggests that RIL PDZ and PTP-BL PDZ motifs mediate two different modes of 
interaction that are based on distinct mechanistic principles, namely internal and C-terminal 
binding. PDZ binding that is not based on C-terminus recognition has been described for 
other systems before. For example, binding of the third PDZ motif in INAD to the TRP 
Ca2+ channel is critically dependent on an internal STV peptide (Shieh and Zhu, 1996), its 
fifth PDZ motif binds an internal segment of phospholipase C-ß (van Huizen et al., 1998), 
and the ALP-1 PDZ motif binds to an internal spectrin-like repeat in a-actinin-1 (Xia et al.,
1997). Furthermore, homo- and heteromeric PDZ-PDZ interactions between the third and 
fourth motif in INAD (Xu et al., 1998) and the motifs in nNOS and a1-syntrophin or 
PSD95 do occur (Brenman et al., 1996). Finally, dual specificity for both internal and C- 
terminal sequences by the same PDZ motif has been observed. The PDZ motifs in INAD, 
nNOS, a1-syntrophin and PSD95 that are involved in the aforementioned PDZ-PDZ 
interactions are also able to recognize C-terminal peptides (Schepens et al., 1997; Stricker 
et al., 1997; Xu et al., 1998). The same situation holds for the second PDZ motif of PTP- 
BL, whose ability to recognize C-terminal T/SxV* peptides was demonstrated convincingly
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(Cuppen et al., 1997; Saras et al., 1997; Sato et al., 1995; Songyang et al., 1997). It should 
be noted, however, that this binding is rather weak as compared to the interactions with the 
LIM domain containing segments of RIL and ZRP-1. Crystal structure analysis of PDZ 
motifs has uncovered the structural basis for C-terminal peptide recognition. A compact 
modular structure, formed by four b-sheets and two a-helices, creates a deep hydrophobic 
cleft that can harbor a short C-terminal peptide (Doyle et al., 1996; Morais Cabral et al.,
1996). Thusfar, it is unclear whether polypeptide-internal interactions use the same 
interaction interface or whether other binding pockets exist on the globular PDZ motif. 
Data supporting the latter view comes from studies on INAD, showing that homo- 
multimerization via PDZ motifs does not prevent recognition of C-terminal targets by the 
same PDZ motifs (Xu et al., 1998). On the other hand, interaction with the nNOS PDZ 
motif seems to inhibit C-terminal peptide binding to the a1-syntrophin PDZ motif (Gee et 
al., 1998), suggesting that -  at least in some cases -  there can be overlap or close proximity 
for the binding interfaces that mediate C-terminus recognition and PDZ motif dimerization. 
Thus, there is the possibility that the binding cleft in some PDZ motifs may be optimally 
tailored to receive both C-termini and internal peptides, whereas others may have two 
distinct binding interfaces, thus precluding interference by binding to different substrates. 
What could be the role of LIM domains in the RIL/PTP-BL/ZRP-1 interactions? One 
possibility is that LIM domains act passively in providing the conformational structure 
necessary for the recognition of internal peptide segments by PDZ motifs. Recent 
experiments indeed demonstrate that the syntrophin PDZ motif recognizes an internal 
peptide that is similar to its C-terminal consensus target only if it is conformationally 
constrained through intramolecular disulfide bond formation (Gee et al., 1998). Yet, 
another possibility is that LIM domains act as dimerization signals (Feuerstein et al., 1994), 
and mediate ZRP-1 and RIL interaction indirectly through the formation of dimers or 
multimers, thereby ‘concentrating’ the proper C-termini for efficient recognition by PDZ 
motifs. Data supporting such a model come from in vitro and two-hybrid experiments on 
syndecan binding to the PDZ protein syntenin, which indicate that at least dimers of the 
syndecan C-terminus are necessary for detectable interaction (Grootjans et al., 1997). 
Finally, LIM domains themselves may function as interaction interface for PDZ motifs. 
Next to homo- and heterophilic interactions (Curtiss and Heilig, 1998), LIM domains are 
found to interact with a variety of other domains (Dawid et al., 1998). For example, the 
LIM domain in LIMK1 interacts with the kinase domain in LIMK1 and 2 (Hiraoka et al.,
1996), LIM domains in Enigma recognize tyrosine-containing motifs in receptor tyrosine 
kinases (Wu et al., 1996) and the N-terminal region of protein kinase C associates with LIM 
domains in ENH, Enigma and LIMK1 (Kuroda et al., 1996). Considering this diversity of 
interaction possibilities LIM domains may thus represent multifunctional interfaces, alike 
the situation with the members of the PDZ domain family.
We here demonstrate that endogenous and transfected RIL co-localizes with ZRP-1 at
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specific F-actin rich structures, like stress fibers and cell-cell contacts. This is in keeping 
with the observation that several important L IM  proteins have a role in adhesion-plaque and 
actin-microfilament organization (Beckerle, 1997; D aw id et al., 1998). The finding that 
epitope-tagged constructs o f  the P D Z and the L IM  domain o f RIL both reveal a similar 
localization was less w ell anticipated. Although many L IM  proteins localize to F-actin and 
L IM  domains have been found to be important for this localization (Arber and Caroni,
1996), no direct interaction o f a L IM  domains with F-actin has been shown thusfar. W e 
can, therefore, most easily explain our findings by assuming that the routing and association 
o f  both artificially truncated RIL domains is determined via  an interaction with endogenous 
full-length RIL (see also Cuppen et al., 1998). Ultimately, other components in the 
multiprotein com plexes to w hich RIL m olecules associate, may be responsible for targeting 
to the highly specialized sub-cellular sites. Interestingly, both A L P -1 and zyxin, that are 
highly homologous to RIL and Z R P -1, respectively, interact with the actin-binding protein 
a-actinin (Crawford et al., 1992; X ia  et al., 1997). Could there thus be a direct role for 
ZR P -1 in the formation o f F-actin rich structures? The Z R P -1 homologue zyxin  has been 
implicated in the spatial control o f  actin filament assembly as w ell as in pathways important 
for cell differentiation (Beckerle, 1997). Both small GTPases like Rho and reversible 
tyrosine phosphorylation play an important role in these processes. For example, V av, a 
guanine nucleotide exchange factor for small GTP-binding proteins in the Rho family, 
interacts directly w ith the proline-rich region o f zyxin  v ia  its SH3 domain (Hobert et al.,
1996). Furthermore, several SH3 domain-containing tyrosine kinases, such as the Src 
fam ily members, co-localize with zyxin. W e should be careful in extrapolating these 
findings, however, as the hom ology o f  Z R P -1 w ith zyxin  in the proline-rich N-terminal half 
is rather limited. Still, it would be interesting to see whether this segment o f  ZR P -1 is 
indeed a target for proteins that contain domains known to recognize proline-rich regions, 
like SH3 (Sparks et al., 1996), W W /W W P (Chan et al., 1996; Chen and Sudol, 1995) or 
E V H 1 modules (Niebuhr et al., 1998). Whatever, based on the findings reported here we 
can now postulate the (putative) combined presence o f both a protein tyrosine phosphatase 
(i.e. PTP-B L) and a small GTPase activating protein with specificity for Rho (i.e. P A R G 1; 
(Saras et al., 1997)) within one large com plex containing Z R P -1. Together with other recent 
findings this opens intriguing perspectives for explaining the dynamic behavior o f  the 
cortical actin cytoskeleton under normal and pathophysiological conditions.
One direct indication for Z R P -1 function in actin remodeling comes from  the identification 
o f  Z R P -1 in a two-hybrid screening for proteins that interact with N e iss e r ia  g o n o r rh o e a e  
OpaP, a member o f a fam ily o f  outer membrane proteins involved in gonococcal adherence 
to and invasion o f human cells (W illiams et al., 1998). Reorganization o f the actin 
cytoskeleton is an important step in the invasion and spreading o f bacteria in eukaryotic 
cells, and OpaP is likely to have a role in this process. Likewise, the similarity between the 
ZR P -1 homologues zyxin  and A ctA , the protein o f L is te r ia  m o n o cy to g en es  that facilitates
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host cell actin remodeling during infection and spread (Golsteyn et al., 1997) may be more 
than just coincidental. It should be stressed, therefore, that PTP-BL, RIL and mZRP-1 are 
localized in vivo at important sites of potential pathogen entry (Fig. 4; Cuppen et al., 1998). 
Besides the cytoskeleton-associated localization, also a nuclear location for mZRP-1 is 
evident in our transfection studies (Fig. 7). Again there is analogy with other members of 
the zyxin family, as the region homologous to the nuclear export signal in chicken zyxin 
(Nix and Beckerle, 1997) is indeed the only highly conserved region between zyxin and 
mZRP-1 outside the LIM domain area. It is, therefore, tempting to speculate that mZRP-1, 
like zyxin, shuttles between the nucleus and specific cytosolic sites for transducing signals 
between these compartments. Likewise, RIL and PTP-BL are also found in the nucleus, 
albeit at very low levels compared to their abundance in the cytosol (Fig. 6; Cuppen et al., 
submitted). Future studies should address the routing mechanism and physiological 
relevance of this phenomenon.
Taken together, our results show that LIM domains are important determinants in PDZ- 
mediated interactions that may shape signaling complexes containing PTP-BL, RIL and 
mZRP-1 that have the potential to be involved in regulating actin cytoskeleton dynamics at 
specialized subcellular sites.
Materials and Methods
Tw o-H ybrid In tera ction  Trap - Plasmid DNAs, the yeast strain EGY48 and the human fetal brain 
cDNA library used for the interaction-trap assay were kindly provided by Dr. Roger Brent and 
colleagues (Massachusetts General Hospital, Boston, MA) and used as described (Gyuris et al., 1993). 
The construction of RIL-PDZ and PTP-BL PDZ baits has been described previously (Cuppen et al., 
1998). The deletion constructs of ZRP-1 were made by sub-cloning fragments, that were generated by 
PCR with human ZRP-1 as template, using synthetic oligonucleotides for introducing the appropriate 
stop codon and EcoRI and XhoI restriction sites. These fragments were cloned in-frame in the pJG4-5 
prey vector and checked for mutations by DNA sequencing. For two-hybrid interaction assays 
plasmids were introduced in yeast strain EGY48 (M ATa trp l ura3 h is3 L£L2'::pLexAop6-LEU2) 
containing the plasmid pSH18-34, which includes the reporter lacZ gene, and tested for an interaction 
as detected by growth and blue coloring on minimal agar-plates lacking histidine, tryptophan, uracil 
and leucine, containing 2% galactose, 1% raffinose and 80 mg/ml X-gal, buffered at pH7 .0 . 
F u ll-le n g th  m ou se Z R P  cD N A  clo n es  - Comparison of obtained prey cDNA sequences with database 
entries was done using the BLAST program (Altschul et al., 1997). Identification of a full-length 
mouse ZRP-1 cDNA clone was done by comparison of the 5 ’ -end of the human ZRP-1 cDNA 
(Genbank accession number AF000974) with the EST sequences in the database of mouse specific 
IMAGE clones at the RZPD resource center (Berlin, Germany). One highly homologous mouse 
cDNA clone (W58878), that contains a start codon at the position anticipated from the human 
sequence, was ordered and sequenced completely.
R N A  exp ression  stu d ies - Total RNA from several mouse (strain C 57BL/6) tissues was prepared 
using the guanidium isothiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 
1987). Fifteen mg RNA was loaded on a 1% formamide agarose gel and after electrophoresis the RNA 
was transferred to nylon membrane according to standard procedures (Sambrook et al., 1989). 
Complete mZRP-1 and GAPDH cDNAs were radioactively labeled by random priming and used as
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probes for hybridization as described (Cuppen et al., 1997). RNA in  situ  hybridization on C 57BL/6 
mouse embryo cryosections was according to previously published protocols (Hendriks et al., 1995). 
To generate ‘sense’ and ‘antisense’ RNA probes the mZRP-1 cDNA (in the pT7T3D-Pac plasmid, 
Pharmacia) was linearized with NotI or EcoRI and used for in vitro transcription by T7 or T3 RNA 
Polymerase, respectively. Both probes were labeled with a 35S-UTP to a specific activity o f >109 
dpm/mg.
E xp ression  p la sm id  con stru ction s - Full-length mouse RIL cDNA (Genbank accession number 
Y 08361) was cloned in the multiple cloning site of the pSG5 expression vector (Green et al., 1988). 
The RIL-PDZ (Y08361, a.a. 1-101), RIL-LIM (Y 08361, a.a. 209-330), BL-PDZ-I-V (Z32740, a.a. 
1002-2018) and BL-PDZ-II (Z32740, a.a. 1352-1450) protein parts were expressed from a modified 
version of the eukaryotic expression vector pSG5, now containing an initiator AUG codon and an in­
frame VSV-G epitope tag (see Cuppen et al., 1998) for detection or immunoprecipitation of the 
produced peptide using monoclonal antibody P5D4 (Kreis, 1986). The EGFP-mZRP fusion protein 
was expressed from the pEGFP-C1 vector (Clontech), by in-frame cloning of a XhoI - HinDIII 
restriction fragment of the EST clone W 58878 containing the complete mouse ZRP-1 cDNA 
sequence.
A n tib od ies  - The affinity-purified polyclonal antibody a-RIL directed against the C-terminal half of 
RIL and the monoclonal a-V SV  antibody P5D4 are described elsewhere (Cuppen et al., 1998; Kreis, 
1986). The polyclonal antibody a-GFP was obtained by immunization of a rabbit with a GST-BFP 
(Blue Fluorescent Protein) fusion protein. The resulting antiserum was found to bind also to the 
widely used EGFP (Enhanced Green Fluorescent Protein) in Western blotting, immunofluorescence 
and immunoprecipitation experiments. For biotinylation, the Ig fraction was bound on a protein A- 
Sepharose column, eluted in 0.1 M  glycine pH2.5, neutralized by addition of 1 M  Tris-HCl pH7 .5, 
and dialyzed against 50 mM NaHCO3 pH8.5. The resulting antibody fraction was biotinylated using 
Immunopure Sulfo-NHS-LC-Biotin according to the manufacturer’ s instructions (Pierce Chemical 
Company, USA).
Im m unoprecipitation  a n d  W estern b lo ttin g  - COS-1 cells were cultured in DMEM/10% fetal calf 
serum. For each assay, 1.5 x  106 cells were electroporated at 0.3 kV and 125 mF using the Bio-Rad 
Gene Pulser with a 4-mm electroporation cuvette, in 200 ml of phosphate-buffered saline (PBS) 
containing 10 mg of plasmid DNA. Cells were plated on a 10-cm dish and cultured for 24 h in 
DMEM/10% fetal calf serum. Cells were washed with cold PBS and lysed on plate with 550 ml ice- 
cold RIPA buffer (50 mM Tris, pH8.0, 100 mM NaCl, 1 mM EDTA, 1% NP-40, 0 .1% SDS, 0 .5% 
DOC, 1 mM PMSF and protease inhibitor cocktail (Boehringer)). After a 1-h incubation on ice, the 
lysate was centrifuged for 10 min at 10,000 x  g  and 4°C, and 50 ml of the lysate was removed for later 
analysis of input protein levels on Western blot (see below). After addition of a-GFP (2 ml rabbit 
polyclonal antiserum) or a-V SV  (2 ml ascites fluid of hybridoma P5D4) and 4-h rotation at 4°C, 50 ml 
of protein A-Sepharose CL-4B (Pharmacia) was added and incubation was prolonged overnight. The 
immunoprecipitates were washed four times with 1 ml RIPA lysis buffer and boiled for 5 min in 50 ml 
of sample buffer (100 mM Tris-HCl, pH6.8, 200 mM dithiothreitol, 4% SDS, 0 .2% bromophenol 
blue, 20% glycerol). 15 ml of lysates and immunoprecipitates were resolved on 10 or 15% 
polyacrylamide gels and transferred to nitrocellulose membranes by Western blotting. Blots were 
blocked using 5% nonfat dry milk in 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 0 .05% Tween 20 
(TBST). The mouse monoclonal a-V SV  antibody P5D4 (10.000 x  diluted ascites fluid) and the rabbit 
polyclonal a-GFP antibody (5000 x  diluted total serum) were used to detect tagged-proteins in the 
lysates and immunoprecipitates. Incubations with primary and secondary (10.000 x  diluted 
peroxidase-conjugated goat anti-mouse IgG or goat anti-rabbit IgG (Pierce)) antibodies and 
subsequent washes were done in TBST, as described elsewhere (Cuppen et al., 1998). Labeled bands 
were visualized using freshly prepared chemiluminescent substrate (100 mM Tris-HCl, pH8.5, 1.25 
mM p-coumaric acid (Sigma), 0.2 mM luminol (Sigma), 0.009 % H2O2) and exposure to Kodak X- 
omat autoradiography films.
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C e ll tran sfection  a n d  Im m u n oflu orescen ce  - A -431 (ATCC: CRL-1555) and Caco-2 (ATCC: HTB- 
37) cells were cultured in DMEM/10% fetal calf serum. Prior to transfection, cells were seeded onto 
14 mm diameter glass coverslips (Menzel-Glaser, Germany) in 24 wells cell culture plates. 
Transfection mix was made by adding 0.3 mg plasmid DNA to 2 mg DAC -30 (Eurogentec, Seraing 
Belgium) in 150 ml OptiMEM (Gibco BRL, Gaithersburg, MD) and incubating for 30 min at room 
temperature. After replacing the culture medium on the cells (30-70 % confluency) with 150 ml fresh 
DMEM containing 10% fetal calf serum, the transfection mix (150 ml) was added to the cells. 
Following a 5-h incubation at 37°C the medium was replaced with fresh DMEM containing 10% FCS 
and incubation was prolonged overnight. The cells were subsequently used for immunofluorescence 
analysis. Because the autofluorescent signal from the EGFP-mZRP fusion protein was rather weak, 
the signal was enhanced using the polyclonal antibody a-GFP. At further steps, solutions are 
prepared in PBS, cells were thoroughly rinsed in PBS between stages, and incubations were 
performed at room temperature. Cells were fixed for 10 min in 2% paraformaldehyde in PHEM buffer 
(60 mM Pipes, 25mM Hepes pH6 .9, 10 mM EGTA, 2 mM MgCl2) and permeabilized with 0 .5% 
Nonidet P-40 for 5 min. Subsequently, free aldehyde groups were quenched for 10 min in 0.1 M 
glycine. 50 ml of affinity-purified rabbit a-RIL (1:10 dilution), rabbit polyclonal a-GFP (1:1000 
dilution) or mouse monoclonal a-V SV  (P5D4 , ascites fluid; 1:1000 dilution) was used for the 1-h 
incubation with primary antibody. Subsequent incubation was for 45 min with 50 ml of FITC- 
conjugated AffiniPure Goat anti-rabbit or Goat anti-mouse IgG (10 mg/ml; Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA) and 2 units Texas Red-conjugated phalloidin (Molecular Probes). 
In cases where EGFP-mZRP and RIL are detected simultaneously, first the RIL protein was detected 
using the affinity-purified polyclonal a-RIL antibody and Texas Red-conjugated AffiniPure Goat 
anti-Rabbit (10 mg/ml; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Subsequently, 
the EGFP-mZRP fusion protein was detected using biotinylated a-GFP (1:250 dilution) and 
streptavidin-FITC (2 mg/ml; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Finally, 
coverslips were rinsed in PBS and water and mounted on glass slides by inversion over 5 ml Mowiol 
mountant (Sigma Chemical Co.). Cells were examined using an M RC1000 confocal laser scanning 
microscope (Bio-Rad).
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Abstract
PTP-BL is a multiple PDZ domain containing protein tyrosine phosphatase with a 
putative role in structuring the cytoarchitecture at apical submembranous sites in 
polarized epithelial cells. In a yeast two-hybrid screening for partner proteins, we 
identified a novel bromodomain-containing protein, BP75, that interacts uniquely 
with the first PDZ domain in PTP-BL via its C-terminal half. Besides the similarity 
to bromodomain proteins, BP75 displays overall homology to a hypothetical protein 
in C . e le g a n s  (C01H6.7) and to a novel domain in a putative DNA binding factor in 
yeast (YN92). Northern blot analysis revealed that BP75 mRNA is expressed in all 
tissues examined and RNA in  s itu  hybridization experiments reveal thymus, lung, 
liver, colon and spinal cord as high expression sites. Transient transfection studies 
show that both BP75 and a PTP-BL deletion mutant consisting essentially of the 
first PDZ domain are located mainly in the nucleus, excluding the nucleoli, but also 
cytoplasmic localization is evident. Full-length PTP-BL, on the contrary, is 
predominantly localized in the cytoplasm, although some basal nuclear staining is 
observed. The described molecular interaction may reflect a mechanism of coupling 
submembranous signaling events and nuclear events.
Introduction
The accurateness of the signal transduction process, whereby extracellular signals evoke a 
specific cellular response, largely relies on mechanisms that regulate steps in the 
transmembrane transmission, and the integration or divergence of signaling pathways 
within the cytosol and nucleus. An important mechanism to achieve specificity in signaling 
is the use of scaffold, anchoring and adapter proteins (Pawson and Scott, 1997). Adapter 
proteins enable the recruitment of specific components to an activated signaling complex, 
as demonstrated by SH2 domain-containing proteins that bind to activated 
autophosphorylated receptor tyrosine kinases (Songyang et al., 1993). Anchoring proteins 
serve to direct an enzymatic activity to a particular subcellular site by confining the enzyme 
to the restricted microenvironment. This regulatory principle is used in the serine/threonine
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phosphatases P P -1, PP-2A  and PP-2B, where the catalytic subunits are bound to regulatory 
subunits that target the enzymatic com plex to its proper subcellular location (Faux and 
Scott, 1996). Scaffold proteins are considered organizers o f  multiprotein complexes, 
creating ‘ signalosom es’ w ith specialized functions at restricted microcompartments 
(Pawson and Scott, 1997). The scaffold proteins can be divided in two groups. One group 
o f  proteins functions as signaling pipelines by placing enzymes close to their substrates, 
increasing both speed and specificity o f  the signal transduction pathways involved. A  well- 
known example is the yeast protein Ste5 , that clusters the successive components o f the 
M A P K  cascade involved in the pheromone mating response (Herskowitz, 1995). The other 
group o f scaffold proteins functions as organizers o f  cross-roads o f signaling pathways by 
integrating and coupling components o f different signaling cascades in a single 
‘ signallosom e’ . This latter principle is used in the process o f  phototransduction in 
D r o so p h ila  photoreceptor cells, where the protein InaD clusters different types o f  enzymes 
and channels v ia  PDZ-mediated interactions (Ranganathan and Ross, 1997). Here, 
clustering is used to regulate serine/threonine phosphorylation and lipid and calcium  
signaling from  a single multiprotein com plex (Tsunoda et al., 1997).
Protein modules like SH2 , SH3 , W W , LIM , W D, P TB, PH, and P D Z domains form  the 
basal building blocks for scaffold, anchoring and adapter proteins, and play an important 
role in the architecture o f  signal transduction com plexes (Bork et al., 1997). The mouse 
protein tyrosine phosphatase P TP-B L (Hendriks et al., 1995) or RIP (Chida et al., 1995), 
and the human homologue o f this protein named P T P -B A S (M aekawa et al., 1994), P T P L 1 
(Saras et al., 1994), P T P 1E  (Banville et al., 1994) or F A P -1 (Sato et al., 1995), have several 
characteristics (Fig. 1) that make them potential organizers o f signal transduction 
com plexes. PTP-B L  harbours five P D Z domains, small (about 90 a.a.) protein modules 
(Kennedy, 1995) that have now been identified in many members o f  a diverse group o f 
proteins (Ponting, 1997) and can mediate protein-protein interactions (Fanning and 
Anderson, 1996; Ranganathan and Ross, 1997). P D Z domains associate with 
transmembrane proteins (Sheng, 1996), cytoskeletal components (Xia et al., 1997) and 
signal transduction enzymes (Ranganathan and Ross, 1997). The five P D Z domains in PTP- 
B L  may thus enable the formation o f large multiprotein com plexes in w hich the 
phosphotyrosine phosphatase action o f PTP-B L  itself can be combined with potential 
downstream substrates, competitor signaling proteins and putative upstream regulatory 
m olecules. Indeed, proteins that interact with P D Z domains o f P TP-B L have already been 
described. Saras et al. (Saras et al., 1997) identified a 160 kD a protein with R ho-G AP 
activity, P A R G 1, that binds to P D Z -IV  and our group has shown that the small adapter 
protein RIL (Kiess et al., 1995) can interact with both PDZ-II and IV  o f P TP-B L (Cuppen 
et al., 1998). Furthermore, the C-terminus o f the apoptosis inducing Fas-receptor was found 
to bind the second P D Z domain in the human homologue o f  P TP-B L (Saras et al., 1997; 
Sato et al., 1995), but this interaction could not be confirmed in mouse (Cuppen et al.,
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1997). The subcellular partitioning o f the multiprotein com plex that results from  PTP-B L 
PDZ-mediated interactions may be further restricted due to the presence o f a FER M  domain 
in P TP-B L. FER M  domains are found in the submembranous, cytoskeleton-associated 
proteins like ezrin, radixin, moesin, merlin and talin (Tsukita and Yonemura, 1997) and can 
bind transmembrane proteins like C D 44 , C D 43 and IC A M -2 (Yonem ura et al., 1998). This 
may explain w hy endogenous PTP-B L  is located submembranously at the apical side o f 
polarized epithelia (Cuppen et al., 1998).
Finally it is o f  note, that the C-terminal catalytic tyrosine phosphatase domain o f PTP-B L 
can be involved in the reversible (de-)phosphorylation o f associated proteins, thereby 
changing the dynamics o f  the multiprotein com plex or the properties or activities o f its 
constituents. W e have found that the interacting molecule RIL is phosphorylated on 
tyrosines in vitro and in vivo and can be dephosporylated by P TP-B L in vitro (Cuppen et 
al., 1998).
P TP-B L thus bears hallmarks o f a scaffold protein that regulates the com plex organization 
and dynamics o f  macromolecular assemblies at the cell cortex. To further identify the 
components o f this com plex we performed a two-hybrid screening for proteins that interact 
with the first P D Z domain o f P TP-B L and identified a novel bromodomain-containing 
protein o f about 75  kDa, B P 75 . The bromodomain, originally described as an evolutionary 
highly conserved 80 amino acid domain in human, D r o so p h ila  and yeast proteins (Haynes 
et al., 1992), is now defined as a conserved sequence o f  approximately 110 amino acids that 
is found in over 40 proteins, several o f  w hich are involved in transcriptional regulation 
(Jeanmougin et al., 1997). Our results suggest that B P75 may have a rather direct role in 
linking signaling events in the PTP-B L multiprotein com plex and the nucleus.
Results
Identification of proteins that interact with PDZ-I of PTP-BL
Several candidate proteins interacting with the first P D Z domain o f P TP-B L were identified 
in a HeLa cell cD N A  library using B L-PD Z-I (Fig. 1A ) as a bait in the yeast two-hybrid 
interaction trap (Gyuris et al., 1993). Four clones out o f  0.9  x  106 transformants remained 
positive after reintroduction into freshly prepared yeast cells containing appropriate bait and 
reporter plasmids. Tw o clones, B P #3 and BP#6 with inserts o f  1.2 and 1.1 kbp respectively, 
were found to represent independent cD N A s from  the same messenger R N A  (Fig. 1B ). 
Comparison o f the amino acid sequences o f their predicted protein products with database 
entries did not reveal any similarity to known proteins. Furthermore, nucleotide database 
searches w ith the B P #3 cD N A  insert showed only hom ology to expressed sequence tags 
(E S T ’ s) from  various tissues, indicating that B P #3 encodes a novel ubiquitously expressed 
protein. Since PTP-B L is o f  mouse origin and the interacting clones were obtained from  a 
human cD N A  library, we isolated mouse cD N A s that are homologous to B P #3 (see below) 
and confirmed the two-hybrid interaction using the cD N A  segment encoding the C-terminal
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A
250 a.a.
PT P -B L  (1-2460) 
BL-PDZ-I (1076-1177)
100 a.a.
interaction 
with BL-PDZ-I
BP75 (1-651) n.d.
BP#3 (323-651) + +
BP#6 (362-651) + +
o
57PBE 51-63­2(3 + +
BP-Cter (620-651) + /-
BP-DCter (362-622) + /-
F ig u re  1: Schematic representation of the protein segments interacting in the two-hybrid trap. 
Depicted are (A) the PDZ-I segment of PTP-BL used as bait and (B) the BP75 segments retrieved 
from the HeLa cDNA library (BP#3 and BP#6) and used as deletion constructs. The numbers 
corresponding to the first and last a.a. positions in the PTP-BL (Z32740) and BP75 (AF084259) 
segments are shown in parentheses, followed by a quantitative interpretation of the two-hybrid 
interaction results with PDZ-I. ++, strong interaction; +/-, very weak interaction. Band 4.1 like 
domain, hatched box; PTP, open box; PDZ domains, black ovals; bromodomain, grey box; BYC- 
homology domain (see text), stippled box.
B
half of the mouse protein (mBP75C, Fig. 1B). To delineate the interacting interface more 
precisely, we subsequently tested deletion mutants of mBP75 (Fig. 1B). Deletion of the C- 
terminus (mBP-DCter) almost completely abolished the interaction, but presence of the C- 
terminus proper (mBP-Cter) is not sufficient for a strong interaction (Fig. 1B). None of the 
mBP75 constructs interacts with an empty bait or with other PDZ domains of PTP-BL (not 
shown). Furthermore, no interaction was observed with the PDZ domain of RIL, nNOS or 
the second PDZ domain of SAP90 (not shown).
Isolation and characterization of mouse BP75 cDNA clones
Sequence analysis of BP#3 and BP#6 cDNA inserts revealed that only partial sequence 
information of the encoded protein had been obtained. To acquire additional sequence data 
and at the same time have a more complete tool to study the biological function of the 
encoded protein, we searched for full-length cDNAs by screening a mouse fetal brain 
cDNA library using the human BP#3 cDNA insert as a probe. Two clones, with inserts of
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1.8 and 2.4 kbp, respectively, were obtained. The 2361 bp insert o f  the longest cD N A  
(Genbank: A F 084259) most probably represents a full-length cD N A  since northern blot 
analysis revealed a transcript o f  about 2.5 kb in length (Fig. 5). The smaller cD N A  was 
found to be identical to the last 1804 bp o f this clone. Sequence analysis revealed a 
polyadenylation sequence located 18 bp upstream o f the poly-A  tract, and an open reading 
frame that specifies a 651 amino acid polypeptide (Fig. 2). The predicted protein has a 
m olecular mass o f  about 75 kDa. In the complete putative protein we found a bromodomain 
(Haynes et al., 1992) and therefore termed it B P 75 for bromodomain-containing protein o f 
75  kDa. The evolutionary highly conserved bromodomain spans about 110 amino acid 
residues and has now been identified in more than 40 different proteins (Jeanmougin et al.,
1997). Database comparison and sequence alignment (Fig. 3A ) reveal that the B P 75 
bromodomain displays the highest similarity to a bromodomain in a hypothetical C .e le g a n s  
protein, C 01H6.7  (Z71258 , (W ilson et al., 1994)), and a human protein called peregrin or 
B R 140 (JC2069 , (Thompson et al., 1994)). Outside the B P 75 bromodomain there is no 
clear similarity with any o f  the known bromodomain-containing proteins, nor any other 
known protein except for the C 01H6.7  protein mentioned and a yeast protein called Y N 92 
(see below). W hen the entire amino acid sequences o f  B P 75 and C 01H6.7  are aligned (Fig. 
3B) it is evident that beside the bromodomain there is a second stretch o f about 80 amino 
acids that is highly conserved. The sequence o f this segment (Fig. 3C) is over 45%  identical 
and almost 70%  similar between C .e le g a n s  and mouse. This same segment is 21%  identical 
and 34%  similar to a region in Y N 92 (P53759) and we therefore w ill refer to this segment 
as B Y C  domain, for its presence in B P75 , Y N 92 and C 01H6 .7 . Y N 92 is a putative 
transcription regulatory protein from  yeast, that contains a D N A  binding Zn(2)-Cys(6) 
fungal-type binuclear cluster domain (Schjerling and Holmberg, 1996), for which no 
hom ology exists in B P 75 .
Analysis o f  B P 75 using the PR O SITE  protein m otif database predicts two consensus 
tyrosine phosphorylation sites (Fig. 2 , underlined, a.a. 14 and 430), two partially 
overlapping bipartite nuclear localization signals (a.a. 66-83  and 80-97 , (Dingwall and 
Laskey, 1991)) and several potential protein kinase C  and casein kinase II phosphorylation 
sites. This suggests a nuclear localization for B P 75 , and indicates that the protein may be 
post-translational m odified by both serine/threonine and tyrosine phosphorylation.
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L  S Q E R
G A A TTC G G C A C G A G C TTC G G CCG CG TCCCG CG CG TG TTTTTTTTTTTCTCG TG A G G G A CC
TCG CG CCG CCG G G CGCGTGCCGTCCCCCTGCCTCGCGGCGCGGGCTCTCGCGGGCCCCGC
TCCCGCCCTCCGCTCGCCTGGCCCGGACCGGAAGCGGCGCCGCACGGCCTGGGCCTGGCG
M G K K H K K H K S 1 0  
CGGGGGGCGGGCTCTGGGGCCCGGTCGGACATGGGCAAGAAGCACAAGAAGCACAAGTCG  
D R H F  Y E E Y V  E K P  L  K L  V  L  K V  G 3 0  
GACCGCCACTTCTACGAGGAGTACGTGGAGAAGCCCCTGAAGCTGGTCCTCAAAGTCGGG  
G S E V  T  E L  S T  G S S G H D S S L  F  E 5 0  
GGGAGCGAGGTCACCGAGCTCTCCACGGGCAGCTCCGGGCACGACTCCAGCCTCTTCGAA  
D R S D H D K H K D R_ _ _K _ _ _R_ _ _ K. _ .K _ _ R_ _ .K  _ _ _K. _ _ G . _ .E  7 0 
g a c a g a a g c g a c c a t g a c a a a c a c a a g g a c a g a a Aa c g ’g a a â a a Ga g g a AGAa a GGc g a g  
_ _K_ .  _Q .  .  A  .  .  P .  -  .G .  .  -E_ .  _E _ .  _K_ .  .  G . _ .R  .  .  _K_ .  _R.  .  _R_ .  .  R . _ .V .  .  K. .  .E  .  .  _D .  .  K. _ .K 9 0
AAGCAGGCTCCCGGGGAAGAGAAGGGGAGAAAACGGAGAAGAGTCAAGGAGGATAAAAAG 
_ KK .  _R _ .  P .  _ .  R . _ .D .  _ R_ .  A  E N E V  D R D L  Q C H V  P  1 1 0  
A AGCGGGATCGAGACCGTGCAGAGAATGAGGTGGACAGAGATCTCCAGTGTCATGTCCCT 
I  R L  D L  P  P  E K P  L  T  S S L  A  K Q E E 1 3 0  
A TAAGATTAGACTTACCTCCTGAGAAGCCTCTTACAAGCTCGTTAGCCAAACAAGAAGAA
V  E Q T  P  L  Q E A  L  N Q L  M R Q L  Q R K 1 5 0  
G TAGAACAGACACCCCTTCAGGAAGCTTTGAATCAGCTCATGAGACAATTGCAAAGAAAA
D P  S A  F  F  S F  P  V  T  D F  I  A  P  G Y S M 1 7 0  
G A C C C A A G TG C TTTC TTTTC A TTTC C TG TG A C G G A TTTTA TTG C G C C TG G C TA C TC C A TG  
I  I  K H P  M D F  S T  M K E K I  K N N D Y 1 9 0  
ATTATTAAACACCCAATGGATTTTAGTACCATGAAAGAAAAGATCAAGAATAACGACTAC 
Q S I  E E L  K D N F  K L  M C T  N A  M I  Y 2 1 0  
CAGTCCATAGAAGAACTAAAGGATAACTTCAAGCTAATGTGTACTAATGCAATGATTTAC 
N K P  E T  I  Y Y K A  A  K K L  L  H S G M K 2 3 0  
AATAAGCCAGAGACCATTTATTATAAAGCTGCAAAGAAGCTGTTGCACTCAGGGATGAAA
I  Q S L  K Q S I  D F  M S D L  2 5 0  
A TTCTCAGTCAGGAGAGAATTCAGAGCCTGAAGCAGAGTATAGACTTCATGTCAGACTTG 
Q K T  R K Q K E R T  D A  C Q S G E D S G 2 7 0  
CAGAAAACTCGGAAGCAGAAAGAACGAACAGATGCCTGTCAGAGTGGGGAGGACAGCGGC 
C W Q R E R E D S G D A  E T  Q A  F  R S P  2 9 0  
TGCTGGCAGCGCGAGAGGGAAGACTCTGGAGATGCTGAAACACAGGCCTTCAGAAGCCCC 
A  K D N K R K D K D V  L  E D K W R S S N 3 1 0  
GCTAAGGACAATAAAAGGAAAGACAAAGATGTGCTTGAAGACAAATGGAGAAGCAGCAAC 
S E R E H E Q I  E R V  V  Q E S G G K L  T  3 3 0  
TCAGAAAGGGAGCATGAGCAGATTGAGCGCGTTGTCCAGGAGTCAGGAGGCAAGCTAACA 
R R L  A  N S Q C E F  E R R K P  D G T  T  T  3 5 0  
CGGCGGCTGGCAAACAGTCAGTGTGAATTTGAAAGAAGAAAACCAGATGGGACAACAACA 
L  G L  L  H P  V  D P  I  V  G E P  G Y C P  V  R 3 7 0  
CTGGGGCTTCTCCATCCTGTGGATCCCATTGTGGGAGAGCCAGGCTACTGCCCTGTGAGA 
L  G M T  T  G R L  Q S G V  N T  L  Q G F  K E 3 9 0  
TTGGGGATGACAACTGGAAGACTGCAGTCTGGAGTGAACACTCTGCAGGGGTTCAAAGAG
P  V  L  Y L  N Y G P  Y S S Y 4 1 0  
GA TAAAAGGAACAGAGTAACCCCAGTATTATACTTGAATTATGGACCCTACAGTTCTTAT 
A  P  H Y D S T  F  A  N I  S K D D S D L  I  Y 4 3 0  
G C C C C A C A TTA TG A CTCTA CA TTTG CCA A TA TTA G CA A A G A TG A TTCTG A TTTA A TCTA C 
S T  Y G E D S D L  P  N N F  S I  S E F  L  A  4 5 0  
TCAACA TA TG G G G A A G A CTCTG A CCTTCCA A A CA A TTTCA G CA TCTCTG A G TTTTTG G CC 
T  C Q D Y P  Y V  M A  D S L  L  D V  L  T  K G 4 7 0  
ACA TG CCAAGATTACCCGTATGTTATGGCAGATAGTTTACTGGATGTTCTAACAAAAGGA 
G H S R S L  Q D L  D M S S P  E D E G Q T  4 9 0  
GGACATTCCAGGAGCCTGCAGGACTTGGACATGTCATCTCCTGAAGATGAAGGCCAGACC 
R A  L  D T  A  K E A  E I  T  Q I  E P  T  G R L  5 1 0  
AGAGCATTGGACACAGCAAAAGAAGCAGAGATTACACAAATAGAGCCAACAGGGCGTTTG 
E S S S Q D R L  T  A  L  Q A  V  T  T  F  G A  P  5 3 0  
GAGTCCAGCAGTCAGGACAGGCTCACAGCACTGCAAGCTGTAACAACCTTTGGTGCTCCA 
A  E V  F  D S E E A  E V  F  Q R K L  D E T  T  5 5 0  
GCTGAAGTCTTTGACTCCGAAGAGGCTGAGGTGTTCCAGAGGAAGCTTGATGAGACGACA 
R L  L  R E L  Q E A  Q N E R L  S T  R P  P  P  5 7 0  
AGATTGCTCAGGGAGCTCCAGGAGGCACAGAATGAGCGACTGAGCACTAGGCCTCCTCCC 
N M I  C L  L  G P  S Y R E M Y L  A  E Q V  T  5 9 0  
AATATG A TCTG TCTCCTG G G TCCTTCTTA CA G A G A A A TG TA CCTTG CTG A A CA A G TG A CC 
N N L  K E L  T  Q Q V  T  P  G D V  V  S I  H G 6 1 0  
AATAACCTCAAAGAACTCACACAGCAAGTGACTCCAGGTGATGTTGTAAGCATACACGGA
V  R K A  M G I  S V  P  S P  I  V  G N S F  V  D 6 3 0  
G TG CG A A A A G CAATGGGGATTTCTGTTCCTTCCCCCATCGTGGGAAACAGCTTCGTAGAT
L T  G E C E E P  K E T  S T  A  E C G P  D A  6 5 0  
TTGACAGGAGAGTGTGAAGAACCTAAGGAGACCAGCACTGCTGAGTGTGGGCCTGACGCG
D K R N R V  T
S
Figure 2: Complete cDNA 
and predicted amino acid 
sequence of mouse BP75.
The arrowheads (a.a. 323 and 
362) indicate the start of the 
clones identified in the two- 
hybrid interaction trap ( BP#3 
and BP#6, respectively). The 
numbers to the left and right 
correspond to nucleotide and 
amino acid positions in the 
BP75 database entry 
(AF084259), respectively. 
The bromodomain and the 
BYC domain (for explanation 
see legend Fig. 3 and text) 
are shown on a dark and light 
grey background. Consensus 
tyrosine phosphorylation sites 
are shown underlined, the 
nuclear localization signal 
sequences are underlined 
with a dashed line and the 
polyadenylation sequence is 
doubly underlined.
AG CTG A A C TA G C C TG G TA TTTG A TTC TA TTA TG TA C A TA G TTTTTC A TTC TG A A C TTG G A
G G TG C TTTTC A G A A G A TA TTA A CTA TTTG TA A A TTG TG TTTTA ATTA A G CTTTG G G A CA G
TTCCTTTTAATG TTCCA A A G A TTG G CCTTG TA TTA G G A A A TA A A G CTG A A CCTG G G A CTG
TGAAAAAAAAAAAAAAAAAAA
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BP75, a novel bromodomain-containingprotein
BP75 interacts with the PTP-BL PDZ moiety when coexpressed in mammalian cells 
To obtain independent evidence for the interaction between BP75 and PTP-BL, we 
cotransfected mammalian epithelial cells (COS-1) with an expression construct encoding 
Myc-epitope-tagged full-length BP75 and a construct encoding the five PDZ domains of 
PTP-BL (BL-PDZ-I-V), or, as a control, the empty expression vector. Specific 
coprecipitation of anti-Myc detectable full-length BP75 was demonstrated for BL-PDZ-I-V 
(Fig. 4) when using an antibody against BL-PDZ-I (Cuppen et al., 1998), confirming the 
results obtained in the yeast two-hybrid interaction trap.
Figure 4: BP75 coprecipitates with PDZ 
domains of PTP-BL.
COS-1 cells were cotransfected with a 
construct encoding cMyc epitope-tagged BP75 
and a construct encoding the five PDZ domains 
of PTP-BL (BL-PDZ-I-V) or empty vector as a 
control. Western blotting using a a-cMyc 
antibody detected a 75 kDa protein in the total 
cell lysates (left panel). After 
immunoprecipitation using a polyclonal 
antiserum directed against the first PDZ 
domain of PTP-BL (a-BL-PDZ-I) 
coprecipitaion of cMyc epitope-tagged BP75 
with the five PDZ domains of PTP-BL is 
shown (right panel). No coprecipitation of 
BP75 is observed in lysates of COS cells 
cotransfected with empty vector.
Figure 3: (facing page) Sequence comparison of the BP75 protein.
(A) The bromodomain of BP75 is shown, aligned with bromodomains from different proteins. The 
original 80 a.a. bromodomain motif (Haynes et al., 1992) and the secondary structure as predicted 
from a multiple alignment of 37 proteins (Jeanmougin et al., 1997) are indicated at the bottom. The 
aligned proteins are the hypothetical C .elegan s protein C01H6.7 (Z71258), human peregrin or B R 140 
(JC2069), Tetrahym ena therm ophila  Histone Acetyltransferase A  (HAT A 1, U47321), mouse CREB 
binding protein (CBP, P45481), mouse RING3 (D89801), human transcription initiation factor 
TFIID, 250 kDa subunit, (TAFII-250, P21675) and human SNF2a  (S45251). The numbers on the left 
and right of the peptides indicate the corresponding N and C-terminal amino acid positions in the 
database entry. Symbols used in the consensus sequence: $, positive charge (K,R); !, (M,L,I,V); %, 
(S,T); #, (Y,F). Residues that are similar in at least half, two-third and all sequences are shown black 
on a grey background, white on a grey background and white on a black background, respectively.
(B) The complete BP75 protein sequence was aligned with the predicted protein C01H6.7 from the
C .eleg an s contig C01h6 . Identical amino acids are shown on a black background and similar amino 
acids are indicated on a grey background. The bromodomain and B Y C  domain are single and double 
underlined, respectively.(C) Multiple alignment of the B Y C  domain of BP75 (AF084259), C 01H6.7 
(Z71258) and YN 92 (P53749). Shading as depicted in A.
MYC-BP75 +
<9
a
Total lysate 
WB: a-MYC
IP: a-BL-PDZ-I 
WB: a-MYC
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BP75 expression pattern
The observed interaction between B P 75 and PTP-B L can only be o f  biological significance 
when both genes are coexpressed in at least some tissues. Therefore, the B P 75 cD N A  insert 
and full-length PTP-BL cD N A  were used to probe a northern blot o f  total R N A  from 
several different mouse tissues. A s shown in Fig. 5A , a transcript o f  about 2.5 kb is highly 
expressed in all tissues examined, with the highest levels in lung, stomach and thymus. The
8.5 kb PTP-B L transcript has a more restricted expression pattern and is most abundant in 
lung, kidney, testis, stomach and skin. To further delineate the B P 75 expression pattern we 
used an antisense B P 75 R N A  probe for in  situ  hybridization on mouse embryo 
cryosections. B P 75 expression is found throughout development in all embryonic stages 
( 10.5 dpc to 18.5 dpc) analysed (not shown). In 16.5 dpc embryos B P 75 is ubiquitously 
expressed, with highest expression levels in thymus, lung, liver, colon and the spinal cord 
(Fig. 6B). Significant expression is also found in salivary glands, vibrissae and skin (Fig. 
6B). N o positive signal was obtained when a B P 75 sense R N A  probe was used (Fig. 6C).
A — 28S
— 18S
B
•  •
C
D
••
— 28S 
18S
28S
18S
Figure 5: Tissue distribution of BP75 and PTP-BL.
Northern blot analysis of total RNA from mouse tissues for BP75 (A) and PTP-BL (B). As a control 
for RNA loading, levels of the housekeeping gene GAPDH (C) and rRNA bands in total RNA on an 
ethidium bromide-stained gel (D) were used. BP75 is expressed ubiquitously in all tissues examined, 
whereas PTP-BL is highly expressed in lung, kidney, testis, stomach and skin and to a lower level in 
brain and thymus.
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Figure 6: BP75 RNA in  situ  hybridization on 16.5 dpc mouse embryo sections.
A  bright field image (A) and dark field images using an antisense BP75 RNA probe (B) and a sense 
BP75 probe (C) on 16.5 dpc mouse embryo cryosections are shown. BP75 is expressed throughout 
the whole embryo with highest expression in thymus, lung, liver, colon and the spinal cord. 
Furthermore, high expression is also observed in salivary glands, vibrissae and skin. BV, blood 
vessel; G, gut; H, heart; Li, liver; Lu, lung; NC, nasal cavity; SC, spinal cord; SG, salivary glands; Vi, 
vibrissae. Bars, 1 mm.
BP75 and PTP-BL protein localization
To study the subcellular distribution of both interactors, full-length cMyc epitope-tagged 
BP75 was expressed transiently in NIH 3T3 fibroblasts and MDCK cells together with 
either the first PTP-BL PDZ domain or full-length PTP-BL. Fluorescent double-labeling 
was performed using a mouse monoclonal antibody against the cMyc tag (9E10; Kari et al., 
1986) and a rabbit polyclonal antibody directed against the first PDZ domain of PTP-BL 
(Cuppen et al., 1998). BP75 localizes predominantly to the nucleus in both fibroblast (Figs. 
7A and C) and MDCK cells (Figs. 7E and G), as does BL-PDZ-I (Figs. 7B and F), although 
cytoplasmic staining is also evident in some cells. There is an interesting correlation 
between BP75 and BL-PDZ-I nuclear and cytoplasmic location in double transfected cells: 
in cells where BP75 is located in the cytoplasm also BL-PDZ-I is cytoplasmically localized. 
Furthermore, at higher magnification a typical distribution pattern that is indicative for a 
nucleoplasmic localization becomes obvious for both BP75 (Fig. 7A, insert) and BL-PDZ-I 
(Fig. 7B, insert). It is interesting to note that PTP-BL PDZ-I is the only domain out of seven 
PDZ domains tested by transient expression, that localizes to the nucleus (unpublished 
observations).
The BP75 localization hardly overlaps with that of the complete PTP-BL protein, although 
both cytoplasmic (Figs. 7C and D, cell indicated by #) and nuclear (Figs. 7C and D,
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indicated by *) colocalization can occasionally be observed in fibroblasts. In MDCK cells 
PTP-BL is localized predominantly in a punctuate pattern at the apical side of the cell, 
corresponding to the microvilli-like membrane protrusions on these cells, but also nuclear 
staining is evident in some cells (Fig. 7H). Hardly any mitotic cells could be found that 
express BP75. However, the few cells observed showed very faint cytosolic staining, 
largely excluding the area of the chromosomes (Figs. 7I and J). These observations suggest 
that BP75 is degraded before or during mitosis.
Discussion
We report here on the identification of two independent clones encoding the C-terminal part 
of a novel bromodomain-containing protein, BP75, that specifically interact with the first 
PDZ domain of PTP-BL. In addition, several observations are described which have 
bearing on the restricted possibilities for this interaction and the limited overlap in both 
cell-type expression and subcellular distribution patterns of the putative partner proteins. 
These different issues need a further discussion in order to obtain a better appreciation of 
the complexity of PTP-BL biology and the role of the PTP-BL’s distinct peptide domains.
It is becoming increasingly clear that PDZ domains, as they occur in PTP-BL and a variety 
of other proteins (Ponting, 1997), are protein-protein interaction modules that generally 
bind to short C-terminal peptides (Saras and Heldin, 1996; Songyang et al., 1997). We 
found that the last 30 amino acids of BP75 are not sufficient for a strong interaction to 
occur (Fig. 1B). Still, the two-hybrid analysis shows that deletion of the last 29 amino acids 
of BP75 almost completely abolishes any detectable interaction. Taken together, this argues 
against a simple model in which PDZ domains uniquely engage in C-terminal peptide 
binding, also because the last three residues of BP75 (-DAS*) do not resemble any of the 
known consensus motifs for PDZ recognition (Songyang et al., 1997). Furthermore, 
screening of a two-hybrid random peptide library to identify a consensus C-terminal 
peptide target sequence for PTP-BL PDZ-I did not result in interacting peptides (E.C., 
M.v.H., unpublished work), whereas the same approach was successful for the neuronal 
NOS PDZ domain (Schepens et al., 1997). Perhaps BL-PDZ-I belongs to a subset of PDZ
Figure 7: (facing page) Confocal images of BP75 and PTP-BL localization in 3T3 and M DCK cells. 
cMyc-tagged BP75 was transiently coexpressed with the first PDZ domain of PTP-BL (A, B, E and 
F) or with full-length PTP-BL (C, D, G and H) in NIH 3T3 (A, B, C, and D) and M DCK cells (E, F, 
G and H). BP75 was detected using a monoclonal antibody against the cMyc-tag (A, C, E and G) and 
BL-PDZ-I and full-length PTP-BL were detected with a rabbit polyclonal antibody directed against 
PDZ-I (B, D, F and H). BP75 was detected in mitotic NIH 3t 3 cells (I) and the DNA was stained 
with propidium iodide (J). The inserts in (A) and (B) show an enlargement of the cell indicated with 
an arrow. In cells coexpressing BP75 and PTP-BL, both cytoplasmic (*) and nuclear (#) 
colocalization is observed (C, D). The bars represent 10 mm.
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domains that is not capable o f  recognizing C-terminal peptide segments in isolation and 
requires accessory presence o f other protein segments. Indeed, evidence is accumulating 
that internal peptide sequences may equally w ell serve as targets for recognition by PD Z 
domains. For example, the binding o f the third P D Z domain in InaD to the TRP C a2+ 
channel is critically dependent on an internal S T V  peptide (Shieh and Zhu, 1996), and the 
fifth InaD P D Z domain binds an internal segment o f  phospholipase C-b (van Huizen et al.,
1998). Furthermore, the A L P -1 P D Z domain binds to an internal spectrin-like repeat in a - 
actinin-1 (X ia et al., 1997) and PTP-B L  P D Z domains II and IV  and the RIL P D Z domain 
require the C-terminal RIL L IM  domain for interaction (Cuppen et al., 1998). A  closer look 
at the critical residues in PTP-B L PDZ-I, that would govern C-terminal peptide binding 
analogous to the situation in the P SD 95 P D Z domain (Doyle et al., 1996), did not reveal, 
however, a structural basis for assuming an impairment o f such mode o f interaction. So, 
there are arguments for both types o f interactions to exist, and our findings are therefore 
most easily interpreted by assuming that combined internal and C-terminal information is 
required for a strong interaction o f B P 75 and PTP-B L  PD Z-I. Interestingly, secondary 
structure prediction suggests the presence o f coiled-coil elements in the C-terminal h a lf o f 
B P 75 (a.a. 534-565) and perhaps dimerization via  these structures may be a prerequisite for 
interaction with B L-PD Z-I.
The interaction identified in the yeast two-hybrid interaction trap was confirmed in an 
independent assay showing coimmunoprecipitation from  transfected mammalian cells o f 
B P 75 w ith a protein segment encompassing the five P D Z domains o f PTP-B L  (Fig. 4). 
Unfortunately, we were unable to show an interaction between full-length proteins in this 
assay. M ost likely, this is due to the very low  P T P-B L  protein levels that were obtained in 
our transfection studies. These and data from  other experiments suggest that overexpression 
o f  the very large fully active P TP-B L protein conflicts with the c e ll’ s viability (E.C., D erick 
Wansink, unpublished work).
For the observed interaction to be o f biological significance at least a partial overlap in 
expression pattern is required. Northern blot (Fig. 5) and R N A  in  s itu  hybridization analysis 
with B P 75 and PTP-B L  probes (Fig. 6; Hendriks et al., 1995) show that B P 75 and PTP-B L 
are coexpressed in some, but not all, tissues. Clear coexpression can be observed in for 
exam ple glandular epithelial cells, thymus and lung. The ubiquitous expression o f B P 75 
m R N A  suggests a structural or general function for the protein and perhaps this is 
modulated by P TP-B L in restricted tissues. In tissues where PTP-B L is not present, such as 
liver, other proteins may interact with B P 75 , but experimental evidence for this possibility 
is lacking.
Another aspect o f  our histological findings, the restricted occurrence o f overlap in 
subcellular distribution between PTP-B L  and B P75 is also enigmatic. Transfection studies, 
as shown in F ig. 7 , reveal B P 75 to have predominantly a nuclear location. This is in 
keeping with the presence o f the bromodomain (Haynes et al., 1992; Jeanmougin et al.,
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1997) and the bipartite nuclear localization signals in the product specified by the full- 
length mouse cDNA. The question whether there is also a role for the BYC domain (the 
conserved segment in BP75, YN92 and C01H6.7), with similarity to the putative 
transcriptional regulatory protein YN92 from yeast, is open for further study. If both the 
bromo- and the BYC domain are considered a key to function one might speculate that 
BP75 may have a role in regulation of chromatin structure and/or transcriptional activity. 
Due to its secondary structure that consists of four a-helices the bromodomain has been 
proposed to mediate protein-protein interactions in the nucleus thereby influencing the 
assembly and/or activity of multiprotein complexes (Haynes et al., 1992; Jeanmougin et al.,
1997). Indeed, GCN5, a putative transcriptional adapter in humans and yeast, was found to 
bind to DNA-dependent protein kinase holoenzyme via its bromodomain, resulting in 
phosphorylation of GCN5 and inhibition of its histone acetyltransferase activity (Barlev et 
al., 1998). Is there compatibility between the behaviour and putative role of BP75 and that 
of PTP-BL? For PTP-BL, we do know that it is localized mainly at the plasma membrane, 
although in some cells a nuclear localization can be observed in our experimental set-up. 
Interestingly, also low levels of endogenous PTP-BL have been found in nuclei of mouse 
keratinocytes (Derick Wansink, unpublished work) leaving open the possibility of BP75 
and PTP-BL to physically interact. Of course, during mitosis there is ample opportunity for 
both proteins to interact, and maybe the low levels of BP75 in the cytoplasm and PTP-BL 
in the nucleus are indicative of a recently acquired post-mitotic state. Alternatively, it is 
possible that BP75 and/or PTP-BL shuttle between cytosol and the nucleus, coupling signal 
transduction processes at the cell cortex to nuclear events or vice versa. In this light it is 
interesting to note that Protein 4.1, which contains an FERM domain like PTP-BL, is also 
located both at the cell membrane and in the nucleus (Krauss et al., 1997). Furthermore, 
several other submembranous proteins like zyxin, ZO-1, b-catenin and plakophilins 2a and 
2b are also found located in the nucleus (Behrens et al., 1996; Gottardi et al., 1996; Huber 
et al., 1996; Mertens et al., 1996; Nix and Beckerle, 1997). Conversely Br140, another 
primarily nuclear bromodomain-containing protein, was initially identified due to its 
copurification with an integrin (Thompson et al., 1994). Shuttling of proteins or protein- 
complexes between compartments may therefore form an important pathway for coupling 
submembranous signaling events to nuclear activity. External stimuli or the catalytic 
activity of enzymes like PTP-BL may regulate these processes. Interestingly, BP75 contains 
two consensus tyrosine phosphorylation sites and many potential serine and threonine 
phosphorylation sites that may regulate its properties in a reversible manner. Furthermore, 
since modulation of proteins by tyrosine phosphorylation and subsequent translocation into 
the nucleus is now seen as a general mechanism of transmitting signals from cell-surface to 
the nucleus (Karin and Hunter, 1995), the lack of coprecipitation of BP75 with full-length 
PTP-BL (Fig. 4) may also be due to direct or indirect modulation of the PDZ-BP75 
interaction by the enzymatic activity of PTP-BL.
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Clearly, to fully understand the importance of PTP-BL as a scaffold protein we require 
more knowledge about the biological processes PTP-BL is involved in. Knock-out mouse 
models could help us as they offer a clear view on the effect of PTP-BL deficiency. 
Recently, a gene trap insertion mutant has been described that displayed no obvious defects 
(Thomas et al., 1998). However, in the model presented by this group part of the scaffold 
function of PTP-BL might still be intact, because only the C-terminal half of the protein 
was deleted. Generation of additional animal and cellular models and the hunting of other 
binding partners may therefore be a good strategy to approach the biological function of 
PTP-BL.
Materials and Methods
Tw o-H ybrid In tera ction  Trap - Plasmid DNAs, the yeast strain EGY48 and the HeLa cell cDNA 
library used for the interaction-trap assay were kindly provided by Dr. Roger Brent and colleagues 
(Massachusetts General Hospital, Boston, MA) and used as described (Gyuris et al., 1993). The 
construction of the PTP-BL PDZ, RIL-PDZ, nNOS PDZ and SAP-PDZ baits has been described 
previously (Cuppen et al., 1998; Schepens et al., 1997). For two-hybrid interaction assays plasmids 
were introduced in yeast strain EGY48 (M ATa trp l ura3 h is3 L£U2::pLexAop6-LEU2) containing 
the plasmid pSH18-34, which includes the reporter la cZ gene, and interactions were validated by 
growth and blue colouring on minimal agar-plates lacking histidine, tryptophan, uracil and leucine, 
which contain 2% galactose, 1% raffinose and 80 mg/ml X-gal, buffered at pH7.0. Comparison of 
candidate prey cDNA sequences with database entries was done using the BLAST program (Altschul 
et al., 1990). Mouse BP75 prey constructs containing the fragment corresponding to the shortest 
human prey insert (mBP75C, a.a. 323-651), the C-terminus of BP75 (BP-Cter, a.a. 620-651) and the 
C-terminal half of BP75 lacking the C-terminus (BP-DCter, a.a. 362-622), were generated by PCR 
using specific primers with either EcoRI or XhoI restriction enzyme recognition sites, using mouse 
full-length BP75 cDNA (AF084259) as a template. The resulting fragments were cloned in-frame in a 
EcoRI and XhoI digested pJG4-5 prey vector (Gyuris et al., 1993). A ll constructs generated by PCR 
were checked for absence of mutations by DNA sequencing.
Iso la tio n  a n d  characterization  o f  m ou se B P 75 cD N A s - The 1.2 kbp BP#3 insert was isolated, 
labelled radioactively by random priming and used to screen a mouse brain l-ZAPII cDNA phage 
library (Stratagene, La Jolla, CA) following standard procedures. Resulting phages were plaque- 
purified and inserts were rescued as pBluescript SK" plasmids according to the manufacturer’ s 
protocols. Nucleotide sequences were determined by double-stranded DNA dideoxy sequencing using 
T3 and T7 sequencing primers on rescued plasmids and subclones derived thereof. Sequences were 
aligned with Multalin (Corpet, 1988) using the Blosum62 comparison table and annotated with 
Genedoc (shareware, version 2 .2.005 (Nicholas and Nicholas, 1997)).
R N A  exp ression  stu d ies - Total RNA from several tissues was prepared using the guanidium 
isothiocyate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987). Fifteen mg RNA 
was loaded on a 1% formamide agarose gel and after electrophoresis the RNA was transferred to a 
nylon membrane (Hybond-N, Amersham) according to standard procedures. Complete mouse BP75, 
PTP-BL and GAPDH cDNAs were radioactively labelled by random priming and used as probes for 
hybridization as described (Cuppen et al., 1997). RNA in  situ  hybridization on mouse embryo 
cryosections was according to previously published protocols (Hendriks et al., 1995). To generate 
‘ sense’ and ‘antisense’ RNA probes, the mouse BP75 cDNA pBluescript-SK-based plasmid was 
linearized with XhoI and NotI, respectively, and used for in vitro transcription by T3 and T7 RNA
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polymerase, respectively. Both probes were labelled with a 35S-UTP (400 Ci/mmol, Amersham) to a 
specific activity of >109 dpm/mg.
E xp ression  p la sm id  con stru ction s - Restriction fragments encoding amino acid stretches 1056-1284 
and 1002-2018 of PTP-BL (Z32740) encompassing PDZ-I and PDZ-I-V, respectively, were cloned 
into a modified version of the eukaryotic expression vector pSG5 (Green et al., 1988) that contains an 
initiator AUG codon at the multiple cloning site. A  construct for the expression of an epitope-tagged 
version of mouse BP75 was generated as follows. Using a subcloned SmaI fragment of BP75 as 
template the 5 ’ -end of the BP75 open reading frame was PCR amplified with a specific 
oligonucleotide (5’ -CGAATTCATGGGCAAGAAGCACAAG-3 ’ , introducing an EcoRI site directly 
in front of the start codon) and the vector-specific T7 oligonucleotide. The resulting 0.2 kbp fragment 
was digested with EcoRI and XmaI and used together with a 1.9 kbp XmaI-XhoI restriction fragment 
of BP75 in a three-way ligation into the EcoRI-XhoI digested pMyc vector. pMyc is a pCDNA3- 
derived vector in which at the 5’ end of the pCDNA3 (Invitrogen) multiple cloning site a synthetic 
DNA fragment was introduced that entails an initiator AUG codon followed by the cMyc-epitope tag 
and an EcoRI site. Full-length PTP-BL (Hendriks et al., 1995) was subcloned as a NotI-XhoI 
restriction fragment in pCDNA3.
Im m unoprecipitation  a n d  W estern b lo ttin g  - COS-1 cells were cultured in DMEM/10% fetal calf 
serum. For each assay, 1.5 x  106 cells were electroporated at 0.3 kV and 125 mF using the Bio-Rad 
GenePulser with a 4-mm electroporation cuvette, in 200 ml of phosphate-buffered saline (PBS) 
containing 10 mg of supercoiled plasmid DNA. Cells were plated on a 10-cm dish and cultured for 24 
h in DMEM/10% fetal calf serum. Cells were washed with cold PBS and lysed on plate with 550 ml 
ice-cold RIPA buffer (50 mM Tris, pH8.0, 100 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% 
DOC, 1 mM PMSF and protease inhibitor cocktail (Boehringer)). After a 1 hour incubation on ice, 
the lysate was centrifuged for 10 min at 10,000 x  g  at 4°C and proteins in 50 ml of the lysate were 
separated for further analysis. After addition of the polyclonal antibody a-BL-PDZ-I (affinity- 
purified, 50 x  diluted; Cuppen et al., 1998) and overnight rotation at 4°C, 50 ml of protein A- 
Sepharose CL-4B (Pharmacia) were added and incubation was prolonged overnight. The Sepharose 
beads with immunobound proteins were washed four times with 1 ml RIPA lysis buffer and boiled for 
5 min in 50 ml of 2x sample buffer (100 mM Tris-HCl, pH6.8, 200 mM dithiothreitol, 4% SDS, 0.2% 
bromophenol blue, 20% glycerol). Fifteen ml of lysates and immunobound proteins were resolved on 
8% polyacrylamide gels and transferred to nitro-cellulose membranes by western blotting. Blots were 
blocked using 5% nonfat dry milk in 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 0 .05% Tween 20 
(TBST). Cell culture supernatant of the a-cMyc hybridoma 9E 10 (Kari et al., 1986) was used to 
detect coprecipitation of epitope-tagged BP75. Incubations with primary and secondary (1 hour, 
10.000 x  diluted peroxidase-conjugated goat anti-mouse IgG (Pierce)) and subsequent washes were 
done in TBST at room temperature. Labelled bands were visualized using freshly prepared 
chemiluminescent substrate (100 mM Tris-HCl, pH8.5, 1.25 mM p-coumaric acid (Sigma), 0.2 mM 
luminol (Sigma), and 0.009 % H2O2).
C e ll tran sfection  - Mouse embryonic fibroblasts (NIH 3T3) and MDCK type II cells (a kind gift of K. 
Ekroos, Heidelberg, Germany) were cultured in DMEM (Gibco BRL, Gaithersburg, MD), 
supplemented with 10% FCS (Zellbiologische Produkte GMBH, St.Salvator, Germany). Prior to 
transfection, cells were seeded onto 14 mm diameter glass coverslips (Menzel-Glaser, Germany) in 
24 wells cell culture plates. Transfection mix was made by adding 0.3 mg supercoiled plasmid DNA 
to 2 mg DAC-30 (Eurogentec, Seraing Belgium) in 150 ml OptiMEM (Gibco BRL, Gaithersburg, 
MD) and incubating for 30 min at room temperature. After replacing the culture medium on the cells 
(at 30-50 % confluency) with 150 ml fresh DMEM containing 10% FCS, the transfection mix (150 ml) 
was added to the cells. Following a 5 hours incubation at 37°C the medium was replaced with fresh 
DMEM containing 10% FCS and incubation was prolonged overnight. Cells were subsequently used 
for immunofluorescence.
Im m u n oflu orescen ce a n d  M icroscop y  - All solutions are prepared in PBS and incubations were
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performed at room temperature in the presence of 1% goat serum. Cells were fixed for 20 min in 2% 
paraformaldehyde, permeabilized with 0.5% Nonidet P-40, and then free aldehyde groups were 
quenched for 10 min in 0.1 M  glycine. 50 ml of a 1:2 dilution of monoclonal mouse a-cMyc 
(hybridoma culture supernatant, 9E 10; Kari et al., 1986) and 1:50 dilution of affinity-purified 
polyclonal rabbit a-BL-PDZ-I (directed against the first PDZ domain of PTP-BL; Cuppen et al., 
1998), was used for the 1 hour incubation with primary antibody. After thoroughly rinsing in PBS, 
cells were incubated for 5 min with the second antibodies, 50 ml of a 1:75 dilution Texas Red- 
conjugated AffiniPure Goat anti-mouse IgG and 1:75 dilution Fluorescein-conjugated AffiniPure 
Goat anti-rabbit IgG (both from Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). In 
cases where DNA was stained with propidium iodine (5 mg/ml) the fluorescein-conjugated AffiniPure 
Goat anti-mouse IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) was used as 
second antibody. Finally the coverslips were rinsed in PBS and water and mounted on slides by 
inversion over 5 ml Mowiol mountant (Sigma Chemical Co.). Cells were examined using a confocal 
laser scanning microscope (M RC1000, Bio-Rad).
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Abstract
P TP-B L is a large intracellular protein tyrosine phosphatase that functions as a 
m olecular scaffold by binding other proteins via its five P D Z motifs. Here, we 
describe the identification and characterization o f the mammalian orthologue o f the 
D r o so p h ila  tumor suppressor warts, m W TS, that interacts specifically w ith the 
fourth P D Z m otif in P T P-B L. The short C-terminal peptide stretch flanking the 
putative serine/threonine kinase domain o f m W TS is sufficient for interaction, both 
in two-hybrid and co-immunoprecipitation experiments. Deletion o f the last three 
residues (-V Y V * ) from  this segment completely abolishes any detectable 
interaction, clearly illustrating C-terminal peptide recognition by the fourth PD Z 
m otif o f  PTP-B L. The m W TS kinase domain is highly homologous to several cA M P  
dependent serine/threonine kinases, including kinases that are implicated in Rho­
mediated signaling. Immunodetection reveals m W TS polypeptides o f  80 and 175 
kD a and shows that m W TS, like PTP-B L, localizes predominantly to the apical side 
o f  epithelial cells. Based upon its subcellular localization and characteristics o f  other 
components in the PTP-BL/m W TS supramolecular complex, we propose a potential 
role for P TP-B L in the remodeling o f the apical actin cytoskeleton.
Introduction
M any o f  the cellular processes that are triggered by signaling cues involve the 
rearrangement o f the actin-based cytoskeleton. Actin  cytoskeletal rem odeling can be 
controlled by members o f  the Rho fam ily o f  Ras-like GTPases, w hich includes Rho, Rac 
and C dc42 (Hall, 1998). In this process also the activation o f proteins with enzymatic 
activity, like the tyrosine and serine/threonine kinases and phosphatases play an important 
role. For example, Rho activity appears poised to stimulate the tyrosine phosphorylation o f 
several proteins, including focal adhesion kinase, p 130 and paxillin (Flinn and Ridley, 
1996; Seckl et al., 1995) and tyrosine kinase inhibitors have been shown to block Rho-
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induced stress fiber assembly in response to lysophosphatidic acid (LPA) (Nobes et al., 
1995). Furthermore, a tyrosine kinase-dependent mechanism, apparently involving Rho 
proteins, regulates activation of phospholipase D  and synthesis of the second messenger 
PtdIns(4 ,5)P2 in H E K -293 cells (Rumenapp et al., 1998). In turn, the cellular level o f 
polyphosphoinositides may form  a control element in cytoskelal organization (Shibasaki et 
al., 1997). C learly in these processes, there is also dependence on the level o f  
phosphorylation o f proteins that regulate the intrinsic activity o f  members o f  the Rho fam ily 
o f  small GTPases. V av, a Rho-GDP/GTP exchange factor (GEF) is tyrosine phosphorylated 
after T C R  stimulation (Turner et al., 1997) and binding o f Ras-GTPase-activating protein 
(G AP) p 190 to R hoG A P  p 160 was found to depend on (tyrosine) phosphorylation o f the 
latter (Bryant et al., 1995). Quite recently, a novel R ho-G AP, P A R G 1, was found to interact 
with a cytosolic protein tyrosine phosphatase, P T P -L 1 (Saras et al., 1997), providing a 
potential direct link between tyrosine dephosphorylation, cytoskeletal dynamics and the 
Rho-signaling web.
W e have been studying P TP-B L (Hendriks et al., 1995) (also known as RIP; Chida et al.,
1995), the mouse orthologue o f human P T P -L 1 (also known as P T P -B A S, P T P -1E  and 
F A P -1; B anville et al., 1994; M aekawa et al., 1994; Saras et al., 1994; Sato et al., 1995). 
This large submembranous protein o f about 270  kD a (see F ig. 1) is predominantly 
expressed in epithelia (Cuppen et al., 1998; Hendriks et al., 1995) and contains a putative 
N-terminal leucine zipper m otif (Saras et al., 1994) follow ed by a region with hom ology to 
the cytoskeleton-membrane linkers band 4. 1, ezrin, radixin and moesin, recently named 
FER M  domain (Chishti et al., 1998). This domain directs PTP-B L  to the apical side o f 
polarized cells, where it localizes at a typical fixed distance from  the cell membrane 
(Cuppen et al., submitted). Between the FER M  domain and the C-terminal protein tyrosine 
phosphatase (PTP) domain, five P D Z  motifs are present. P D Z  motifs are small protein 
modules that mediate protein-protein interactions (Fanning and Anderson, 1996; 
Ranganathan and Ross, 1997; Saras and Heldin, 1996) and can associate with 
transmembrane proteins (Sheng, 1996), cytoskeletal components (Xia et al., 1997) and 
signal transduction enzymes (Ranganathan and Ross, 1997). Several binding partners for 
the P D Z  motifs in P TP-B L have already been identified and these suggest a potential role 
for the resulting multi-protein com plex in regulating the actin-based cytoskeleton. Am ong 
the interactors are the R ho-G A P P A R G 1, which associates with the fourth P D Z m otif in the 
human orthologue o f P T P-B L  (Saras et al., 1997), and the L IM  domain proteins Z R P -1 
(Cuppen et al., submitted) and RIL (Cuppen et al., 1998), w hich bind most strongly to the 
second and fourth P D Z domain. Both RIL and Z R P -1 colocalize with F-actin and thus may 
cluster w ith the structural and signaling components o f  the cytoskeleton, potentially in a 
similar w ay as their closest homologues A L P -1 (X ia et al., 1997) and zyxin  (Crawford et 
al., 1992).
Here, we describe the characterization o f the mouse orthologue o f  the D r o so p h ila  tumor
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suppressor warts (W TS), a protein that emerged from  two hybrid screening and specifically 
binds to the fourth P D Z m otif in PTP-BL. Interestingly, mutations in D r o so p h ila  W TS 
cause apical hypertrophy o f  imaginal disc epithelial cells (Justice et al., 1995). L ike dW TS 
mouse W T S is highly homologous to several cA M P  dependent serine/threonine kinases, 
including kinases that are implicated in Rho-mediated signaling, and it localizes 
predominantly to the apical side o f epithelial cells.
Results
Identification of proteins interacting with PTP-BL PDZ motifs
Candidate proteins interacting w ith the five P D Z motifs o f  P TP-B L were obtained from  a 
human G 0-fibroblast and a HeLa cD N A  library, using B L -P D Z -I-V  (Fig. 1A ) as a bait in 
the yeast two-hybrid interaction trap (Gyuris et al., 1993). Sequence analysis showed that 
three clones, H G 3 and H G 5 from  the HeLa library and H G21 from  the fibroblast library, 
are independent but overlapping clones encoding short C-terminal peptides o f  84, 32 and 71 
amino acids, respectively (Fig. 1B ). The interaction strength, as determined by blue 
coloring on X -gal assay plates, decreased with decreasing length o f the encoded peptide. 
Comparison o f the cD N A  inserts and the encoded peptides with entries o f  nucleotide and 
protein databases initially revealed no clear hom ology to known proteins, indicating that 
H G 3/5/21 cD N A s encode a novel protein.
The obtained clones are homologous to Drosophila WTS.
Next, by screening o f expressed sequence tag (EST) databases, the H G 3/5/21 inserts were 
found to be almost identical to a human E ST  (accession number: R 75698) that was 
previously named D R E S7 for D r o so p h ila -Related Expressed Sequence-7 (Banfi et al.,
1996). D R E S sequences are defined as human E ST  sequences that are homologous to 
known D r o so p h ila  sequences implicated in mutant phenotypes. Interestingly, D R E S7 
shares hom ology w ith the D ro so p h ila  tumor suppressor warts (W TS). Comparison o f the 
D R E S7 cD N A  sequence with the H G 3/5/21 inserts revealed several point mutations and 
nucleotide deletions, probably representing sequence errors in the D R E S7 cD N A  sequence. 
U sing the individually determined H G 3/5/21 sequences, and the D R E S7 sequence 
information from  the database, we could, however, generate an open reading frame 
encoding a peptide (hW TS) o f 187 amino acids (Fig. 2) which, as anticipated, is indeed 
highly homologous (56% ) to the C-terminus o f D r o so p h ila  W TS (dW TS). Clearly, D R E S7 
does not represent a full-length cD N A  clone and therefore we used the 5 ’ -end o f the 
D R E S7 cD N A  sequence to search for E S T ’ s encoding N-proxim al sequences. W e 
identified one overlapping mouse E ST  (W 81967) and sequenced this cD N A  completely. 
The insert was found to be highly homologous to the human cD N A  sequence in the coding 
region (79 %  identical), but the 3 ’ -U TR  was much longer than for the human cD N A . The 
much shorter 3 ’ -U TR  for H G 3/5/21 (not shown), is probably caused by alternative priming
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A
Interaction with 
HG3/HG21/HG5
B
' PTP-BL (1 -2460)
BL-PDZ-I-V 0 0
 
- 2 1 ) + +
BL-PDZ-I-II (1063-1493) -
BL-PDZ-II-III 3 cn - 6 1 -
BL-PDZ-III-V 6)49714 + +
-VIV-Z­D-PL­B 7 cn - 9 ) + +
BL-PDZ-I (1076-1077) -
BL-PDZ-II (1352-1450) -
BL-PDZ-III (1471-1601) -
BL-PDZ-IV (1756-1855) + +
BL-PDZ-V (1853-1946) -
dWTS (1-1099)
mWTS (partial) (1-557)
Interaction
BL-PDZ-I
HG3 (478-557) + +
HG21 (490-557) + +
HG5 (530-557) +
HG3-C-3 (478-554) -
mWTS-C (478-557) + +
Figure 1: Schematic representation of the peptides used in the two-hybrid interaction trap.
Shown are (A) the regions of PTP-BL used as baits and (B) the peptides as they were retrieved from 
the GO-fibroblast and HeLa cDNA library, compared with the available mouse and D rosophila  WTS 
proteins. In addition, the mouse construct (mWTS-C) and the human construct lacking the last three 
amino acid residues (HG3-C-3) are shown. Between brackets, the corresponding first and last amino 
acid positions of the peptides in PTP-BL and mouse WTS (see also Fig. 2) are shown. Two hybrid 
interaction results with either HG3, HG21 or HG5 (A) or BL-PDZ-I-V (B) are schematically 
indicated: ++, very strong interaction; +, strong interaction; -, no interaction detectable. FERM 
domain, hatched box; catalytic PTP domain, open box; PDZ motifs, black ovals; serine/threonine 
kinase domain, gray box; poly-glutamine stretch, stippled box.
of reverse transcriptase during cDNA synthesis at an A-rich stretch in the human mRNA. 
Indeed, sequences homologous to the mouse 3’-UTR are present in the human EST library 
and these entries contain an A-rich stretch at the site corresponding to the 3’-end of the 
HG3/5/21 clones. Next, the 5’-end of the EST W81967 insert was used to screen a mouse 
brain cDNA-phage library. Two positive phages were isolated, mWTS#2 and mWTS#4, 
that extended the open reading frame as deduced from W81967 with 157 and 295 N- 
terminal amino acid residues, respectively. mWTS#4 contains the longest insert of about
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3.3 kbp and an open reading frame o f about 1.7 kbp. Northern blot analysis reveals a 
transcript o f  about 6.5 kb (Fig. 5), indicating that the obtained clones still are not full- 
length. Except for the stretch o f the first 50 amino acids, the deduced peptide (m W TS) o f 
557 amino acids, is highly homologous to the C-terminal part o f  D r o so p h ila  W T S (72%) 
and spans the entire putative cAM P-dependent serine/threonine kinase domain (Fig. 2).
m WTS is the closest mammalian homologue of the Drosophila tumor suppressor warts 
Comparison o f the m W TS peptide with entries o f  protein databases revealed high 
hom ology w ith other members o f  the fam ily o f  cAM P-dependent serine/threonine kinases 
(Fig. 3A). Alignm ent across the kinase domains o f these proteins (Fig. 3B) shows that the 
mouse W TS kinase domain is 70%  identical to the D r o so p h ila  W T S kinase domain and 
49%  to that in an uncharacterized C .e le g a n s  protein, T 20F 10.1, resulting from  the 
C .e le g a n s  genome project (W ilson et al., 1994). In absence o f sequence information for the 
entire kinase domain in the human W T S the most homologous human kinase domain 
present in currently existing databases is that found in the nuclear kinase Ndr. This protein, 
however, lacks the large N-terminal segment present in D r o so p h ila  W TS. The yeast protein 
O RB6, that is essential for maintenance o f cell polarity and is involved in mitotic control, 
also lacks this region. Other homologues (all about 34 %  identical in the kinase domain) 
include effectors o f the small GTP-binding protein fam ily Rho, like C D C 42-binding kinase, 
R O C K -1, R O C K -2 and the myotonic dystrophy protein kinase (DM PK). These latter 
proteins are all characterized by an N-terminal kinase domain and a large C-terminal 
segment that can form  coiled-coil structures. Furthermore, the kinase domains in these 
proteins all lack the large insertion between subdomains V II and VIII. Therefore, based on 
the structural similarities between m W TS and dW TS, i.e. the presence o f structurally 
similar kinase domains flanked by very short C-terminal sequences, we suggest that the 
novel protein segment described here stems from  the mouse orthologue o f  the D ro so p h ila  
tumor suppressor warts.
Figure 2: (facing page) Sequence alignment of the available mouse and human WTS protein 
sequences with the corresponding peptide segment in D rosophila .
The partial protein sequences of mouse and human WTS were aligned with D rosophila  WTS (acc.no. 
A 56155) using MULTALIGN. Black arrowheads indicate the start positions of clones HG3, HG21 
and HG5, respectively, that were originally identified in the two-hybrid interaction screening with the 
BL-PDZ-I-V bait. The open arrowhead indicates the start of the EGFP-hWTS-C protein used for the 
coprecipitation assay (Fig. 4). Horizontal arrows mark the beginning and end of the kinase domain 
and a vertical arrow indicates the start of EST W81967. Amino acids conserved in all three species 
are shown white on a black background, whereas residues conserved in two species are indicated on a 
gray background. Gaps are indicated by dashes (-).
142
mWTSinteractian with PTP-BL
143
Chapter 7
144
mWTS interaction with PTP-BL
Characterization of the interaction between PTP-BL and WTS
W e used deletion mutants o f  the segment encompassing the five P D Z  motifs o f  P T P -B L  in 
the yeast two-hybrid interaction trap to identify the region mediating the interaction with 
W T S (Fig. 1A). A ll constructs containing the coding segment for the fourth P D Z m otif 
resulted in a strong interaction with the proteins encoded by the three clones that were 
identified initially (Fig. 1A). In line with this, constructs lacking PDZ-IV-encoding 
sequences remained negative. These results clearly show that P D Z -IV  is both necessary and 
sufficient for interaction. Since it is now w ell established that P D Z motifs can recognize 
short C-terminal peptide segments (Fanning and Anderson, 1996; Saras and Heldin, 1996; 
Songyang et al., 1997), we tested the importance o f the C-terminus o f W TS for the 
interaction with the PTP-B L  P D Z motif. Indeed, deletion o f the last three amino acids from 
the longest hW TS peptide (HG3-C -3) resulted in a complete loss o f interaction with B L- 
P D Z -I-V  (Fig. 1B) or B L -P D Z -IV  alone (not shown). Although the last four amino acids 
(-P V Y V * ) are conserved between human and mouse, the preceding 20 amino acids are 
much less conserved (Fig. 2). Therefore, we also tested the observed interaction for 
peptides o f  murine origin only. A s shown in Fig. 1, the mouse peptide stretch that 
corresponds to the H G 3 peptide, m W TS-C, interacts strongly w ith BL-PD Z-I-V.
WTS C-terminus co-precipitates with PTP-BL PDZ motifs
To confirm  the observed interaction in a more physiological surrounding, we co-transfected 
mammalian epithelial cells (C O S -1) with expression constructs encoding E G FP fused to the 
last C-terminal 49 amino acids o f  hW TS and a V S V -G  epitope-tagged version o f the PTP- 
B L  segment encompassing the five P D Z motifs. A s a control, wild-type E G FP was co­
transfected. B y  W estern blotting we could readily detect all transiently expressed proteins
Figure 3: (facing page) Sequence comparison of mouse WTS and homologous proteins.
The predicted amino acid sequences of mouse WTS, mWTS, the D rosophila  tumor suppressor WTS, 
dWTS (A56155), a predicted kinase from C .elegans, CeKIN (T20F 10.1, Z 81594), human nuclear 
kinase Ndr (I38133), yeast ORB6 (O13310), N. crassa COT-1 (P38679), rat myotonic dystrophy 
kinase-related Cdc42-binding kinase, M R CK a (AF021935), mouse Rho-associated coiled-coil 
containing protein kinase p160, ROCK-1 (U58512), mouse myotonic dystrophy protein kinase, 
DMPK (P54265), C. elegans LET-502 (U85515) and the C -a subunit of mouse cAMP-dependent 
protein kinase, PKA (P05132) were compared using the MULTALIN program (Corpet, 1988). (A) 
The position of the putative catalytic domain is shown in black, and the percent amino acid identity of 
this region with the predicted mouse WTS protein is shown in white. (B) Multiple sequence 
alignment of the catalytic domains and the immediate flanking sequences of the proteins shown in 
(A). mWTS, a.a. 119-522; CeKIN, a.a. 481-871; Ndr, a.a. 68-452; ORB6, a.a. 72-464; COT-1, a.a. 
215-619; M RCKa, a.a. 56-411; DMPK, a.a. 50-412; ROCK-1, a.a. 55-406; LET-502, a.a. 47-399; 
PKA, a.a. 23-351. The 11 subdomains that are highly conserved in the protein kinase family (Hanks 
et al., 1988) are underlined and designated by Roman numerals. Darkness of shading indicates the 
conservation of residues (black, 100% similar, dark grey, at least 80%  similar, light grey, at least 60% 
similar).Gaps are represented by dashes.
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in the supernatant o f  the lysates (Fig. 4). Both wild-type EG FP and the hW T S-C  fusion 
protein are efficiently immunoprecipitated using the a-G F P  polyclonal antibody. The V S V - 
tagged PD Z motifs are coprecipitated very efficiently with EG FP-hW TS-C, but not at all 
with wild-type EG FP as a control (Fig. 4). Co-immunoprecipitation experiments from cells 
in which single PTP-B L PD Z motifs were coexpressed with the W T S C-terminus 
confirmed that only the fourth PTP-BL PD Z m otif is binding to hW TS (not shown). These 
findings independently confirm the results obtained in the yeast two-hybrid interaction trap.
Figure 4: Coprecipitation of hWTS C- 
terminus with PTP-BL PDZ motifs. 
V SV epitope-tagged PDZ motifs of 
PTP-BL (BL-PDZ-I-V) were 
transiently coexpressed in COS-1 cells 
with EGFP-tagged hWTS C-terminus 
(EGFP-hWTS-C) or as a control, wild­
type EGFP. The presence of the EGFP- 
(upper panel) and VSV-tagged (lower 
panel) proteins in the supernatant of the 
lysate (sup, left two lanes) and in a- 
GFP immunoprecipitates (right two 
lanes) was detected by Western blot 
analysis of protein samples following 
size-separation on 15% (upper panel) 
and 8% (lower panel) SDS-PAGE gels. 
Coprecipitated PDZ motifs were 
detected only for EGFP-hWTS-C, 
whereas the EGFP control remains 
negative.
WB: a-VSV
BL-PDZ-I-V +  +  +  +
EGFP-hWTS-C +  - +  -
EGFP - +  - +
mWTS RNA and protein expression
The interaction o f W T S with PTP-BL can only be o f  biological significance when there is 
overlap in expression patterns. Previous studies have shown an epithelial expression pattern 
for PTP-B L (Cuppen et al., 1998; Hendriks et al., 1995). To determine the tissue 
distribution o f mouse W T S  m R N A a Northern blot o f  total R N A  from several different 
mouse tissues was probed with the partial m W TS cD N A . A  transcript o f  about 6.5 kb was 
present in all tissues examined (Fig. 5). High m W TS m R N A levels are observed in lung, 
kidney, brain and stomach. In the latter organ also a smaller transcript o f  about 4 kb is 
detected (Fig. 5).
SUP IP a-G FP
EGFP-hWTS-C->
EGFP“ >
WB: a-eGFP
- 1 7 5  KDa
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Figure 5: Tissue distribution of mWTS messenger RNA.
Northern blot analysis of the mWTS expression levels in total RNA isolated from different adult 
mouse tissues (top panel). As a control for RNA loading, the ethidium bromide staining pattern of the 
gel is shown (bottom panel). mWTS is expressed in all tissues examined, with high levels in lung, 
kidney, brain, and stomach. The 28S and 18S ribosomal bands, corresponding to 4.6 and 1.9 kb 
transcript lengths, respectively, are indicated.
To study W T S protein expression and localization, a polyclonal antibody was raised against 
a GST-fusion protein containing the last 84 amino acids o f human W TS (78%  homologous 
to mouse W T S  in this region). Resulting serum (a-W T S) was tested on lysates o f  C O S -1 
cells expressing an E G FP fusion protein harboring the last 49 amino acids o f human W TS 
(EG FP-hW TS-C), or wild-type E G FP as a control. The a-W T S  antibody specifically 
recognizes the E G FP -hW TS-C  fusion protein, whereas no protein was detected in lysates 
from E G FP transfected cells or by the pre-immune serum (Fig. 6A). Next, the a-W T S  
antibody was used to detect endogenous protein in total lysates o f several mouse tissues. No 
specific labeling o f proteins was observed when the pre-immune serum was used (not 
shown). The a-W T S  antibody recognizes proteins o f 175 and 80 kD a (Fig. 6B). In brain 
and testis only the 175 kD a band is labeled, and a shorter exposure reveals the band to be a 
doublet, with highest intensity for the lower band. In thymus, spleen, lung and ovarium
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EGFP EGFP-hWTS-C
Figure 6: Tissue distribution of mWTS protein.
The polyclonal antiserum raised against a GST-fusion protein of the hWTS C-terminus was tested on 
lysates of COS-1 cells transiently expressing EGFP (A, left three lanes) or EGFP-hWTS-C (A, right 
three lanes). No protein was recognized using the pre-immune serum, whereas the a-WTS antiserum 
specifically recognizes the EGFP-hWTS peptide. As a control for protein expression, EGFP (fusion- 
)protein was detected using a polyclonal a-GFP antiserum. The a-WTS serum was used to detect 
endogenous WTS protein in total lysates of several mouse tissues (B). 80 and 175 kDa proteins are 
specifically recognized in several tissues, whereas in skeletal muscle a 160 kDa protein is detected.
both the 80 and the 175 kDa protein are expressed, whereas in stomach and kidney the 80 
kDa protein is most prominent. In muscle, a single protein o f about 160 kD a is detected.
mWTS in situ localization
The a -W T S  antiserum was used to test the tissue distribution o f W T S in mouse. In general, 
high expression is observed apically in simple epithelium, although also other cell types are 
found positive. High levels o f W T S were found in colon epithelium (Fig. 7A ) and in the 
epithelium covering the bronchii in lung (Fig. 7B). M ost protein is localized apically, but 
also some basolateral staining is evident. In kidney, high expression is found in the the 
collecting tubules and the epithelium covering the renal pelvis (Fig. 7C). Expression o f 
W T S in the non-glandular part o f  the stomach is very low, whereas high expression is 
found in the glandular epithelium. Here, the signal is most prominent at the apical side o f 
the cells (Fig. 7D). In skeletal muscle, W T S localizes to submembranously along the fibers 
(Fig. 7E), and higher magnification also reveals a striated staining within the fibers (Fig. 
7F). Furthermore, in heart a highly restricted localization o f m W TS is observed at 
intercalated discs (not shown). In skin, only low  expression is observed in stratified 
epithelium, but high expression is seen in glandular epithelium, i.e. sweat glands (Fig. 7G). 
In brain and testis, W T S is expressed ubiquitously (not shown). To monitor antiserum 
specificity, parallel sections were incubated with pre-immune serum, but no significant 
labeling was observed (not shown).
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Figure 7: In situ protein 
expression of mouse WTS. 
The mWTS protein was 
visualized in cryosections of 
mouse colon (A), lung (B), 
kidney (C), stomach (D), 
skeletal muscle (E and F) and 
skin (footpad) (G) using 
immunofluorescence labeling 
with a-WTS polyclonal 
antiserum. mWTS is 
predominantly expressed in 
cells of epithelial origin, 
where it localizes apically. 
Furthermore, in skeletal 
muscle a submembranous 
staining is evident (E) and 
higher magnification (F) 
shows a striated staining 
pattern.
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Discussion
In our search for proteins that interact with the P D Z motifs in PTP-B L, we identified three 
independent clones encoding the mammalian orthologue o f the D r o so p h ila  tumor 
suppressor warts (also termed lats for large tumor suppressor; X u  et al., 1995), a 
serine/threonine kinase fam ily member. Deletion studies show that the fourth P D Z m otif in 
P TP-B L is necessary and sufficient for this strong interaction. The shortest W T S  clone that 
was identified by two-hybrid screening encodes the last 32 amino acids C-terminal to the 
kinase domain. Ablation o f the last three amino acids (-V -Y -V -*) com pletely abolished any 
detectable interaction. These results point to a classical PDZ-mediated interaction, 
involving a single P D Z m otif and a C-terminal peptide sequence in the partner protein 
(Fanning and Anderson, 1998; Saras and Heldin, 1996). Indeed, screening o f oriented 
peptide libraries had shown that short C-terminal peptides that together yield  the consensus 
(I/Y/V)-Y-(Y-K)-(V/K/I)-* (residues in bold are preferred) are recognized by the fourth 
P D Z m otif o f  the human orthologue o f  P TP-B L (referred to as PTPbas-5 in the paper by 
(Songyang et al., 1997). Furthermore, two other binding targets have been described for this 
P D Z motif. First, the 150 kD a GTPase-activating protein for Rho, P A R G 1, was identified 
in pull-down experiments from cell lysates using P T P -B A S P D Z motifs as baits (Saras et 
al., 1997). A  G ST -P D Z -IV  fusion protein was found to bind specifically to an imm obilized 
peptide corresponding to the C-terminal four residues (-P-Q -F-V-*) o f this protein. 
Secondly, the L IM  domain-containing protein RIL can interact with both PDZ-II and PDZ- 
IV  o f PTP-B L  (Cuppen et al., 1998). Deletion o f the last four amino acids o f RIL (-V-E-L- 
V -*) completely abolishes the interaction with P D Z -IV  but has no influence on the 
interaction with PDZ-II. The merging o f all C-termini that are now known to bind to PDZ- 
IV  in PTP-B L, including the W T S C-terminus (-P -V -Y -V -*) described here, does not yield 
a clear consensus peptide sequence: -[P ,V ,I,Y ]-[Q ,V ,E ,Y ]-[F ,Y ,L ]-V -*. Only the valine at 
the -1 position is consistently present. Nevertheless, this m otif produces no additional hits 
when used to scan the complete SwissProt and translated E M B L  databases for potential 
binding proteins. Thus, although this target appears rather vague, one may expect the PTP- 
B L  P D Z -IV  m otif to bind specifically and selectively to only a very small number o f 
proteins in the proteome, including m W TS.
Intriguingly, although the C-terminal segment flanking the kinase domain is not overall 
evenly conserved between human, mouse and D ro so p h ila , the last four amino acids are 
com pletely identical. This suggests that the PDZ-mediated interaction, w hich we show here 
for the mouse and human W T S peptide, might be functionally w ell preserved during 
evolution. This may also hold for behaviour which determines W T S ’ s subcellular 
localization. Absence o f  W T S results in hyperproliferation as w ell as apical hypertrophy o f 
imaginal disc epithelial cells and, therefore, D r o so p h ila  W T S was expected to localize at 
apical or apical-lateral epithelial cell margins (Watson, 1995). Indeed, we here show that 
mouse W T S is localized predominantly at the apical side o f epithelial cells. This highly
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specific localization may be mediated via  the interaction w ith PTP-B L, which is targeted 
apically in epithelial cells by virtue o f its FER M  domain (Cuppen et al., submitted). 
Unfortunately, sofar no D r o so p h ila  protein tyrosine phosphatase that resembles PTP-B L 
has been reported. It is o f  note, however, that PTP-B L shares hom ology with two other, 
non-PTP, D r o so p h ila  tumor suppressor gene products; Expanded and Discs-large 
(Boedigheim er et al., 1993; Hendriks et al., 1995; W oods and Bryant, 1991). Domains in 
these proteins may fu lfill an accessory role in the assembly o f submembranous 
supramolecular structures necessary for epithelial growth and homeostasis. N ext to 
epithelial expression, there is also clear expression o f m W TS in skeletal muscle, where 
P TP-B L is absent (Fig. 7). Strikingly, the m W TS protein in muscle has a molecular weight 
o f  about 160 kDa, slightly smaller than in other tissues. A lso here it has a restricted 
localization, resulting in a both a submembranous and striated pattern. These observations 
suggest a specialized function for m W TS, like in epithelia. In brain and testes a single 
peptide o f 175 kDa is recognized, whereas in lysates o f  stomach, thymus, spleen, lung and 
ovarium two peptides, o f  80 and 175 kDa, are recognized by our antiserum. Although 
Nothern blot analysis reveals a second, shorter transcript, this messenger is only expressed 
in stomach, and therefore makes alternative splicing unlikely as an explanation for the two 
protein products. Evidently, we cannot exclude that our antibody cross-reacts with other 
(homologous) proteins To add further to the com plexity o f  the situation, we would like to 
note that in testis and brain the 175 kD a band appears as a doublet, suggesting that m W TS 
may be subjected to post-translational modification.
W hat could be the biological role for W TS-PTP -B L interaction and W T S activity? Based 
on the high hom ology between the partial mouse W T S peptide, D ro so p h ila  W T S and other 
known kinases some speculative predictions can be made. Presence o f the large insert 
between the conserved subdomains V II and VIII, as w ell as the C-terminal location o f the 
kinase domain classify W TS, Ndr, C O T -1, ORB6 and the putative C. elegans kinase as 
novel subgroup in the subfamily o f  serine/threonine kinases. Interestingly, when we ommit 
Ndr-like proteins, which are a nuclear group o f proteins (M illward et al., 1995), there is a 
great deal o f  convergence in the properties o f  these proteins. The C O T -1 (colonial 
temperature sensitive-1) protein o f Neurospora was identified by study o f  a temperature­
sensitive mutant that causes compact colonial growth. Strains lacking C O T -1 have a defect 
in hyphal tip elongation and a concomitant increase in hyphal branching (Yarden et al., 
1992). The yeast ORB6 protein kinase functions in the control o f  cell morphology, 
maintaining a polarized actin cytoskeleton and promoting polarized growth, while delaying 
the onset o f  mitosis (Verde et al., 1998). Interestingly, o r b 6  interacts genetically with o rb 2, 
w hich encodes the P ak1/Shk1 protein kinase, a component o f  the R as1 and Cdc42- 
dependent signaling pathway. M ore distant homologues o f  W T S include Rho-associated 
coiled-coil-containing protein kinase-1 and 2 (R O C K -1/2 ; Leung et al., 1995; Matsui et al., 
1996; N akagawa et al., 1996), the M yotonic Dystrophy Protein kinase (Groenen and
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W ieringa, 1998; Mahadevan et al., 1992), the M yotonic Dystrophy kinase-releated C D C 42- 
binding kinase (M R C K a/ß; Leung et al., 1998) and C .e le g a n s  L E T -502 (Wissmann et al.,
1997). R O C K -1/2 and M R C K a/ß  are effectors o f  small GTPases and are, like L E T -502, 
among others implicated in phosphorylation o f the myosin-binding subunit o f  m yosin light 
chain (M LC) phosphatase, and M L C  itself. Rho kinase may also regulate the cytoskeleton 
by phosphorylating the ezrin/radixin/moesin proteins (Matsui et al., 1998; Shaw et al.,
1998).
Based on these similarities we would like to propose that m W TS acts in a Rho-mediated 
regulation o f actin cytoskeleton remodeling. P TP-B L may act in this web as an apical 
submembranous scaffold protein, tethering both actin binding proteins, like Z R P -1 and 
RIL, and proteins, that are actively involved in actin-cytoskeleton modification, like 
P A R G 1 and m W TS. It is not know how exactly P T P-B L  action on reversible tyrosine 
phosphorylation is merged here with the wide repertoire o f  Rho-mediated signaling Hoever, 
i f  the capture o f the Rho inactivator (P A R G 1) and the (potential) Rho effector (m W TS) by 
the fourth PD Z domain in PTP-B L would be o f  some competitive nature, this opens an 
intruiging possibility for agonistic and antagonistic regulation o f Rho-dependent signaling.
Materials and methods
Tw o-H ybrid In tera ction  Trap - Plasmid DNAs, the yeast strain EGY48 and the human fetal brain 
cDNA library used for the interaction-trap assay were kindly provided by Dr. Roger Brent and 
colleagues (Massachusetts General Hospital, Boston, MA) and used as described (Gyuris et al., 1993). 
The HeLa and the human GO fibroblast libraries were generously provided by J. Gyuris 
(Massachusetts General Hospital, Boston, MA) and C. Sardet (MIT, Boston, MA). The construction 
of most of the PTP-BL PDZ baits has been described previously (Cuppen et al., 1998). BL-PDZ-I-II 
was made by subcloning a 1.3 kbp DraI fragment from full-length PTP-BL in pEG202 and BL-PDZ- 
II-III, BL-PDZ-III-V and BL-PDZ-IV-V were generated by PCR, using synthetic oligonucleotides for 
introducing EcoRI and XhoI restriction sites, and cloned in-frame in the pEG202 bait vector. The 
prey HG3-C-3 (see below) was made by PCR, using the oligonucleotide 5’ - 
CCCTCGAGTCAAGGCTGGCAGCCTTCAGT-3’ in combination with a pJG4-5-vector specific 
primer, and HG3 as template. In the construct a premature stop codon and a XhoI restriction site were 
introduced. The prey construct encoding the mouse peptide corresponding to HG3 (mWTS-C) was 
made by PCR using the oligonucleotide 5’ -GGGAATTCGTGGATGAAGAAAGCCCC-3’ in 
combination with a T3 primer and the mouse EST clone W 81967 as template, followed by subcloning 
of an EcoRI-XhoI restriction fragment of the resulting amplicon in the prey vector pJG4-5. All 
constructs made were checked for the absence of mutations by DNA sequencing. For two-hybrid 
interaction assays plasmids were introduced in yeast strain EGY48 (M ATa trp l ura3 h is3 
L£L2'::pLexAop6-LEU2) containing the plasmid pSH18-34, which includes the reporter la cZ  gene, 
and tested for an interaction as detected by growth and blue coloring on minimal agar-plates lacking 
histidine, tryptophan, uracil and leucine, containing 2% galactose, 1% raffinose and 80 mg/ml X-gal, 
buffered at pH 7.0.
Id en tifica tio n  of m ou se W T S cD N A s - Comparison of the obtained human prey cDNA sequences 
with database entries was done using the BLAST program (Altschul et al., 1997). Identification of a
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mouse WTS cDNA clone was done by comparison of the insert of HG3 with the EST sequences in 
the database of mouse specific IMAGE clones at the RZPD resource center (Berlin, Germany). One 
highly homologous mouse cDNA clone (W81967) from this collection was retrieved and sequenced 
completely. Next, the insert from this clone was isolated, labeled radioactively by random priming 
and used to screen a mouse brain l-ZAPII cDNA phage library (Stratagene) following standard 
procedures. Out of 0.65 x  106 plaques, two were found positive for the mWTS cDNA. These phages 
were plaque-purified and inserts were rescued as pBluescript SK- plasmids according to the 
manufacturer’ s protocols, and sequenced using specific oligonucleotides. The predicted polypeptide 
was compared with database entries using the BLAST program (Altschul et al., 1997). The available 
predicted protein sequence of mouse, human and D rosophila  WTS and related kinase domains were 
aligned with Multalin (Corpet, 1988) using the blosum62 comparison table and annotated with 
Genedoc (shareware, version 2 .2 .005; Nicholas and Nicholas, 1997).
A n tibod ies - The complete insert of the HG3 prey (EcoRI-EcoRI-XhoI fragment) was subcloned in 
the prokaryotic expression vector pGEX-1N (Pharmacia), which was modified to generate a XhoI site 
3’ to the EcoRI site. GST-fusion protein of the C-terminal 84 amino acids was produced in E.coli 
DH5a  and isolated according to the supplier’s instructions by binding to glutathione Sepharose beads 
(Pharmacia). The purified protein was used to immunize a rabbit. The rabbit polyclonal a-GFP 
(whole serum) and the mouse monoclonal a-V SV  (P5D4, ascites) have been described elsewhere 
(Cuppen et al., submitted; Kreis, 1986).
E x p ressio n  constructs - The eukaryotic expression construct for the C-terminus of hWTS (EGFP- 
hWTS-C) was made by subcloning an EcoRI-XhoI fragment from plasmid HG3 into the mammalian 
expression vector pEGFP-C2 (Clontech). Since the HG3 cDNA insert contains an internal EcoRI site, 
the resulting EGFP-fusion protein from this construct contains only the last 49 amino acids from 
human WTS (open arrowhead in Fig. 2). The expression construct encoding VSV-tagged PDZ-I-V 
(BL-PDZ-I-V) has been described elsewhere (Cuppen et al., 1998).
Im m unoprecipitation  experim ents - COS-1 cells were cultured and transfected by electroporation as 
described previously (Cuppen et al., 1998). One day after transfection, cells were washed with cold 
PBS and lysed on plate with 550 ml ice-cold RIPA buffer (50 mM Tris, pH 8.0, 100 mM NaCl, 1 mM 
EDTA, 1% NP-40, 0. 1% SDS, 0.5% DOC, 1 mM PMSF and protease inhibitor cocktail 
(Boehringer)). After a 1-hour incubation on ice, the lysate was centrifuged for 10 minutes at 10,000 x 
g  at 4°C and proteins in 50 ml of the lysate were separated for further analysis. After addition of the 
polyclonal antibody a-GFP (2 ml complete serum) and overnight rotation at 4°C, 50 ml of protein A- 
Sepharose CL-4B (Pharmacia) were added and incubation was prolonged overnight. The Sepharose 
beads with immunobound proteins were washed four times with 1 ml RIPA lysis buffer and boiled for 
5 minutes in 50 ml of sample buffer (100 mM Tris-HCl, pH 6.8, 200 mM dithiothreitol, 4% SDS, 
0.2% bromophenol blue, 20% glycerol). Fifteen ml of lysates and immunobound proteins were 
resolved on 15% and 8% polyacrylamide gels and transferred to nitrocellulose membranes by western 
blotting. Blots were blocked using 5% nonfat dry milk in 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 
and 0.05% Tween 20 (TBST). The polyclonal a-GFP (5.000 x  diluted) was used to detect production 
and immunoprecipitation of the EGFP-fusion protein and the monoclonal a-V SV  (10.000 x  diluted 
ascites) was used to detect coprecipitated proteins. Incubations (1 hour) with primary and secondary 
antisera (10.000 x  diluted peroxidase-conjugated goat anti-mouse or goat anti-rabbit IgG (Pierce)) and 
subsequent washes were done in TBST at room temperature. Labeled bands were visualized using 
freshly prepared chemiluminescent substrate (100 mM Tris-HCl, pH 8.5, 1.25 mM p-coumaric acid 
(Sigma), 0.2 mM luminol (Sigma), and 0.009% H2O2).
N orthern  b lo ttin g  - Total RNA from several mouse (strain C 57BL/6) tissues was prepared using the 
guanidium isothiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987). 
Fifteen mg RNA was loaded on a 1% formamide agarose gel and after electrophoresis the RNA was 
transferred to nylon membrane (Hybond-N, Amersham) according to standard procedures. The 
complete cDNA insert of EST W81967 was radioactively labeled by random priming and used as 
probe for hybridization as described (Cuppen et al., 1998).
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W estern b lo ttin g  - Protein lysates from several mouse (strain C 57BL/6) tissues were made by 
mechanical disintegration of tissue in an equal volume (0.5 to 2 ml) of lysis buffer (50 mM Tris pH 
8.0, 150 mM NaCl, 1 mM EDTA, 0.1 mM PMSF and containing protease inhibitor cocktail 
(Boehringer)). Next, detergents were added (final concentration 1% Nonidet P-40, 0.5% Na-DOC, 
0.1% SDS) and the lysates were incubated at 4°C for 1 hour, followed by centrifugation for 30 
minutes at 10.000 g and 4°C. The protein concentration in the supernatants was determined according 
to Bradford (Bradford, 1976). Fifty mg of protein was loaded per lane on a 8% polyacrylamide gel and 
transferred to nitrocellulose membrane (Hybond-C+, Amersham) by Western blotting. Blots were 
blocked and incubated with primary (a-WTS, total serum 5.000 x  diluted) and secondory antibodies 
(peroxidase-conjugated goat anti-rabbit IgG (Pierce), 10.000 x  diluted) as described above, followed 
by chemiluminescent detection.
Im m u n oflu orescen ce assay  - 6 mm cryo-sections of unfixed mouse (strain C57BL/6) tissues were cut 
and mounted on Superfrost/Plus slides (Menzel Gläser, Germany). After thawing, sections were fixed 
for 10 minutes in 2 % paraformaldehyde in PHEM buffer (60 mM Pipes, 25 mM Hepes pH 6.9, 10 
mM EGTA, 2 mM MgCl2). Subsequently, free aldehyde groups were quenched for 10 minutes in 0.1 
M  glycine in PBS and tissue sections were incubated in primary antibody (a-WTS or preimmune 
serum, 1000 x  diluted in PBS, containing 1% goat serum) for 1 hour at room temperature. After 
washing three times for 10 minutes in PBS, specific labeling was detected by a 1-hour incubation in 
FITC-conjugated AffiniPure Goat anti-rabbit IgG (10 mg/ml in PBS containing 1% goat serum; 
Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Finally, sections were washed three 
times for 10 minutes in PBS, rinsed in water and mounted in Mowiol (Sigma Chemical Co.).
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A d e lb e r tu sp le in  1, 6525 E K  N ijm eg en , T he N eth erla n d s.
From the data presented in the preceding chapters we can now provide a provisional picture 
o f  the microenvironment where the protein tyrosine phosphatase PTP-B L  is active. The 
highly restricted subcellular localization o f P TP-B L combined with the properties o f  the 
proteins that interact with its P D Z domains point to a role in the submembranous 
microfilament-based cytoarchitecture, and/or the structural dynamics thereof. PTP-B L  is 
most prominently expressed in polarized epithelia, where it is located almost exclusively at 
the apical side o f the cell (Hendriks et al., 1995, and Chapter 4) due to targeting properties 
that reside within its FER M  domain (Chapter 2). The presence o f five P D Z motifs enable 
P TP-B L to function as a scaffold protein and organize submembranous multi-protein 
complexes. In the previous chapters several PTP-B L  associating proteins have been 
discussed, namely the L IM  domain-containing (adaptor-like) proteins RIL and Z R P -1, the 
mouse homologue o f  the D r o so p h ila  tumor suppressor Warts and member o f the Rho­
kinase fam ily, m W TS and a GTPase activating protein with high activity towards Rho, 
P A R G 1 (reported by Saras et al., 1997). M ost recently, w e identified the proteoglycan 
syndecan-4 as a binding partner for the third P D Z m otif in P TP-B L (E.C., unpublished 
observations).
Although these associations form  strong indirect evidence for a scaffolding function for 
PTP-B L, it remains speculative until now whether the protein forms indeed a core element 
in a multi-protein com plex and also the function o f such a com plex remains elusive. 
Nevertheless, based upon our findings and data from  the literature describing proteins with 
similar domains, we can propose a working model for PTP-B L  function as shown in Fig. 1 
(numbers between parentheses in text below  refer to the numbers in this figure).
The FER M  domain in PTP-B L  targets the protein to its restricted subcellular microdomain, 
the apical submembranous region, by an unknown but dynamic mechanism. Thus far, no 
proteins have been identified that interact with the FER M  domain and also our own efforts 
to identify such proteins by two-hybrid screenings remained unsuccessful. It is however, 
tempting to speculate that analogous to other members o f  the FER M  protein fam ily, this
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domain may interact with transmembrane proteins like IC A M -1, IC A M -2, C D 42 or C D 43 , 
or other as yet unidentified apical transmembrane proteins ( 1). Alternatively, the FER M  
domain o f PTP-B L  m ay participate in concatemerization as has been described for the 
actin-binding E R M  proteins (2). Although we found no evidence for an interaction o f the 
FER M  domain o f P TP-B L w ith ezrin in transfected M D C K  cells, it is quite w ell possible 
that this domain may interact with other known or unknown members o f  the E R M  
subfamily, like radixin, moesin or merlin.
The P D Z motifs in P TP-B L form  the most clearcut example o f domains that can function as 
anchoring sites for various proteins. M otifs II and IV  interact strongly w ith the L IM  domain 
containing proteins RIL (3) and ZR P -1 (4). In turn, these proteins may function as adapter 
proteins, as they can mediate additional interactions via their L IM  and P D Z domains. Also, 
the proline-rich N-terminus o f ZR P -1 may recruit SH3, W W /W W P or E V H 1 domain- 
containing proteins into a larger com plex. In addition, RIL potentially is involved in 
regulating di- or multi-merization o f PTP-B L  by form ing inter- and intra-molecular 
interactions. Interestingly, this may result in dimerization o f the catalytic phosphatase 
domain o f PTP-B L, w hich by itself can engage in a w eak but specific homotypic interaction 
in a two-hybrid assay (5). It is o f  note here that ligand-induced dimerization has been 
demonstrated to regulate catalytic activity for some transmembrane PTPs, thus RIL-induced 
dimerization may reflect such a mechanism for P T P-B L. M oreover it is important to 
emphasize that RIL can exist in a tyrosine phosphorylated state and thus may represent a 
genuine substrate for P TP-B L. I f  true, this would add regulatory potential to the 
multimerization processes involving both proteins.
Both RIL and ZR P -1 colocalize with actin-rich structures suggesting a direct or indirect 
interaction with F-actin (6). Analogous to the situation for their closest homologues A L P -1 
(Xia et al., 1997) and zyxin  (Crawford et al., 1992), this may be mediated via  an interaction 
with the actin crosslinking protein a-actinin. The observation o f binding o f PTP-B L  to 
P A R G 1 and m W TS, further substantiates the relationship between PTP-B L and the actin 
cytoskeleton. The 150 kD a P A R G 1 protein (7) contains a GTPase-activating protein (GAP) 
domain as found in several proteins that modulate the action o f Rho-like GTPases. In vitro, 
P A R G 1 displays strong G A P  activity on Rho, and to a lesser extend on Rac and C dc42 
(Saras et al., 1997). Rho fam ily members are w ell known effectors for remodeling o f the 
actin cytoskeleton (8). Moreover, Rho also regulates the activation o f dormant E R M  fam ily 
members (9). For example, ezrin is activated by phosphorylation on both tyrosine and 
serine residues and subsequently relocates to the apical plasma membrane where it forms 
concatamers and binds certain transmembrane proteins and F-actin. Several 
serine/threonine kinases that act downstream o f Rho and that are implicated in such 
processes have been identified (Hall, 1998; Tapon and Hall, 1997). M ost interestingly, 
m W TS ( 10) is a close relative o f this Rho kinase family. Absence o f W T S in D r o so p h ila
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causes apical hypertrophy in imaginal disc epithelial cells (Justice et al., 1995), indeed 
suggesting an important role in apical cytoskeleton remodeling and morphogenesis. Thus, 
although Rho-dependence and substrate specificity for m W TS still have to be 
demonstrated, there is the contention that the scaffolding function o f P TP-B L may result in 
the recruitment o f  a potential Rho effector and a Rho inactivating component in the same 
complex, providing an intriguing example o f ‘hard-wiring’ or ‘channeling’ o f  a signaling 
circuitry.
Another interesting observation concerns the rapid tyrosine dephosphorylation o f ezrin, 
follow ing translocation o f this membrane-cytoskeletal linker protein to the apical 
membrane (Berryman et al., 1995). Since PTP-B L is localized in the same m icro­
compartment, it may be that its phosphatase activity mediates this process ( 11). Syndecans, 
the binding partner for the third PTP-B L P D Z motif, may also play a role as they can 
function as coreceptors for tyrosine kinases and are implicated in cell adhesion (Couchman 
and Woods, 1996; W oods and Couchman, 1998). Their highly conserved cytoplasm ic 
domain is phosphorylated on tyrosines, binds PIP2 and P K C , and interacts with the actin 
cytoskeleton ( 12), potentially via  the PDZ-containing C A SK /L IN -2 protein, or via  protein 
4. 1.  B y  extrapolating these observations, one may conclude that phosphorylation on 
tyrosine residues is a necessary event promoting m obility and translocation o f proteins in 
the submembranous cell cortex. Their relocation is stopped and properties are changed by 
dephosphorylation once they reach their ultimate destination, in a highly specific 
microdomain. Indeed, the importance o f reversible tyrosine phosphorylation in remodeling 
o f  cellular structures, like for example cell-cell and cell-substratum contacts, is 
convincingly demonstrated in many studies using P T K  and PTP inhibitors.
Taken together, our findings and those o f others suggest that P TP-B L may be important for 
shaping the apical microenvironment, by recruiting proteins that interact directly or 
indirectly w ith filamentous actin, like RIL, ZR P -1 and syndecan-4, and/or remodel the 
actin-based cytoskeleton, like m W TS and P A R G 1. Although many oncogenic and tumor 
suppressor proteins have been found to participate in (sub)membranous signaling and 
cytoskeletal organization, there is no direct indication that PTP-B L itself functions as a 
classical tumor suppressor, as might be suspected based on its structural similarities (see 
Chapter 1 o f  this thesis). Rather, remodeling o f the apical compartment may be crucial for 
developmental processes and dynamic events during tissue homeostasis at the adult stage. 
Surprisingly, mice lacking the complete catalytic domain o f P TP-B L do not show obvious
Figure 1: (facing page) Working model for PTP-BL function.
Structural and functional connections between the potential multi-protein complex coordinated by 
PTP-BL and the actin-based cytoskeleton are outlined schematically. For detailed explanation see 
text. Solid and dashed arrows indicate proven and hypothetical interactions or links, respectively.
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phenotypic consequences; they develop normal, are fertile and do not (yet) develop tumors 
(Thomas et al., 1998; D .G . Wansink, personal communication). From this unanticipated 
feature, one may conclude that PTP-B L function is redundant, or that cellular plasticity 
allows alternative scenarios to compensate the loss o f PTP-B L  activity. This model is, 
however, somewhat in contrast to our finding that it is impossible to obtain epithelial cell 
lines that overexpress functional PTP-BL, or to generate cell lines stably expressing 
catalytic mutants (Chapter 2). Perhaps, the apparent discrepancy in biological effects that 
catalytic P TP-B L (point)mutants and a deletion mutation, involving the complete catalytic 
domain as w ell as the last four P D Z motifs o f  P TP-B L (Thomas et al., 1998), have on 
normal cell survival, may be caused by the ability o f  the point mutants to ‘trap’ its normal 
tyrosine-phosphorylated substrate (Flint et al., 1997). Trapping o f substrates thus prohibits 
these proteins to participate in cellular processes and protects them from  dephosphorylation 
by other PTPs, whereas absence o f  the complete catalytic segment o f  PTP-B L  may still 
enable the substrate to interact with other (apical) PTPs. Different gene lesions may thus be 
categorized as (dominant negative) gain-of-function or loss-of-function mutations, 
respectively.
Future experiments should address the potential value o f the proposed (hypothetical) 
structural and functional arrangement(s), and test the involvement o f  PTP-B L  in apical 
processes as diverse as phagocytosis, pathogen entry, and synapse formation. Once an 
appropriate read-out has been found for P TP-B L function, the role for the different 
associated proteins can subsequently be tested using interaction defective or catalytically 
inactive mutants. The scheme proposed here can be considered a working model that may 
help in directing future experiments aimed at the biological significance o f the PTP-B L- 
containing multi-protein com plex.
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Phosphorylation on tyrosine residues in particular proteins is an important mechanism for 
signal transduction within eukaryotic cells. As such this posttranslational modification 
principle plays a critical role in the regulation of many cellular events, including cell 
proliferation, differentiation, metabolism, and cytoskeletal function. The overall cellular 
phosphotyrosine levels are controlled by the dynamic balance of the activities of protein 
tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). Here, we present our 
efforts to elucidate the biological function of one member of the family of PTPs, PTP-BL, 
which is predominantly expressed in epithelia. This 250 kDa cytosolic protein harbors 
several interesting modular protein domains that are also found in several submembranous 
and tumor suppressor proteins (see Chapter 1). To learn more about PTP-BL’s function we 
have chosen to study the properties of its different domains and to characterize its 
molecular environment.
In Chapter 2 we focus on the mechanisms that regulate PTP-BL’s catalytic activity and 
substrate specificity. We show, by transient expression of modular protein domains of PTP- 
BL in epithelial MDCK cells, that presence of the FERM domain in the protein is both 
necessary and sufficient for its targeting to the apical side of epithelial cells. Furthermore, 
we describe an EGFP-based cell sorting protocol to obtain stable expressing cell pools for 
specific proteins, for which conventional approaches failed. Immuno-electron 
microscopical studies revealed that PTP-BL FERM domain-containing fusion proteins are 
enriched in villi and have a typical submembranous location at about 10-15 nm from the 
plasma membrane. In addition, fluorescence recovery after photobleaching (FRAP) 
experiments showed that PTP-BL confinement is based on a dynamic steady state and that 
complete redistribution of the protein in the cell is mediated via a cytosolic pool, rather than 
by lateral movement. Finally, we show that PTP-BL phosphatase domains are involved in 
homotypic interactions. Together with its highly restricted subcellular 
compartmentalization this may regulate the substrate specificity and catalytic activity of 
PTP-BL.
In Chapter 3 we followed up on observations published by Sato et al. (Science, 1995, 
268:411-415), that implicate PTP-BL as a negative regulator of Fas-mediated apoptotic 
signaling. Indeed, a direct interaction between the human Fas receptor C-terminus and the 
second PDZ motif in PTP-BL could be confirmed. However, we show that this interaction 
is not conserved for the mouse Fas receptor. In addition, using transfected T lymphoma cell 
lines we found no inhibitory effect of PTP-BL upon triggering apoptosis with mouse or 
human Fas-activating antibodies. Together with the markedly different tissue expression 
patterns for PTP-BL and Fas receptor, these findings rule out a key role for protein tyrosine 
phosphatase PTP-BL in the Fas-mediated death pathway.
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Next, the yeast two-hybrid interaction assay was used to characterize the binding partners 
for the different modules in P T P-B L. Our search for proteins that can interact with the five 
P D Z motifs in PTP-B L led to the identification and characterization o f RIL (C h ap ter  4), a 
small adaptor-like protein consisting o f an N-terminal P D Z m otif and a C-terminal LIM  
domain. The RIL L IM  domain was found to be important for binding to the P D Z m otif o f 
RIL itself and the second and fourth P D Z m otif in P TP-B L. Immunohistochemical studies 
revealed a submembranous colocalization o f P TP-B L and RIL in epithelial cells. In 
addition, we found the RIL L IM  domain to be phosphorylated on tyrosine in vitro and in 
v iv o . In turn, the phoshorylated domain can be dephosphorylated in vitro by the PTP 
domain o f P T P -B L . Our data point to the presence o f a double PDZ-binding interface on 
the RIL L IM  domain and suggest tyrosine phosphorylation as a regulatory mechanism for 
LIM -PD Z associations in the assembly o f multiprotein complexes.
In C h a p ter  5 we provide another example o f PDZ-mediated interactions with a LIM - 
domain containing protein, namely zyxin-related protein-1 (ZR P-1). The second out o f 
three L IM  domains in Z R P -1 is sufficient for a strong interaction with RIL. Also an 
interaction with the third L IM  domain is evident, provided the segment still contains its 
proper C-terminus. Z R P -1 also interacts with the second P D Z m otif in PTP-BL. For this 
interaction to occur both the third L IM  domain and its C-terminus are necessary. R N A  
expression profiles for Z R P -1, RIL and PTP-B L  are overlapping, most notably in tissues o f  
epithelial origin. Furthermore, we show that ZR P -1 can be co-precipitated with RIL and 
P TP-B L P D Z polypeptides and finally, using transfection experiments in epithelial cells we 
demonstrate a striking co-localization o f ZR P -1 and RIL w ith F-actin structures.
In C h a p ter  6 we describe a novel bromodomain-containing protein, B P75 , that interacts 
uniquely w ith the first P D Z domain in PTP-B L via  its C-terminal half. B P75 displays 
overall hom ology to a hypothetical protein in C . e le g a n s  and a putative D N A  binding factor 
in yeast, and is ubiquitously expressed, w ith thymus, lung, liver, colon and spinal cord as 
high expression sites. Transient transfection studies show that B P 75 is located mainly in the 
nucleus, excluding the nucleoli, but also cytoplasm ic localization is evident. PTP-B L, on 
the contrary, is predominantly localized in the cytoplasm, although some basal nuclear 
staining is observed. Perhaps the molecular interaction described in this chapter reflects a 
mechanism o f coupling submembranous signaling events and nuclear events, but additional 
experiments are necessary to further test this conception.
In C h a p ter  7 we describe the identification and characterization o f the mammalian 
orthologue o f  the D r o so p h ila  tumor suppressor warts, m W TS, that interacts specifically 
with the fourth P D Z m otif in P TP-B L. The short C-terminal peptide stretch flanking the 
putative serine/threonine kinase domain o f m W TS is sufficient for interaction, both in two- 
hybrid and co-immunoprecipitation experiments. Deletion o f the last three residues 
com pletely abolishes any detectable interaction, clearly illustrating C-terminal peptide 
recognition by the fourth P D Z m otif o f  PTP-B L. The m W TS kinase domain is highly
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homologous to several cA M P  dependent serine/threonine kinases, including kinases that are 
implicated in Rho-mediated signaling. Immunodetection o f m W TS protein reveals peptides 
o f  80 and 175 kD a and shows that m W TS, like PTP-BL, localizes predominantly to the 
apical side o f epithelial cells.
Finally, in C h a p ter  8, all information on PTP-B L  and its molecular environment that is 
gathered in this thesis work is presented in the context o f  literature data on submembranous 
signaling webs, and fitted into a working model. W e propose that the different components 
that bind and surround P TP-B L may form  a dynamic supramolecular assembly w ith a role 
in the (re-)modeling o f the apical submembranous actin cytoskeleton.
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Fosforylering van tyrosine residuen in bepaalde eiwitten vormt een belangrijk mechanisme 
voor de overdracht van signalen in eukaryote cellen. Diverse cellulaire processen, zoals cel 
deling, cel differentiatie, metabolisme en cytoskeletaire functies, worden gereguleerd door 
middel van deze post-translationele modificatie. De totale cellulaire fosfotyrosine niveau’s 
worden gecontroleerd door de dynamische balans tussen de activiteiten van proteine 
tyrosine kinases (PTKs) en proteine tyrosine fosfatases (PTPs). In dit proefschrift 
presenteren we onze inspanningen om de biologische functie van een lid van de familie van 
PTPs, PTP-BL, op te helderen. PTP-BL komt voornamelijk tot expressie in epitheliale 
celtypes en het ongeveer 250 kDa grote cytosolische eiwit bevat verschillende interessante 
modulaire eiwit domeinen, die ook voorkomen in diverse submembrane eiwitten en tumor 
suppressoren (zie Hoofdstuk 1). Om meer te weten te komen over de functie van PTP-BL 
is er voor gekozen om de eigenschappen van deze modulaire domeinen te bestuderen en om 
de moleculaire omgeving van het eiwit in kaart te brengen.
In Hoofdstuk 2 focusseren we op het mechanisme dat de katalytische activiteit en substraat 
specificiteit van PTP-BL bepaalt. Door de verschillende modulaire eiwitdomeinen van 
PTP-BL transiënt tot expressie te brengen in gekweekte cellen van epitheliale oorsprong 
(MDCK), laten we zien dat aanwezigheid van het FERM domein in het eiwit zowel 
noodzakelijk als voldoende is voor het bepalen van de specifieke subcellulaire lokalisatie 
aan de apicale kant van epitheliale cellen. Verder beschrijven we een cel-sorteringsmethode 
voor het genereren van celpopulaties, die een bepaald eiwit stabiel tot expressie brengen. 
Deze methode is gebaseerd op het gebruik van eiwitten die gefuseerd zijn met het 'Green- 
Fluorescent-Protein' (EGFP) en kan als alternatief dienen indien conventionele 
benaderingen falen. Immuno-electronen microscopie op stabiel expreserende MDCK 
cellen, die met behulp van deze methode zijn verkregen, laten zien dat fusie-eiwitten welke 
het FERM domein van PTP-BL bevatten, zich op een afstand van ongeveer 10 tot 15 
nanometer van de plasma membraan bevinden en verrijkt aanwezig zijn in de villi. Door 
middel van ‘Fluorescence Recovery After Photobleaching’ (FRAP) experimenten laten we 
zien dat deze specifieke subcellulaire lokalisatie dynamisch is en dat complete redistributie 
van PTP-BL in levende cellen plaatsvindt binnen 20 tot 30 minuten. Onze waarnemingen 
suggereren dat deze redistributie wordt gemedieerd via een cytosolische pool en niet door 
laterale beweging. Tenslotte laten we zien dat het katalytische fosfatase domein van PTP- 
BL een homotypische interactie kan aangaan. Samen met de zeer specifieke 
compartimentalizering van het eiwit, zou dit het mechanisme kunnen vormen dat de 
substraatspecificiteit en de katalytische activiteit van PTP-BL bepaalt.
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In Hoofdstuk 3 beschrijven we de experimenten die we uitgevoerd hebben naar aanleiding 
van  observaties gedaan door Sato et al. (Science, 1995, 268:411-415), welke een rol voor 
P TP-B L impliceren als negatieve regulator van Fas-gemedieerde apoptose (gereguleerde 
cel dood). H oewel w e de directe interactie tussen de humane Fas receptor en het tweede 
P D Z m otief in PTP-B L  kunnen bevestigen, blijkt dat deze interactie niet geconserveerd is 
voor de muizen Fas receptor. Verder laten we zien dat overexpressie van PTP-B L in T- 
lymphoma cellijnen geen inhibiterend effect heeft op apoptose v ia  de muizen o f humane 
Fas receptor. Gecombineerd met de duidelijk verschillende w eefsel expressie patronen voor 
P TP-B L en de Fas receptor, sluiten deze bevindingen een centrale rol voor PTP-B L in de 
Fas-gemedieerde celdood signalering uit.
Vervolgens hebben we de gist ‘two-hybrid interaction trap’ gebruikt om eiwitten te 
identificeren die kunnen associëren met de verschillende modules in PTP-BL. Een 
screening naar interacterende eiwitten met de v ijf  PD Z motieven van P TP-B L leidde tot de 
identificatie en karakterisatie van RIL (H oofdstuk 4), een klein adapter eiwit dat bestaat uit 
een N-terminaal P D Z m otief en een C-terminaal L IM  domein. Het RIL L IM  domein is 
belangrijk voor associatie met het P D Z m otief van  RIL z e lf  en met het tweede en vierde 
P D Z m otief in PTP-BL. Immunohistochemie laat zien dat zow el P TP-B L als RIL 
submembraan gelokaliseerd zijn in eptihelia. Verder laten we zien dat het RIL L IM  domein 
gefosforyleerd kan worden op tyrosines, zow el in vitro als in vivo en dat het fosfatase 
domein van  PTP-B L  het gefosforyleerde domein kan defosforyleren in vitro. Onze 
waarnemingen geven indicaties dat er een dubbele PDZ-bindende interface is op het RIL 
L IM  domein en suggereren dat tyrosine fosforylering een rol kan spelen in de regulering 
van L IM -PD Z gemediëerde interacties bij de opbouw van m ulti-eiwit complexen.
In Hoofdstuk 5 beschrijven we een ander voorbeeld van PDZ-gem edieerde interacties met 
een LIM -dom ein bevattend eiwit, genaamd Z R P -1 (zyxin-related protein-1). Het tweede 
van  de drie L IM  domeinen in Z R P -1 is voldoende voor een sterke interactie met RIL. Ook 
het derde L IM  domein interacteert met RIL, echter alleen als de normale C-terminus 
vo lledig  aanw ezig is. Hetzelfde domein in Z R P -1 kan ook interacteren met het tweede PD Z 
m otief van  PTP-BL. R N A  expressieprofielen voor Z R P -1, RIL en PTP-B L laten zien dat er 
overlap is in expressie, met name in weefsels van  epitheliale oorsprong. Verder laten we 
zien dat ZR P -1 gecoprecipiteerd kan worden met PDZ-bevattende segmenten van RIL en 
P TP-B L en dat ZR P -1 en RIL colocalizeren met F-actine-rijke structuren in epitheliale 
cellen.
In Hoofdstuk 6 beschrijven we een nieuw bromodomein-bevattend eiwit, B P75 , waarvan 
de C-terminale helft exclusief interacteert met het eerste P D Z m otief van  PTP-BL. B P75 is 
over de volledige lengte hom oloog aan een hypothetisch eiwit van C.elegans en bevat 
verdere enkele domeinen, die hom oloog zijn  aan een m ogelijk D N A  bindende factor uit 
gist. B P75 komt in vele weefsels voor, met hoge expressie niveaus in thymus, long, lever, 
darm en ruggenmerg. Transiënte expressie studies laten zien dat B P75 voornam elijk in de
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celkern is gelokaliseerd, met uitzondering van de nucleoli, hoewel ook cytoplasmatische 
lokalisatie kan worden waargenomen. In tegenstelling hiermee wordt PTP-BL met name in 
het cytoplasma terug gevonden, met slechts een zeer lage expressie in de celkern. Mogelijk 
reflecteert de hier beschreven moleculaire interactie een mechanisme dat submembrane 
signaaltransductie koppelt met nucleaire gebeurtenissen, echter additionele experimenten 
zijn noodzakelijk om dit concept verder te testen.
In Hoofdstuk 7 beschrijven we de identificatie en karakterisatie van de vertebrate 
ortholoog van de Drosophila tumor suppressor warts, mWTS, welke specifiek interacteert 
met het vierde PDZ motief van PTP-BL. Het korte C-terminale peptide dat flankeert aan het 
voorspelde serine/threonine kinase domein van mWTS, is voldoende voor een sterke 
interactie, zowel in two-hybrid als co-immunoprecipitatie experimenten. Deze interactie 
kan volledig ongedaan gemaakt worden door deletie van de de laatste drie aminozuur 
residuen van mWTS, hetgeen duidelijk een PDZ-gemedieerde interactie met een C- 
terminaal peptide illustreert. Het kinase domein van mWTS is sterk homoloog aan 
verschillende cAMP-afhankelijke serine/threonine kinases, inclusief kinases welke 
betrokken zijn bij Rho-gemedieerde signaaltransductie. Immunodetectie van mWTS eiwit 
toont peptiden van 80 en 175 kDa groot aan en immunohistochemie laat zien dat mWTS, 
net als PTP-BL, voornamelijk aan de apicale kant van epitheliale cellen is gelokaliseerd.
In Hoofdstuk 8, tenslotte, wordt alle informatie met betrekking tot PTP-BL en haar 
moleculaire omgeving, welke beschreven is in dit proefschrift, geplaatst in de context van 
data uit de literatuur en samengevat in een hypothetisch werkmodel. Hierin stellen we voor 
dat de verschillende componenten die PTP-BL binden en omgeven een dynamisch multi- 
eiwit complex vormen dat betrokken is bij het (re-) modelleren van het apicale 
submembrane actine-cytoskelet.
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